Sentence,class,file
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/71/49/cia-12-667.PMC5396840.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/71/49/cia-12-667.PMC5396840.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/25/60/cmar-9-115.PMC5396842.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/25/60/cmar-9-115.PMC5396842.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 115–130Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  115 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S100210Drainage of malignant ascites: patient selection  and perspectives Maciej Stukan Department of Gynecologic   Oncology, Gdynia Oncology Center,   Szpitale Wojewodzkie w Gdyni   Sp.",Non-OADS,/arxiv_data1/oa_pdf/25/60/cmar-9-115.PMC5396842.pdf
"z o.o., Powstania Styczniowego 1, 81-519 Gdynia, PolandTel +48 6 9211 2481 Fax +48 5 8726 0296Email maciej.stukan@gmail.comJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: StukanRunning head recto: Drainage of malignant ascitesDOI: http://dx.doi.org/10.2147/CMAR.S100210",Non-OADS,/arxiv_data1/oa_pdf/25/60/cmar-9-115.PMC5396842.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/25/60/cmar-9-115.PMC5396842.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 130 Stukan 34.,Non-OADS,/arxiv_data1/oa_pdf/25/60/cmar-9-115.PMC5396842.pdf
The GSE33630 gene  expression profile data was downloaded f rom the Gene Expres - sion Omnibus  database ( https://www.ncbi.nlm.nih.gov/geo/ )  from the National Center for Biotechnology Information based  on the platform of the GPL570 Affymetrix Human Genome  U133 Plus 2.0 array.,OADS,/arxiv_data1/oa_pdf/cc/35/ol-13-01-0167.PMC5396846.pdf
"In the present study, the GO functions  and pathways of the selected DEGs were enriched using  DAVID in the GO ( http://www.geneontology.org ) and KEGG  (http://www.genome.ad.jp/kegg/ ) databases with the adjusted  P‑value (q‑value) of <0.05.PPI interaction network construction and selection of  significant modules.",OADS,/arxiv_data1/oa_pdf/cc/35/ol-13-01-0167.PMC5396846.pdf
Cytoscape ( http://www.cytoscape.org/ ) was used  to construct the PPI interaction network (24).,OADS,/arxiv_data1/oa_pdf/cc/35/ol-13-01-0167.PMC5396846.pdf
http://cran.rproject.,Non-OADS,/arxiv_data1/oa_pdf/cc/35/ol-13-01-0167.PMC5396846.pdf
"Then, construction of DCN based on DEGs http://dx.doi.org/10.1016/j.jbo.2017.04.003 Received 15 March 2017; Received in revised form 5 April 2017; Accepted 6 April 2017E-mail address: chenxr689@163.com .Journal of Bone Oncology 7 (2017) 18–22 Available online 08 April 2017 2212-1374/ © 2017 The Author.",Non-OADS,/arxiv_data1/oa_pdf/04/7a/main.PMC5396855.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/7a/main.PMC5396855.pdf
Generation of DCN Cytoscape ( http://cytoscape.org/ ) is an open source software which integrates bio-molecular interactions with high-throughput expression data as well as other molecular states into a uni ﬁed conceptual network [19].,OADS,/arxiv_data1/oa_pdf/04/7a/main.PMC5396855.pdf
"In our study, human GO annotations comprised of 19,003 GO terms covering 18,402 genes were retrieved from the GO consortium ( http://geneontology.org/ ).",OADS,/arxiv_data1/oa_pdf/04/7a/main.PMC5396855.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/c1/main.PMC5396856.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.04.012 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/c1/main.PMC5396856.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2e/0f/main.PMC5396857.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.027 178,OADS,/arxiv_data1/oa_pdf/2e/0f/main.PMC5396857.pdf
"This type of tumor has an aggressive behavior, responsible of venous obstructionas an early manifestation because of its crucial location and the lowresistance of the veins walls to compression [7].T od i ﬀerentiate atrophy from congenital absence of the liver, it is useful to look at http://dx.doi.org/10.1016/j.ejro.2017.04.001 Received 20 March 2017; Accepted 3 April 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ac/7d/main.PMC5396858.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/7d/main.PMC5396858.pdf
"3 (April (2)) (2013) 799 –815, http://dx.doi.org/10.1002/cphy.c120022 .",Non-OADS,/arxiv_data1/oa_pdf/ac/7d/main.PMC5396858.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a3/3b/jpr-10-897.PMC5396922.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a3/3b/jpr-10-897.PMC5396922.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 897–904Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  897 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S133235Postoperative pain and patient-controlled epidural  analgesia-related adverse effects in young and  elderly patients: a retrospective analysis of  2,435 patients Jae Chul Koh Y oung Song So Yeon Kim Sooyeun ParkSeo Hee KoDong Woo Han Department of Anesthesiology and  Pain Medicine, Anesthesia and Pain Research Institute, Y onsei University College of Medicine, Seoul, South KoreaAbstract:  In this retrospective study, data of 2,435 patients who received fentanyl and ropiva- caine-based patient-controlled epidural analgesia (PCEA) for pain relief after elective surgery  under general or spinal anesthesia were reviewed.",Non-OADS,/arxiv_data1/oa_pdf/a3/3b/jpr-10-897.PMC5396922.pdf
"3Correspondence: Dong Woo Han Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, South KoreaTel +82 2 2019 3529Fax +82 2 3463 0940Email hanesth@yuhs.acJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Koh et alRunning head recto: PCEA related adverse effectsDOI: http://dx.doi.org/10.2147/JPR.S133235",Non-OADS,/arxiv_data1/oa_pdf/a3/3b/jpr-10-897.PMC5396922.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/a3/3b/jpr-10-897.PMC5396922.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 904 Koh et al  26.,Non-OADS,/arxiv_data1/oa_pdf/a3/3b/jpr-10-897.PMC5396922.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/30/opth-11-697.PMC5396923.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 697–700Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  697Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12418 3 Management of Duane retraction syndrome  with prismatic glasses ebru Demet aygit1 Murat Kocamaz1 asli inal1 Korhan Fazil1 Osman Bulut Ocak1 serpil akar2 Birsen gokyigit1 1strabismus Department, Beyoglu  eye Training and research hospital,   istanbul, T urkey; 2Ophthalmology  Department, Medicine Faculty,   Baskent University, istanbul, T urkeyPurpose:  To report the results of using prismatic glasses for Duane retraction syndrome (DRS).",Non-OADS,/arxiv_data1/oa_pdf/0d/30/opth-11-697.PMC5396923.pdf
"Some patients Correspondence: ebru Demet aygit strabismus Unit, Beyoglu eye Training  and research hospital, Bereketzade  Cami sokak number 2, Beyoglu,  istanbul, 34421, Turkey Tel +90 533 492 6446 email ebrudemet@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Aygit et al Running head recto: Management of Duane retraction syndrome with prismatic glasses DOI: http://dx.doi.org/10.2147/OPTH.S124183",Non-OADS,/arxiv_data1/oa_pdf/0d/30/opth-11-697.PMC5396923.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0d/30/opth-11-697.PMC5396923.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/30/opth-11-697.PMC5396923.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/0d/30/opth-11-697.PMC5396923.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 111–122Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 111 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S133481A framework for measuring self-management  effectiveness and health care use among pediatric  asthma patients and families Pavani Rangachari College of Allied Health Sciences,   Augusta University, Augusta, GA, USAAbstract: Asthma is associated with substantial health care expenditures, including an estimated  US$56 billion per year in direct costs.",Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
"1–3 A recurring theme in the asthma management  literature is that costly symptoms of asthma, including hospitalization and multiple ED Correspondence: Pavani Rangachari College of Allied Health Sciences, Augusta University, Augusta, GA, USATel +1 706 721 2622email prangachari@augusta.eduJournal name: Journal of Asthma and Allergy Article Designation: ReviewY ear: 2017V olume: 10Running head verso: RangachariRunning head recto: Self-management effectiveness and health care use for pediatric asthmaDOI: http://dx.doi.org/10.2147/JAA.S133481",Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
Available from: http://www.cdc.gov/asthma/pdfs/Asthma_Reimbursement_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
Available from: http://asthmaregionalcouncil.org/wp-content/uploads/2014/02/2010_Investing-in-Best-Practices-for-Asthma-A-Business-Case.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/c7/2a/jaa-10-111.PMC5396924.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ott-10-2139.PMC5396925.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2139–2146OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2139Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12941 3 inhibition of PcsK9 protects against radiation- induced damage of prostate cancer cells si-shun gan* Jian-Qing Ye* lei Wang Fa-Jun Qu chuan-Min chu Yi-Jun Tian Wei Yang Xin-gang cui Department of Urinary surgery  of Third affiliated hospital, second  Military Medical University, shanghai,   People’s republic of china *These authors contributed equally  to this workBackground:  Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protein expressed  primarily in the liver, formerly known to maintain plasma lipid homeostasis by regulating low- density lipoprotein receptor levels, and its exact role in the radioresistance of prostate cancer  (PCa) remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ott-10-2139.PMC5396925.pdf
"It was first described in 2003, when correspondence: Xin-gang cui Department of Urinary surgery of Third  Affiliated Hospital, Second Military  Medical University, no 700, north Moyu  road, Jiading District, shanghai 201805,  People’s republic of china email cuixg2016@sohu.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Gan et al Running head recto: Inhibition of PCSK9 protects radiation-induced damage of PCa cells DOI: http://dx.doi.org/10.2147/OTT.S129413",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ott-10-2139.PMC5396925.pdf
"Available from: http://www.cancerresearchuk.org/ health-professional/cancer-statistics/statistics-by-cancer-type/prostate- cancer#heading-Zer o. Accessed March 9, 2017.",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ott-10-2139.PMC5396925.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ott-10-2139.PMC5396925.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/f1/ott-10-2139.PMC5396925.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijn-12-3023.PMC5396927.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3023–3036International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3023OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13194 9 Targeted delivery of thymosin beta 4 to the  injured myocardium using creKa-conjugated  nanoparticles Zheyong huang1,* Yanan song1,* Zhiqing Pang2 Bo Zhang3 hongbo Yang1 hongtao shi1 Jing chen1 hui gong1,4 Juying Qian1 Junbo ge1,4 1shanghai Institute of cardiovascular  Diseases, Zhongshan hospital, Fudan  University, 2school of Pharmacy,   Fudan University, Key laboratory  of smart Drug Delivery, Ministry  of education, shanghai, 3Institute  of hematology, Union hospital,   Tongji Medical college, huazhong  University of science & T echnology,   Wuhan, hubei, 4Institute of Biomedical  science, Fudan University, shanghai,   People’s republic of china *These authors contributed equally  to this workPurpose:  Thymosin beta 4 (T β4) has multiple beneficial facets for myocardial injury, but its  efficiency is limited by the low local concentration within the infarct.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijn-12-3023.PMC5396927.pdf
"Thymosin beta 4 (T β4), a 43-amino-acid-sequestering peptide expressed in the  embryonic heart, plays a critical role in epicardial development and coronary artery  formation.3,4 Recent studies revealed that T β4 increased cardiac function by promoting  the survival of cardiomyocytes,5–7 activating resident epicardial progenitor cells,4,8–12  and modulating inflammatory responses.13 Being a peptide, T β4 has additional  advantages over conventional growth factors because of its small size, high activity, and  minimized immunogenicity,14 and Tβ4 has been regarded as an attractive therapeutic  agent for MI clinically (NCT00743769).correspondence: Junbo ge shanghai Institute of cardiovascular  Diseases, Zhongshan hospital, Fudan  University, 180 Fenglin road, shanghai  200032, People’s republic of china Tel +86 21 6404 1990 ext 2153 Fax +86 21 6422 3006 email junboge@126.co m  Zhiqing Pang school of Pharmacy, Fudan University,  Key laboratory of smart Drug  Delivery, Ministry of education, 826  Zhangheng road, shanghai 201203,  People’s republic of china email zqpang@fudan.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Huang et al Running head recto: T β4 delivery system for cardiac repair DOI: http://dx.doi.org/10.2147/IJN.S131949",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijn-12-3023.PMC5396927.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijn-12-3023.PMC5396927.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijn-12-3023.PMC5396927.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 171–178International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  171RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S12535 6 New developments in the treatment of hypoactive  sexual desire disorder – a focus on Flibanserin Christopher J Jayne1 Michael J Heard2 Sarah Zubair3 Dustie L Johnson4 1Greater Houston Urogyn,   2Department of Ob/Gyn, St Joseph  Medical Center, The Heard Institute,   3Department of Natural Sciences, The  University of Houston – Downtown,   Houston, 4Reproductive Solutions Inc.,   Midland, TX, USA Abstract:  The objective of the authors is to highlight the historical complexities for the  diagnosis and treatment of hypoactive sexual desire disorder (HSDD) with a focus on Flibanserin.",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
"Flibanserin’s use has the potential to be the cornerstone in treatment  paradigms for premenopausal women with HSDD.Correspondence: Christopher J Jayne St Joseph Medical Center, 1315 St  Joseph Parkway Suite, 1306 Houston,  TX 77002, USA Tel +1 832 924 8788 email cjayne.ghu@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Jayne et al Running head recto: New developments in the treatment of hypoactive sexual desire disorder DOI: http://dx.doi.org/10.2147/IJWH.S125356",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
Available  from: http://www.who.int/reproductivehealth/topics/sexual_health/ sh_definitions/en /.,Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
"Presentation at Meeting of the FDA Advisory Committee for Reproduc - tive Health Drugs; June 18, 2010; Available from: http://www.fda.gov/ downloads/advisorycommittees/committeesmeetingmaterials/drugs/ reproductivehealthdrugsadvisorycommittee/ucm248751.pd f. Published  June 18, 2010.",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
"Available from: https://www.fda.gov/NewsEvents/Newsroom/Pres - sAnnouncements/ucm458734.ht m. Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
Available from: http://www.zestra.com/ about/clinical-evidence/index.php.,Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
"Available from: https://www.avlimil.com/Index.asp x.  Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/6c/ijwh-9-171.PMC5396928.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a0/f9/jbm-8-035.PMC5396929.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a0/f9/jbm-8-035.PMC5396929.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 35–40Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  35 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S134932Prevalence of anemia and its associated factors  among pregnant women receiving antenatal care  at Aymiba Health Center, northwest Ethiopia Fikir Asrie Department of Hematology and  Immunohematology, School of Biomedical and Laboratory Sciences,  College of Medicine and Health Sciences, University of Gondar,  Gondar, EthiopiaIntroduction: Anemia is a global public health problem in both developing and developed  countries; ~1.62 billion people suffer from anemia, and pregnant women are the most susceptible  to it.",Non-OADS,/arxiv_data1/oa_pdf/a0/f9/jbm-8-035.PMC5396929.pdf
"4 It is Correspondence: Fikir Asrie School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, PO Box 196, Gondar, EthiopiaTel +251 91 803 1782Email fikirie2000@gmail.com Journal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: AsrieRunning head recto: Prevalence of anemia and its associated factors among pregnant womenDOI: http://dx.doi.org/10.2147/JBM.S134932",Non-OADS,/arxiv_data1/oa_pdf/a0/f9/jbm-8-035.PMC5396929.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/a0/f9/jbm-8-035.PMC5396929.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 40 Asrie and appreciation to the participants, who voluntarily par - ticipated in this study, as well as the Aymiba Health Center  workers for their unstinted support, guidance, and material for the study.",Non-OADS,/arxiv_data1/oa_pdf/a0/f9/jbm-8-035.PMC5396929.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/0a/ott-10-2077.PMC5396930.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2077–2085OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2077Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13296 4 expression and activity of the urokinase  plasminogen activator system in canine primary  brain tumors John h rossmeisl1–3 Kelli hall-Manning4 John l robertson1,3,5 Jamie n King1,2 rafael V Davalos3,5 Waldemar Debinski3 subbiah elankumaran6,† 1Veterinary and comparative neuro- Oncology laboratory, 2Department of  small animal clinical sciences, 3The  Brain T umor center of excellence,   Wake Forest Baptist Medical center  comprehensive cancer center,   Winston-salem, nc, 4Virginia T ech  animal laboratory services, Virginia- Maryland college of Veterinary  Medicine, 5Department of Biomedical  engineering and Mechanics, Virginia  T ech-Wake Forest University school  of Biomedical engineering and  sciences, Virginia T ech, 6Department of  Biomedical sciences and Pathobiology,   Virginia-Maryland college of  Veterinary Medicine, Blacksburg,   Va, Usa †The authors regret to advise of the  passing of Dr subbiah elankumaran  prior to publicationBackground:  The expression of the urokinase plasminogen activator receptor (uPAR), a  glycosylphosphatidylinositol-anchored protein family member, and the activity of its ligand,  urokinase-type plasminogen activator (uPA), have been associated with the invasive and meta - static potentials of a variety of human brain tumors through their regulation of extracellular  matrix degradation.",Non-OADS,/arxiv_data1/oa_pdf/a0/0a/ott-10-2077.PMC5396930.pdf
"Keywords:  brain tumor, neuro-oncology, dog, animal model, protease, meningioma, glioma Background While the pathophysiology of tumor progression and metastasis is complex, a fundamental  step in the process is the ability of neoplastic cells to initiate proteolysis.1 Degradation of  basement membranes (BM) and the extracellular matrix (ECM) is necessary for cancer  cells to breach natural tissue barriers, migrate, invade, and induce microenvironmental  remodeling and angiogenesis.1–3 A growing body of evidence has indicated that serine  proteases and metalloproteinases are key extracellular proteolytic enzymes that are overex - pressed in many solid tumors of several species, including cats, dogs, and humans.3–6 Activation of plasminogen to form plasmin is a central event in the regulation of  extra- and pericellular proteolysis in both physiological and pathological states, as correspondence: John h rossmeisl Veterinary and comparative neuro- Oncology laboratory, Virginia-Maryland  college of Veterinary Medicine, 225  Duckpond Drive, Mail code 0442,  Virginia Tech, Blacksburg, Va 24061, Usa Tel +1 540 231 3595 Fax +1 540 231 1676 email jrossmei@vt.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Rossmeisl et al Running head recto: uPAR in canine brain tumors DOI: http://dx.doi.org/10.2147/OTT.S132964",Non-OADS,/arxiv_data1/oa_pdf/a0/0a/ott-10-2077.PMC5396930.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/0a/ott-10-2077.PMC5396930.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/0a/ott-10-2077.PMC5396930.pdf
Available from: http://www.vetmed.,Non-OADS,/arxiv_data1/oa_pdf/a0/0a/ott-10-2077.PMC5396930.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/10/ott-10-2147.PMC5396933.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2147–2154OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2147Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12845 1 soluble cytotoxic T -lymphocyte antigen 4:  a favorable predictor in malignant tumors after  therapy Qiqi liu1,* Pingping hu1,* guodong Deng1 Jingxin Zhang2 ning liang1 Jian Xie1 lili Qiao3 hui luo4 Jiandong Zhang1 1Department of radiation Oncology,   Qianfoshan hospital affiliated to  shandong University, shandong  University, Jinan, 2Division of  Oncology, Department of graduate,   Weifang Medical college, Weifang,   3Department of Oncology, The Fifth  People’s hospital of Jinan, Jinan,   4Department of radiation Oncology,   henan cancer hospital affiliated to  Zhengzhou University, Zhengzhou  University, Zhengzhou, henan,   People’s republic of china *These authors contributed equally  to this workPurpose:  Soluble cytotoxic T-lymphocyte antigen 4 (sCTLA-4), one of the isoforms of  CTLA-4, was discovered to be critical in downregulating the negative signal of CTLA-4 in  T-cell responses.",Non-OADS,/arxiv_data1/oa_pdf/ae/10/ott-10-2147.PMC5396933.pdf
"Generally, CTLA-4 is known as an immunoregulatory correspondence: Jiandong Zhang Department of radiation Oncology,  Qianfoshan Hospital Affiliated  to shandong University, Jinan,  People’s republic of china Tel +86 531 135 8312 34 ext 86 email jiandongzhang165@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Liu et al Running head recto: Soluble cytotoxic T-lymphocyte antigen 4 DOI: http://dx.doi.org/10.2147/OTT.S128451",Non-OADS,/arxiv_data1/oa_pdf/ae/10/ott-10-2147.PMC5396933.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ae/10/ott-10-2147.PMC5396933.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/10/ott-10-2147.PMC5396933.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/91/69/opth-11-689.PMC5396934.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 689–696Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  689Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13089 9 hydroxychloroquine for treatment of rheumatoid  arthritis: multifocal electroretinogram and laser  flare-cell photometry study stefano sebastiani Michela Fresina Mauro Cellini emilio C Campos Department of experimental,   Diagnostic, and specialty Medicine,   Ophthalmology service, University  of Bologna, Bologna, italyPurpose:  To evaluate early changes in multifocal electroretinogram (mfERG) and subclinical  aqueous humor flare and cellularity in patients receiving hydroxychloroquine (HCQ) as treat - ment for rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/91/69/opth-11-689.PMC5396934.pdf
"Nowadays it seems possible  that chronic inflammation localized in joint tissues can be the result of autoimmune  reactions that firstly affects synovial tissue, and then may extend to cartilage and  bone tissues.6,7Correspondence: Mauro Cellini Policlinico Sant’Orsola-Malpighi,  Ophthalmology service, University of  Bologna, Via Pelagio Palagi 9, Bologna  40138, italy Tel/fax +39 051 214 2835 email mauro.cellini@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Sebastiani et al Running head recto: mfERG and laser flare-cell photometry in HCQ treatment DOI: http://dx.doi.org/10.2147/OPTH.S130899",Non-OADS,/arxiv_data1/oa_pdf/91/69/opth-11-689.PMC5396934.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/91/69/opth-11-689.PMC5396934.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/69/opth-11-689.PMC5396934.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/9b/rmhp-10-041.PMC5396935.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/9b/rmhp-10-041.PMC5396935.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2017:10 41–48Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 41 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S128277 Environmental arsenic exposure and risk of  diabetes type 2 in Ron Phibun subdistrict,   Nakhon Si Thammarat Province, Thailand:  unmatched and matched case–control  studies Kwanyuen Sripaoraya1,2  Wattasit Siriwong1  Sumol Pavittranon2  Robert S Chapman1 1College of Public Health Sciences,   Chulalongkorn University, Bangkok,   2Medical Life Sciences Institute,   Department of Medical Sciences,   Ministry of Public Health, Nonthaburi,  ThailandBackground: There are inconsistent findings on associations between low-to-moderate level  of arsenic in water and diabetes risk from previous epidemiological reports.",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/rmhp-10-041.PMC5396935.pdf
"5–8  Some limitations from previous studies such as study design, exposure assessment, Correspondence: Kwanyuen Sripaoraya   Medical Life Sciences Institute,  Department of Medical Sciences, Ministry of Public Health, 88/7 Tivanon Road, Muang District, Nonthaburi 11000, Thailand Tel +66 85 044 1977 Email kwanyuen.s@dmsc.mail.go.th Journal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Sripaoraya et alRunning head recto: Arsenic and diabetes risk, Ron Phibun subdistrict, ThailandDOI: http://dx.doi.org/10.2147/RMHP .S128277",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/rmhp-10-041.PMC5396935.pdf
"Risk Management and Healthcare Policy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/rmhp-10-041.PMC5396935.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 48 Sripaoraya et al further research on the relationship between environmental  arsenic and diabetes risk in the study area and elsewhere in Thailand.,Non-OADS,/arxiv_data1/oa_pdf/e6/9b/rmhp-10-041.PMC5396935.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/9f/jpr-10-881.PMC5396938.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/9f/jpr-10-881.PMC5396938.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 881–886Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  881 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S129198An evaluation of two different methods of  coccygectomy in patients with traumatic  coccydynia Hasan Ulas Ogur Firat Seyfettino ğlu Ümit T uhanio ğlu Hakan CicekSefa Zohre Department of Trauma and  Orthopedics, Adana Numune Training and Research Hospital, Adana, T urkeyPurpose: The aim of this study was to evaluate the results of partial and total coccyx excisions  in patients with traumatic coccydynia resistant to conservative treatment.",Non-OADS,/arxiv_data1/oa_pdf/fc/9f/jpr-10-881.PMC5396938.pdf
"3,4Correspondence: Firat Seyfettino ğlu Department of Trauma and Orthopedics,  Adana Numune Training and Educational Hospital, Serinevler mah, Ege Bagtur Bulvarı, Yüreğir/Adana, TurkeyTel +90 532 716 9721Fax +90 322 355 0155Email firatseyf@yahoo.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Ogur et alRunning head recto: Evaluation of coccygectomy in patients with traumatic coccydyniaDOI: http://dx.doi.org/10.2147/JPR.S129198",Non-OADS,/arxiv_data1/oa_pdf/fc/9f/jpr-10-881.PMC5396938.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/fc/9f/jpr-10-881.PMC5396938.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 886 Ogur et al unnecessary to be too insistent on conservative treatment.,Non-OADS,/arxiv_data1/oa_pdf/fc/9f/jpr-10-881.PMC5396938.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/ff/ijn-12-2979.PMC5396939.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2979–2993International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2979OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13300 9 synthesis of magnetic molecularly imprinted  polymers with excellent biocompatibility for the  selective separation and inhibition of testosterone  in prostate cancer cells Xiaoshuang Tang1,2 Feng li1 Jing Jia1 chao Yang1 Wei liu1 Ben Jin1 Xinyang Wang1 ruixia gao3 Dalin he1,4 Peng guo1,4 1Department of Urology, The First  affiliated hospital of Xi’an Jiaotong  University, 2Department of Urology,   The second affiliated hospital of  Xi’an Jiaotong University, 3Institute  of analytical science, school of  science, Xi’an Jiaotong University,   4Key laboratory for Tumor Precision  Medicine of shaanxi Province, Xi’an,   shaanxi, People’s republic of chinaPurpose:  Androgen plays an important role in the progression of prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/4c/ff/ijn-12-2979.PMC5396939.pdf
"TSTO is produced mainly  in ovaries, testes, and adrenal cortex, which could maintain muscle strength and correspondence: Peng guo Department of Urology, The First  Affiliated Hospital of Xi’an Jiaotong  University, 277 Yan-Ta West road,  Xi’an, shaanxi 710061, People’s  republic of china Tel +86 298 532 3661 email guopeng661@mail.xjtu.edu.c n ruixia gao Institute of analytical science, school of  science, Xi’an Jiaotong University, Xi’an  710049, People’s republic of china Tel +86 298 265 5399 email ruixiagao@mail.xjtu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Tang et al Running head recto: Fe3O4@TSTO-MIPs for inhibition of TSTO in prostate cancer DOI: http://dx.doi.org/10.2147/IJN.S133009",Non-OADS,/arxiv_data1/oa_pdf/4c/ff/ijn-12-2979.PMC5396939.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4c/ff/ijn-12-2979.PMC5396939.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/ff/ijn-12-2979.PMC5396939.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 179–188International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  179OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12018 4 Factors influencing maternal mortality among  rural communities in southwestern Nigeria Dominic ezinwa azuh1 akunna ebere azuh2 emeka Joshua Iweala3 Davies Adeloye1 Moses akanbi1 raphael c Mordi4 1Department of Demography and  social statistics, 2Department of  Estate Management, 3Biochemistry and  Molecular Biology Unit, Department  of Biological Sciences, 4Department of  Chemistry, Covenant University, Ota,   Ogun State, NigeriaBackground:  Maternal mortality and morbidity reflect the status of population health and  quality of life across nations.",Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
edu.n g Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Azuh et al Running head recto: Factors influencing maternal mortality in southwestern Nigeria DOI: http://dx.doi.org/10.2147/IJWH.S120184,Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
Available from: https://www.unfpa.org/ sites/default/files/event-pdf/icpd_eng_2.pd f.   6.,OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
Available from: http://www.un.org/ en/events/pastevents/millennium_summit.shtml .,Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
Available from: http://www.unfpa.,Non-OADS,/arxiv_data1/oa_pdf/18/a1/ijwh-9-179.PMC5396940.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2017:4 59–69Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 59 CliniC al Trial repor T open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S122507 open-label phase ii clinical trial in 75 patients  with advanced hepatocellular carcinoma receiving  daily dose of tableted liver cancer vaccine,  hepcortespenlisimut-l Marina G Tarakanovskaya1 Jigjidsuren Chinburen2 purev Batchuluun2 Chogsom Munkhzaya2 Genden purevsuren2 Dorjiin Dandii3 Tsogkhuu Hulan3 Dandii oyungerel4 Galyna a Kutsyna5 alan a reid6 Vika Borisova6 allen i Bain7 Vichai Jirathitikal7 aldar S Bourinbaiar6–8 1ekomed llC, 2national Cancer  Center, 3Monserum llC, 4national  Center for public Health, Ulaanbaatar,   Mongolia; 5Department of infectious  Diseases, luhansk State Medical  University, luhansk, Ukraine;   6immunitor China ltd, Beijing, people’s  republic of China; 7immunitor inc,   Vancouver, BC, Canada; 8immunitor  llC, Ulaanbaatar, MongoliaBackground: An increasing number of studies is now devoted to immunotherapy of cancer.",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
"Unfortunately, Correspondence: aldar S Bourinbaiar immunitor llC, 25 peace avenue, Ulaanbaatar 13381, Mongoliaemail aldar@immunitor.comJournal name: Journal of Hepatocellular Carcinoma Article Designation: Clinical Trial ReportY ear: 2017V olume: 4Running head verso: Tarakanovskaya et alRunning head recto: Hepcortespenlisimut-L for advanced HCCDOI: http://dx.doi.org/10.2147/JHC.S122507",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
The  abstract of this poster  presentation was  published online in  the Journal for Immunotherapy of Cancer 2015;3(Suppl 2):  P200 and can be found in the following link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649454/.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
"Journal of Hepatocellular Carcinoma 2017:4submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 69 Hepcortespenlisimut-l for advanced HCC  36.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
Available from https://www.statnews.,OADS,/arxiv_data1/oa_pdf/3d/ca/jhc-4-059.PMC5396941.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/ab/ijn-12-2995.PMC5396942.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2995–3007International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2995OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12877 5 antibacterial activity and cytocompatibility of  an implant coating consisting of TiO2 nanotubes  combined with a gl13K antimicrobial peptide Tao li1,2 Na Wang1 su chen1 ran lu1 hongyi li2 Zhenting Zhang1 1Department of Prosthodontics,   school of stomatology, capital  Medical University, 2Key laboratory of  advanced Functional Materials, school  of Materials and engineering, Beijing  University of T echnology.",Non-OADS,/arxiv_data1/oa_pdf/65/ab/ijn-12-2995.PMC5396942.pdf
"100,  Beijing 100124, People’s republic of  china Tel +86 10 6739 1101 Fax +86 10 6739 1101 email lhy06@bjut.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: GL13K antimicrobial peptide on TiO2 nanotube-coated titanium implants DOI: http://dx.doi.org/10.2147/IJN.S128775",Non-OADS,/arxiv_data1/oa_pdf/65/ab/ijn-12-2995.PMC5396942.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/65/ab/ijn-12-2995.PMC5396942.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/ab/ijn-12-2995.PMC5396942.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/1e/ijn-12-2941.PMC5396944.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2941–2950International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2941OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12523 1 anti-FgFr1 aptamer-tagged superparamagnetic  conjugates for anticancer hyperthermia therapy Przemysław M Jurek* Konrad Zabłocki* Urszula Waśko Maciej P Mazurek Jacek Otlewski Filip Jeleń Department of Protein engineering,   Faculty of Biotechnology, University  of Wrocław, Poland *These authors contributed equally  to this workAbstract:  Compounds that recognize and strongly bind to molecular targets are one of  the cornerstones of modern pharmaceutics.",Non-OADS,/arxiv_data1/oa_pdf/e2/1e/ijn-12-2941.PMC5396944.pdf
"They are recognized by FGFRs, a family of transmembrane receptors Correspondence: Filip Jeleń Faculty of Biotechnology, University  of Wrocław, Fryderyka Joliot-Curie 14a,  50-383 Wrocław, Poland email filip.jelen@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Jurek et al Running head recto: Targeted anticancer hyperthermia therapy using aptamers  DOI: http://dx.doi.org/10.2147/IJN.S125231",OADS,/arxiv_data1/oa_pdf/e2/1e/ijn-12-2941.PMC5396944.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/1e/ijn-12-2941.PMC5396944.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/1e/ijn-12-2941.PMC5396944.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b4/71/ijgm-10-125.PMC5396945.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b4/71/ijgm-10-125.PMC5396945.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 125–129International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 125 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S129829Hypothermia due to limbic system involvement  and longitudinal myelitis in a case of Japanese  encephalitis: a case report from India Santhosh Narayanan1  NK Thulaseedharan1  Gomathy Subramaniam2  Geetha Panarkandy1  VK Shameer1  Arathi Narayanan1 1Department of General Medicine,   2Department of Radiodiagnosis,   Government Medical College,   Kozhikode, Kerala, IndiaAbstract:  Japanese encephalitis (JE) is an infectious encephalitis prevalent in Asia.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/ijgm-10-125.PMC5396945.pdf
"Muscle groups in all  Correspondence: Santhosh Narayanan   Department of General Medicine,  Government Medical College, Kozhikode, Kerala 673008, IndiaTel +91 989 565 8833Email drsanthosh4@gmail.comJournal name: International Journal of General Medicine Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Narayanan et alRunning head recto: Hypothermia and longitudinal myelitis in Japanese encephalitisDOI: http://dx.doi.org/10.2147/IJGM.S129829",Non-OADS,/arxiv_data1/oa_pdf/b4/71/ijgm-10-125.PMC5396945.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/ijgm-10-125.PMC5396945.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 129 Hypothermia and longitudinal myelitis in Japanese encephalitis,Non-OADS,/arxiv_data1/oa_pdf/b4/71/ijgm-10-125.PMC5396945.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/46/61/nss-9-109.PMC5396946.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/46/61/nss-9-109.PMC5396946.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 109–115Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  109 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S128513Sleep disturbance linked to suicidal ideation   in postural orthostatic tachycardia syndrome Cathy Lynn Pederson1 Jill Blettner Brook2 1Department of Biology, Wittenberg  University, Springfield, OH, USA;   2PatientsCount, Anchorage, AK, USAObjective: We investigated the prevalence of suicidal ideation in relationship with symptoms  of sleep disruption in people with postural orthostatic tachycardia syndrome (POTS).",Non-OADS,/arxiv_data1/oa_pdf/46/61/nss-9-109.PMC5396946.pdf
"1 Common symptoms include chronic fatigue and pain, as well  as diminished quality of life.1–3 POTS is a heterogeneous disorder,4 and includes  symptoms such as neuropathic pain,1 poor sleep efficiency,5 headaches, palpitations,  tremors, gastrointestinal disturbance, facial flushing,6 and orthostatic symptoms like  dizziness, lightheadedness, and syncope.7 Many people have developed POTS after  a viral infection, surgery, motor vehicle accident, concussion, or during pregnancy.8,9  Many with POTS report sleep disruption at night,6,10–12 including poor sleep effi- ciency and increased sleep fragmentation.5 Activation of the sympathetic nervous  system may explain sleep disruption in some POTS patients,5,13 while sleep disruption  could also be due to chronic pain and hyperarousal.11,14 In polysomnography studies,  people with POTS have a reduction in the heart rate variability for both low frequency Correspondence: Cathy Pederson Department of Biology, Wittenberg University, PO Box 720, Springfield,  OH 45501, USATel +1 937 327 6481Email: cpederson@wittenberg.eduJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Pederson and Blettner BrookRunning head recto: Sleep and suicidal ideation linked in POTSDOI: http://dx.doi.org/10.2147/NSS.S128513",Non-OADS,/arxiv_data1/oa_pdf/46/61/nss-9-109.PMC5396946.pdf
2016; https://www.cdc.gov/nchs/products/data-briefs/db241.htm.,OADS,/arxiv_data1/oa_pdf/46/61/nss-9-109.PMC5396946.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/46/61/nss-9-109.PMC5396946.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/20/ott-10-2097.PMC5396947.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2097–2106OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2097Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12400 8 Targeting the PD-1 pathway in pediatric solid  tumors and brain tumors Lars M wagner1 val R Adams2 1Division of Pediatric Hematology/ Oncology, 2Department of Pharmacy  Practice and Science, University of  Kentucky, Lexington, KY, USAAbstract:  While remarkable advances have been made in the treatment of pediatric leukemia  over the past decades, new therapies are needed for children with advanced solid tumors and  high-grade brain tumors who fail standard chemotherapy regimens.",Non-OADS,/arxiv_data1/oa_pdf/3d/20/ott-10-2097.PMC5396947.pdf
"Given this success, and  the recent expansion of immunotherapies for adult cancers detailed below, attention Correspondence: Lars M wagner Division of Pediatric Hematology/ Oncology, Office C-453, 800 Rose Street,  Lexington, KY 40536, USA Tel +1 859 218 0931 Fax +1 859 257 1888 email lars.wagner@uky.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Wagner and Adams Running head recto: Targeting the PD-1 pathway in pediatric solid tumors and brain tumors DOI: http://dx.doi.org/10.2147/OTT.S124008",Non-OADS,/arxiv_data1/oa_pdf/3d/20/ott-10-2097.PMC5396947.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3d/20/ott-10-2097.PMC5396947.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/ott-10-2097.PMC5396947.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/a0/ndt-13-1081.PMC5396949.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1081–1088Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1081OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13114 4 T umor necrosis factor- α and -β genetic  polymorphisms as a risk factor in saudi patients  with schizophrenia saeed Kadasah1 Misbahul arfin2 sadaf rizvi2 Mohammed al-asmari2 abdulrahman al-asmari2 1Department of Psychiatry, 2Division  of Molecular Biology & genetics,   scientific research center,   Prince sultan Military Medical city,   riyadh, saudi arabiaBackground:  Schizophrenia is one of the most common devastating psychiatric disorders  that negatively affects the quality of life and psychosocial functions.",Non-OADS,/arxiv_data1/oa_pdf/c0/a0/ndt-13-1081.PMC5396949.pdf
"Keywords:  schizophrenia, tumor necrosis factor, gene polymorphism, genetics, psychiatric  disorder Introduction Schizophrenia is one of the most common devastating psychiatric disorders with a  lifetime morbidity risk of 0.5%–2.7% and heritability estimated at up to 80%.1–3 The  genetic, neurodevelopmental, neurotransmitter, and neuroimmunological hypotheses  have been suggested to explain the etiopathogenesis of schizophrenia.4,5 It involves the  interplay of complex polygenic influences and environmental risk factors operating  on brain maturational processes.correspondence: abdulrahman al-asmari Scientific Research Centre, Prince Sultan  Military Medical city, PO Box 7897,  riyadh 11159, saudi arabia email abdulrahman.alasmari@gmail.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Kadasah et al Running head recto: TNF gene polymorphism in schizophrenia patients DOI: http://dx.doi.org/10.2147/NDT.S131144",Non-OADS,/arxiv_data1/oa_pdf/c0/a0/ndt-13-1081.PMC5396949.pdf
Power  was calculated online ( http://www.stat.ubc.ca/ ~rollin/stats/ ssize/caco.htm l).,OADS,/arxiv_data1/oa_pdf/c0/a0/ndt-13-1081.PMC5396949.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c0/a0/ndt-13-1081.PMC5396949.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/a0/ndt-13-1081.PMC5396949.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 855–865Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  855 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S124859Mechanical factors and vitamin D deficiency in  schoolchildren with low back pain: biochemical  and cross-sectional survey analysis Ahmad H Alghadir1  Sami A Gabr1,2  Einas S Al-Eisa1 1Rehabilitation Research Chair,   College of Applied Medical Sciences,   King Saud University, Riyadh, Kingdom of Saudi Arabia;  2Department of  Anatomy, Faculty of Medicine,  Mansoura University, Mansoura, EgyptObjective: This study was designed to evaluate the role of vitamin D, muscle fatigue  biomarkers,  and mechanical factors in the progression of low back pain (LBP) in schoolchildren.",Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
"2–6 In a meta-analysis study, a higher prevalence rate of LBP was reported in children  and adolescents compared with old population and a higher recurrence of LBP and the Correspondence: Sami A Gabr   Rehabilitation Research Chair, College  of Applied Medical Sciences, King Saud University, PO Box 10219, Riyadh 11433, Kingdom of Saudi Arabia   Tel +966 5 6206 0018   Fax +966 1 469 8541   Email sgabr@ksu.edu.saJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Alghadir et alRunning head recto: Mechanical factors and vitamin D deficiency in children with low back painDOI: http://dx.doi.org/10.2147/JPR.S124859",Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
Available from: http://pain-topics.org/pdf/vitamind-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
Available from: https://www.gov.uk/government/publications/sacn-update-on-vitamin-d-2007.,Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 865 Mechanical factors and vitamin D deficiency in children with low back pain 102.,Non-OADS,/arxiv_data1/oa_pdf/88/6b/jpr-10-855.PMC5396951.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/12/ott-10-2127.PMC5396954.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2127–2137OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2127Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12787 2 mir-762 can negatively regulate menin in ovarian  cancer rui hou1 Zhuo Yang1 shiZhuo Wang1 DaMing chu1 Qifang liu1 Jia liu1 luo Jiang2 1Department of Obstetrics and  gynecology, 2Department of  Ultrasound, shengjing hospital  affiliated to china Medical University,   shenyang, People’s republic of chinaAbstract:  Ovarian cancer accounts for the major part of the mortality attributable to female  reproductive system malignant tumors worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c2/12/ott-10-2127.PMC5396954.pdf
"In ovarian cancer, numerous miRNAs have been suggested to have functional correspondence: luo Jiang Department of Ultrasound, shengjing  Hospital Affiliated to China Medical  University, 36 sanhao street,  heping District, shenyang 110004,  People’s republic of china Tel/fax +86 24 96615 33111 email jiangluo2016@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Hou et al Running head recto: miR-762 in ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S127872",Non-OADS,/arxiv_data1/oa_pdf/c2/12/ott-10-2127.PMC5396954.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/12/ott-10-2127.PMC5396954.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/12/ott-10-2127.PMC5396954.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/75/ndt-13-1071.PMC5396959.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1071–1080Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1071OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12808 6 are psychiatric comorbidities and associated  cognitive functions related to treatment response  to methylphenidate in boys with attention-deficit/ hyperactivity disorder?",Non-OADS,/arxiv_data1/oa_pdf/02/75/ndt-13-1071.PMC5396959.pdf
"It is among the most prevalent neuropsychiatric disorders affecting  5%–10% of children worldwide.1 Despite that existing stimulant treatment (primarily  by methylphenidate, MPH) falls short of a cure to eradicate ADHD, it remains the correspondence: Patrick Wl leung Department of Psychology, The chinese  University of Hong Kong, 3/F, Sino  Building, shatin, hong Kong, People’s  republic of china Tel +852 3943 6502 Fax +852 2603 5019 email pleung@cuhk.edu.h k Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chan et al Running head recto: Treatment response to MPH in ADHD children DOI: http://dx.doi.org/10.2147/NDT.S128086",Non-OADS,/arxiv_data1/oa_pdf/02/75/ndt-13-1071.PMC5396959.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/02/75/ndt-13-1071.PMC5396959.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/02/75/ndt-13-1071.PMC5396959.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/75/ndt-13-1071.PMC5396959.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/ott-10-2115.PMC5396961.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2115–2126OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2115Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13048 1 a blockade of PD-l1 produced antitumor and  antimetastatic effects in an orthotopic mouse  pancreatic cancer model via the Pi3K/akt/mTOr  signaling pathway lei Zhao1 cheng li2 Fei liu2 Y onghong Zhao2 Jun liu2 Ye hua1 Jinyang liu1 Jiapeng huang1 chunlin ge1 1Department of Pancreatic and Biliary  surgery, The First hospital of china  Medical University, 2Department of  immunology, college of Basic Medical  sciences, china Medical University,   shenyang, liaoning, People’s republic  of chinaBackground:  Pancreatic cancer is one of the most aggressive and intractable malignant tumors,  and most deaths from pancreatic cancer are related to metastases.",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/ott-10-2115.PMC5396961.pdf
"Keywords:  PD-L1 blockade, pancreatic cancer, spontaneous liver metastasis, PI3K/Akt/mTOR  pathway, PTEN, MMP2, MMP9 Introduction Pancreatic cancer is one of the most intractable and highly malignant tumors.1 Most  patients with pancreatic cancer are asymptomatic until they are diagnosed at an  advanced stage of their disease.2 Although great progress has been made in treating  pancreatic cancer with surgery, chemotherapy, radiotherapy, and combined treatment, correspondence: chunlin ge Department of Pancreatic and Biliary  surgery, The First hospital of china  Medical University, shenyang, liaoning,  110001, People’s republic of china Tel +86 139 9830 3666 email gechunlin@139.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhao et al Running head recto: Blockade of PD-L1 suppresses growth and metastasis of pancreatic cancer DOI: http://dx.doi.org/10.2147/OTT.S130481",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/ott-10-2115.PMC5396961.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/ott-10-2115.PMC5396961.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/ott-10-2115.PMC5396961.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e8/75/ott-10-2107.PMC5396962.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2107–2114OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2107Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13243 2 gastric cancer, nutritional status, and outcome Xuechao liu1,2,* haibo Qiu1,2,* Pengfei Kong1,2,* Zhiwei Zhou1,2 Xiaowei sun1,2 1state Key laboratory of Oncology in  south china, collaborative innovation  center for cancer Medicine,   2Department of gastric surgery, sun  Yat-sen University cancer center,   guangzhou, People’s republic of  china *These authors contributed equally  to this workBackground:  We aim to investigate the prognostic value of several nutrition-based indices,  including the prognostic nutritional index (PNI), performance status, body mass index, serum  albumin, and preoperative body weight loss in patients with gastric cancer (GC).",Non-OADS,/arxiv_data1/oa_pdf/e8/75/ott-10-2107.PMC5396962.pdf
"Nutritional status has been closely linked to cancer mortality.7,8 Recently, studies  have proved that several nutrition-based indices, such as the prognostic nutritional  index (PNI), body mass index (BMI), serum albumin, and preoperative body weight  loss, have important prognostic value across varied malignancies, including GC.9–12  A study of 1,249 cases from Chen et al found that a low BMI might be associated  with poorer survival among patients with stage III–IV GC.13 Hinata et al reported  that impaired performance status was associated with an unfavorable prognosis in  patients with urothelial carcinoma of the bladder who underwent radical cystectomy.14 correspondence: Xiaowei sun Department of gastric surgery, sun  Yat-sen University cancer center,  651 east Dongfeng road, guangzhou  510060, guangdong Province,  People’s republic of china Fax +86 20 8734 3123 email sunxw@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Liu et al Running head recto: Prognostic value of nutrition-based indices DOI: http://dx.doi.org/10.2147/OTT.S132432",Non-OADS,/arxiv_data1/oa_pdf/e8/75/ott-10-2107.PMC5396962.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/75/ott-10-2107.PMC5396962.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/75/ott-10-2107.PMC5396962.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/58/ijn-12-2951.PMC5396965.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2951–2956International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2951OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13444 1 a strategy to minimize the sensing voltage drift  error in a transistor biosensor with a nanoscale  sensing gate hyun Woo son1,* Minhong Jeun1,* Jaewon choi1,2 Kwan hyi lee1,2 1center for Biomaterials, Biomedical  research Institute, Korea Institute  of science and T echnology, seoul,   2Department of Biomedical  engineering, Korea University of  science and T echnology, Daejeon,   republic of Korea *These authors contributed equally  to this workAbstract:  An ion-sensitive field-effect transistor (ISFET) biosensor is thought to be the center  of the next era of health diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/f1/58/ijn-12-2951.PMC5396965.pdf
"When the biosensor applies highly reactive nanowires and thin films correspondence: Kwan hyi lee center for Biomaterials, Biomedical  research Institute, Korea Institute  of science and Technology,  5 hwarangno 14-gil, seongbuk-gu,  seoul 02792, republic of Korea Tel +82 2 958 6804 Fax +82 2 958 5308 email kwanhyi@kist.re.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Son et al Running head recto: Minimizing the sensing voltage drift error in a nanoscale transistor sensing gate DOI: http://dx.doi.org/10.2147/IJN.S134441",Non-OADS,/arxiv_data1/oa_pdf/f1/58/ijn-12-2951.PMC5396965.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f1/58/ijn-12-2951.PMC5396965.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/58/ijn-12-2951.PMC5396965.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/5c/ijn-12-3009.PMC5396966.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3009–3021International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3009OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13012 5 Tat-functionalized liposomes for the treatment  of meningitis: an in vitro study caterina Bartomeu  garcia1,* Di shi2,* Thomas J Webster2 1Department of chemical engineering,   Universitat rovira i Virgili, Tarragona,   spain; 2Department of chemical  engineering, Northeastern University,   Boston, M a, Usa *These authors contributed equally  to this workAbstract:  Bacterial meningitis has become a global concern, because of the emergence of  antibiotic-resistant bacteria.",Non-OADS,/arxiv_data1/oa_pdf/86/5c/ijn-12-3009.PMC5396966.pdf
"Polymers, antimicrobial peptides, correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, 360 huntington  avenue, Boston, Ma 02115, Usa Tel +1 617 373 6585 email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bartomeu Garcia et al Running head recto: Tat-functionalized liposomes in meningitis DOI: http://dx.doi.org/10.2147/IJN.S13012 5",Non-OADS,/arxiv_data1/oa_pdf/86/5c/ijn-12-3009.PMC5396966.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/86/5c/ijn-12-3009.PMC5396966.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/5c/ijn-12-3009.PMC5396966.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b2/b8/ijn-12-2733.PMC5396969.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2733–2748International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2733OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12752 8 Magnetic and ph dual-responsive mesoporous  silica nanocomposites for effective and low-toxic  photodynamic therapy Jieqiong Zhan1,2,* Zhiqiang Ma2,* Dan Wang3 Xinfang li2 Xiangui li2 lijing le2 anfeng Kang2 Pengwei hu1 lan she2 Feng Yang1,2 1Department of Pharmacy, hebei  North University, Zhangjiakou, hebei,   2Department of Inorganic chemistry,   school of Pharmacy, 3Department of  Obstetrics and gynecology, shanghai  changzheng hospital, second Military  Medical University, shanghai, People’s  republic of china *These authors contributed equally  to this workAbstract:  Nonspecific targeting, large doses and phototoxicity severely hamper the clinical  effect of photodynamic therapy (PDT).",Non-OADS,/arxiv_data1/oa_pdf/b2/b8/ijn-12-2733.PMC5396969.pdf
"However, most photosensitizers such as nonspecific correspondence: Feng Yang Department of Inorganic chemistry,  school of Pharmacy, second Military  Medical University, 325 guohe  road, shanghai 200433, People’s  republic of china Tel +86 21 8187 1218 email yangfeng1008@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhan et al Running head recto: Magnetic and pH dual-responsive mesoporous silica nanocomposites DOI: http://dx.doi.org/10.2147/IJN.S127528",Non-OADS,/arxiv_data1/oa_pdf/b2/b8/ijn-12-2733.PMC5396969.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b2/b8/ijn-12-2733.PMC5396969.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/b8/ijn-12-2733.PMC5396969.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a7/39/jpr-10-887.PMC5396972.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a7/39/jpr-10-887.PMC5396972.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 887–895Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  887 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S122918Thoracic epidural analgesia reduces myocardial  injury in ischemic patients undergoing major  abdominal cancer surgery Mohamad Farouk  Mohamad1 Montaser A Mohammad1 Diab F Hetta1 Eman Hasan Ahmed2 Ahmed A Obiedallah3 Alaa Ali M Elzohry1 1Department of Anesthesia, ICU and  Pain Relief, 2Department of Clinical  Pathology, South Egypt Cancer  Institute, 3Department of Internal  Medicine, Faculty of Medicine, Assiut University, Arab Republic of EgyptBackground and objectives: Major abdominal cancer surgeries are associated with significant  perioperative mortality and morbidity due to myocardial ischemia and infarction.",Non-OADS,/arxiv_data1/oa_pdf/a7/39/jpr-10-887.PMC5396972.pdf
"Consequently, postoperative cardiovascular complications are expected to increase, 1 and perioperative acute myocardial infarction (AMI) has become a major  health concern.2,3Correspondence: Mohamad  Farouk MohamadAssuit University, South Egypt Cancer Institute, Anesthesia and Pain Management Department, 71515, El-Methaque street, Assuit city, Arab Republic of EgyptTel +20 88 2357007; +20 2 3748 4536 Fax +20 88 2354130; +20 2 3748 7704 Email mfaroukma@gmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Mohamad et alRunning head recto: Effect of perioperative PCEA on  ischemic cardiac injuryDOI: http://dx.doi.org/10.2147/JPR.S122918",Non-OADS,/arxiv_data1/oa_pdf/a7/39/jpr-10-887.PMC5396972.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/a7/39/jpr-10-887.PMC5396972.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 895 Effect of perioperative PCEA on  ischemic cardiac injury 22.,Non-OADS,/arxiv_data1/oa_pdf/a7/39/jpr-10-887.PMC5396972.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/ijn-12-2957.PMC5396976.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2957–2978International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2957RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S12768 3 A review of drug delivery systems based on  nanotechnology and green chemistry: green  nanomedicine Hossein Jahangirian1 ensieh Ghasemian  Lemraski2 Thomas J webster1 Roshanak Rafiee- Moghaddam3 Yadollah Abdollahi4 1Department of Chemical engineering,   Northeastern University, Boston,   MA, USA; 2Department of Chemistry,   Faculty of Science, Ilam University,   Ilam, Iran; 3School of Chemical  Sciences and Food T echnology, Faculty  of Science and T echnology, Universiti  Kebangsaan Malaysia, Selangor,   4Department of electrical engineering,   Faculty of engineering, University of  Malaysia, Kuala Lumpur, MalaysiaAbstract:  This review discusses the impact of green and environmentally safe chemistry  on the field of nanotechnology-driven drug delivery in a new field termed “green nanomedi - cine”.",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/ijn-12-2957.PMC5396976.pdf
"Moreover,  although the original intended use of nanomedicine was to improve human health,  NPs can be purposely misused for other intentions as many researchers have been  reporting due to soiling or maximizing the toxicity of the NPs.4,5 Too often, as well,  NP or nanomaterial (such as carbon nanotubes [CNTs]) synthesis techniques involve Correspondence: Hossein Jahangirian Department of Chemical engineering, 313  Snell engineering Center, Northeastern  University, 360 Huntington Avenue,  Boston, MA 02115, USA Tel +1 9821 4463 2143 email kamran.jahangirian@gmail.co mJournal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Jahangirian et al Running head recto: Drug delivery systems based on nanotechnology and green chemistry DOI: http://dx.doi.org/10.2147/IJN.S127683",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/ijn-12-2957.PMC5396976.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/ijn-12-2957.PMC5396976.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/ijn-12-2957.PMC5396976.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 867–880Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  867 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S131779The efficacy and safety of S-flurbiprofen plaster  in the treatment of knee osteoarthritis: a phase II,  randomized, double-blind, placebo-controlled,  dose-finding study Ikuko Yataba1 Noboru Otsuka1 Isao Matsushita1 Hideo Matsumoto2 Yuichi Hoshino3 1Taisho Pharmaceutical Co, Ltd,   2Institute for Integrated Sports  Medicine, School of Medicine, Keio  University, T okyo, 3Department of  Orthopedics Surgery, School of Medicine, Jichi Medical University,  T ochigi, JapanBackground: Nonsteroidal anti-inflammatory drug (NSAID) patches are convenient for use and  show much less gastrointestinal side effects than oral NSAIDs, whereas its percutaneous absorp- tion is not sufficient for the expression of clinical efficacy at satisfactory level.",Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
"Keywords:  nonsteroidal anti-inflammatory drugs, patch, double-blind, visual analog scale,  topical, optimal dose,  randomized controlled trial Introduction Osteoarthritis (OA) is a disease characterized by chronic pain, inflammation, and  impaired overall functioning, significantly affecting the quality of life.1,2 Incidence of  OA is increasing by rising aged population, and it is highly prevalent.3,4 Among the pharmacological treatments for symptomatic OA, nonsteroidal anti- inflammatory drugs (NSAIDs) are widely used.5–7 However, NSAIDs are known to have  a risk of adverse reactions related to class effects of NSAIDs such as  gastrointestinal Correspondence: Noboru Otsuka Taisho Pharmaceutical Co, Ltd, 3-24-1 Takada, Toshima-ku, Tokyo 170-8633, JapanTel +81 3 3985 1402Fax +81 3 3985 0716Email n-otsuka@so.taisho.co.jp Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Y ataba et alRunning head recto: Efficacy of new NSAID plaster on osteoarthritisDOI: http://dx.doi.org/10.2147/JPR.S131779",Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
Available from: http://www.who.int/medicines/areas/priority_medicines/BP6_12Osteo.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
Avail-able from: http://www.aaos.org/cc_files/aaosorg/research/guidelines/treatmentofosteoarthritisofthekneeguideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 880 Yataba et al  7.,Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
Available from: https://www.nice.org.uk/guidance/cg177/evidence/full-guideline-191761309.,Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInforma - tion/Guidances/UCM071577.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/a1/jpr-10-867.PMC5396977.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2087–2095OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2087Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S13028 5 Can involved-field irradiation replace elective nodal  irradiation in chemoradiotherapy for esophageal  cancer?",Non-OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
"Although involved-field irradiation (IFI) is performed  for most cases of non-small cell lung cancer and Hodgkin’s lymphoma, relatively few  studies have reported the results of IFI for esophageal cancer.7,8 Of these, Zhao et al9  Correspondence: Xudong Hu Department of Radiation Oncology,  Shandong Cancer Hospital Affiliated  to Shandong University, No 440, Jiyan  Road, Jinan 250117, Shandong Province,  People’s Republic of China Tel +86 531 8 6762 6932 Fax +86 531 8 6762 6931 email drhuxudong@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Wang et al Running head recto: Involved-field irradiation for esophageal cancer DOI: http://dx.doi.org/10.2147/OTT.S130285",Non-OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
Materials and methods Literature search The medical databases PubMed ( https://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
"nih.gov/pubme d), Medline ( https://www.medline.com /),  ISI Web of Science ( https://www.webofknowledge.com /),  and ClinicalTrials .gov (https://ClinicalTrials.gov /) were  searched for English and non-English publications (last  update: May 30, 2016).",OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
All statistical analyses were performed using the Review  Manager (version 5.3) software package ( http://tech.cochrane.,OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/17/ott-10-2087.PMC5396978.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/ppa-11-769.PMC5396979.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 769–779Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  769OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12821 7 effect of adherence on daytime sleepiness, fatigue,  depression and sleep quality in the obstructive  sleep apnea/hypopnea syndrome patients  undertaking nasal continuous positive airway  pressure therapy Yeying Wang1,2 li Ai1 Jiahong luo2 ran li1 Yanlin chai1 Xiaojie he1 Yu cao1 Y ongxia li1 1Department of respiratory Medicine,   The second Affiliated hospital  of Kunming Medical University,   2Department of epidemiology  and Biostatistics, school of  Public health, Kunming Medical  University, chenggong new city,   Kunming, Yunnan Province, People’s  republic of chinaObjectives:  The aims of this study were to describe changes in day- and nighttime symptoms  and the adherence to nasal continuous positive airway pressure (nCPAP) during the first 3-month  nCPAP therapy among newly diagnosed patients with obstructive sleep apnea/hypopnea  syndrome (OSAS) and to identify the effect of adherence on the changes in day- and nighttime  symptoms during the first 3 months.",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/ppa-11-769.PMC5396979.pdf
"Keywords:  OSAS, nCPAP, Epworth Sleepiness Scale, Fatigue Severity Scale , Zung’s Self- Rating Depression Scale, the Pittsburgh Sleep Quality Index Background Obstructive sleep apnea/hypopnea syndrome (OSAS) is characterized by repetitive  obstruction of the upper airway during sleep, causing obstructive apneas leading to correspondence: Yongxia li Department of respiratory Medicine, The  Second Affiliated Hospital of Kunming  Medical University, no 374 Dianmian  road, Kunming 650101, Yunnan Province,  People’s republic of china Tel +86 136 5881 0805 Fax +86 871 6535 2087 email liyongxia@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Wang et al Running head recto: Effect of nCPAP on OSAS patients DOI: http://dx.doi.org/10.2147/PPA.S128217",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/ppa-11-769.PMC5396979.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/ppa-11-769.PMC5396979.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/36/main.PMC5397011.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.011 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/36/main.PMC5397011.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 105 e107,Non-OADS,/arxiv_data1/oa_pdf/69/36/main.PMC5397011.pdf
"16 (2) (2013 Feb) 217 e218, http://dx.doi.org/10.1093/icvts/ivs429 .",Non-OADS,/arxiv_data1/oa_pdf/69/36/main.PMC5397011.pdf
Such a definition has the merit to emphasize theReceived: 9 August 2016 Revised: 21 December 2016 Accepted: 27 March 2017 Heliyon 3 (2017) e00283 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Export flows by route (PJ) −Cumulative values No Route Risk −100% Risk −50% - - Reference Revenue 100% Revenue 90% Revenue 80% 1 Gas AZJ −MED 1489 1592 1477 1477 2 Gas KZK −RUS−EU 3255 3417 3255 3255 3 Gas TKM −AZJ−MED 0 0 0 0 4 Gas TKM −India 3480 3480 3480 3480 5 Gas TKM −IRA 2153 1854 2142 2142 6 Gas TKM −KZK−RF−EU 10914 11644 10916 10916 7 Gas TKM −UZB−KZK−CHI 12409 12876 12392 12392 8 Gas TKM −UZB−TAJ−KYR−CHI 0 0 0 0 9 Gas UZB −KZK−RF−E U 0 000 10 Oil AZJ −MED 13866 13917 13828 13828 11 Oil KZK −AZJ−MED 13435 9150 6150 6150 12 Oil KZK −CHI 2660 3196 3422 3422 13 Oil KZK −IRA−World 0 0 0 0 14 Oil KZK −RF−MED 15807 19167 21663 21663 Article No~e00283 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
"References [1] International Energy Agency, What is energy security (n.d.).. http://www.iea.",Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
http://data.worldbank.org/country .,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
http://minerals.usgs.gov/minerals/pubs/country/ .,OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
http://www.iea.org/statistics/ .,OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
"[19] Energy Information Administration, Overview of oil and natural gas in the Caspian Sea region (2013) 1 –25.http://www.eia.gov/countries/analysisbriefs/ Caspian_Sea/caspian_sea.pdf .",Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
http://www.iea-etsap.org/web/Docs/TIME- SDoc-Intro.pdf .,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
http://www.iea.org/statistics/ statisticssearch/ .,OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
Article No~e00283 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00283 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/5d/main.PMC5397012.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/5f/main.PMC5397013.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.010 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/5f/main.PMC5397013.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 116 e117,Non-OADS,/arxiv_data1/oa_pdf/ab/5f/main.PMC5397013.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.002 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/20/main.PMC5397014.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 113 e115,Non-OADS,/arxiv_data1/oa_pdf/dd/20/main.PMC5397014.pdf
http://dx.doi.org/10.1016/j.redox.2017.03.019 Received 21 March 2017; Accepted 22 March 2017DOI of original article: http://dx.doi.org/10.1016/j.redox.2017.03.002Redox Biology 12 (2 017) 755–757 Available online 24 March 2017 2213-2317/ © 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/bf/2d/main.PMC5397015.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/2d/main.PMC5397015.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/c7/main.PMC5397016.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.007 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/c7/main.PMC5397016.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 99 e104,Non-OADS,/arxiv_data1/oa_pdf/c9/c7/main.PMC5397016.pdf
"In yeast, Sir2 is a key modulator of both replicative and chronological aging [23,24] .I n http://dx.doi.org/10.1016/j.redox.2017.04.015 Received 22 March 2017; Received in revised form 5 April 2017; Accepted 8 April 2017⁎Correspondence to: Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.",OADS,/arxiv_data1/oa_pdf/0f/5a/main.PMC5397018.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/5a/main.PMC5397018.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.04.015 .,OADS,/arxiv_data1/oa_pdf/0f/5a/main.PMC5397018.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2017:10 107–114Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  107 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S126305CYP2C19 polymorphism frequency in Russian  patients in Central Russia and Siberia with acute  coronary syndrome Karin B Mirzaev1 Elena M Zelenskaya2  Olga L Barbarash3 Vladimir I Ganyukov3 Konstantin A Apartsin4,5 Natalya O Saraeva4 Konstantin Y Nikolaev6,7 Kristina A Ryzhikova1 Galina I Lifshits2,5,7 Dmitry A Sychev1 1Russian Medical Academy of  Continuous Professional Education,   Ministry of Health of the Russian Federation, Moscow,  2Federal State- Financed Research Institution “Institute of Chemical Biology and Fundamental Medicine”, Siberian  Branch of the Russian Academy  of Sciences, Novosibirsk,  3Federal  State-Financed Research Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Siberian  Branch of the Russian Academy of  Sciences, Kemerovo,  4State-Financed  Health Institution “Irkutsk Regional Badge of Honour Clinical Hospital”,   5Federal State-Financed Research  Institution “Irkutsk Research Center”,  Siberian Branch of the Russian Academy of Sciences, Irkutsk City,   6Federal State-Financed Research  Institution “Research Institute of Internal and Preventive Medicine”,   7Federal State Autonomous Institution  of Higher Education “Novosibirsk National Research State University”,  Novosibirsk, RussiaPurpose: The aim of this study is to investigate the frequency of CYP2C19*2, *3 allelic vari- ants, associated with poor response to clopidogrel, and CYP2C19*17 , associated with excessive  response to clopidogrel, in patients with acute coronary syndrome (ACS) from Siberia and Moscow regions of Russia.",Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
"3 Therefore, it is crucial for antiplatelet therapy implementation to determine Correspondence: Karin B Mirzaev Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, Barrikadnaya Street  2/1, Moscow 123995, Russia Tel +7 985 272 0253Email karin05doc@yandex.ruJournal name: Pharmacogenomics and Personalized Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Mirzaev et alRunning head recto:  CYP2C19 polymorphism frequency in Russian patients with ACSDOI: http://dx.doi.org/10.2147/PGPM.S126305",Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs310/ru/.,Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
Available from: http://www.ssmu.ru/upload/filesarchive/files/dissertacija_Muslimova_file_1_1402.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
"Pharmacogenomics and Personalized Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 114 Mirzaev et al,Non-OADS,/arxiv_data1/oa_pdf/03/59/pgpm-10-107.PMC5397026.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/35/main.PMC5397098.pdf
http://dx.doi.org/10.1016/j.btre.2017.02.002 2215-017X/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/35/main.PMC5397098.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  14  (2017)  34–37 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/16/35/main.PMC5397098.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2017.02.002 .",OADS,/arxiv_data1/oa_pdf/16/35/main.PMC5397098.pdf
http://dx.doi.org/10.1016/j.btre.2017.02.004 2215-017X/©  2017  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/78/ba/main.PMC5397100.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  14  (2017)  8–15 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/78/ba/main.PMC5397100.pdf
"Lafayette.,  1999  Available  at http://www.lgseeds.com/LG_Tech2/resources/charcoalrotPU.pdf.",Non-OADS,/arxiv_data1/oa_pdf/78/ba/main.PMC5397100.pdf
http://dx.doi.org/10.1016/j.btre.2017.02.001 2215-017X/©  2017  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/70/c9/main.PMC5397105.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  14  (2017)  1–7 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/70/c9/main.PMC5397105.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/06/main.PMC5397106.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.007 2215-017X/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/06/main.PMC5397106.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  14  (2017)  27–33 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/3f/06/main.PMC5397106.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2016.12.007 .",OADS,/arxiv_data1/oa_pdf/3f/06/main.PMC5397106.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
http://dx.doi.org/10.1016/j.btre.2017.02.003 2215-017X/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  14  (2017)  16–26 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Fluids  84 (2013)  89–97,  doi:http://dx.doi.org/10.1016/j.sup ﬂu.2013.09.014 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"67  (2005)  21–33,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Fluids  109  (2016)  35–42,  doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Fluids  28  (2004)  121 –191,  doi:http://dx.doi.org/ 10.1016/S0896-8446(03)00029-9 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Deshpande,  G.  Madras,  Synthesis  of  biodiesel  in  supercritical alcohols  and  supercritical  carbon  dioxide,  Fuel  89  (2010)  1641 –1646,  doi: http://dx.doi.org/10.1016/j.fuel.2009.08.012 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Fluids  92  (2014)  70–74,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"39  (2010)  3317 –33333,  doi:http://dx.doi.org/10.1039/ b909964f .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"4  (2004)  460 –464,  doi:http://dx.doi.org/10.1002/elsc.200420047 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"64  (2010)  140 –145,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"46  (2011)  2225 –2231, doi:http://dx.doi.org/10.1016/j.procbio.2011.08.006 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"48  (2010)  246 –252, doi:http://dx.doi.org/10.1016/j.bej.2009.10.021 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"3 (2014)  13–19,  doi:http://dx.doi.org/10.1016/j.bcab.2013.12.005 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"90  (2014)  36–43,  doi:http://dx.doi.org/ 10.1016/j.bej.2014.05.004 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"13 (2002)  390 –397,  doi:http://dx.doi.org/10.1016/s0958-1669(02)00341-5 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"122  (2015)  93–116,  doi:http://dx.doi.org/ 10.1016/j.molcatb.2015.08.022 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"39  (2006)  235 –251,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
2  (2013)  1–9 (http://new.ijlbpr.com/jlbpradmin/upload/ijlbpr_51d452a2abcec.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"130  (2016)  58–69,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"12  (2010)  555,  doi:http://dx.doi.org/10.1039/b919088k .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"42  (2013)  6223 –6235,  doi:http://dx.doi.org/10.1039/ C3CS60075K .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"42  (2013)  6437,  doi:http://dx.doi.org/ 10.1039/c3cs35506c .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"42  (2013)  6236,  doi:http://dx.doi.org/10.1039/ c3cs35511j .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"40  (2007)  1451 –1463, doi:http://dx.doi.org/10.1016/j.enzmictec.2007.01.018 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"353  (2011)  2885 –2904,  doi:http://dx.doi.org/ 10.1002/adsc.201100534 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"42  (2013)  6290 –6307,  doi:http://dx.doi.org/10.1039/c2cs35231a .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"33  (2015)  435 –456,  doi: http://dx.doi.org/10.1016/j.biotechadv.2015.03.006 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"16  (1998)  181 –204,  doi:http://dx.doi.org/10.3109/10242429809003198 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"6  (2002)  446 –451, doi:http://dx.doi.org/10.1021/op0200165 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Jones,  The  sequence,  crystal  structure determination  and  reﬁnement  of  two  crystal  forms  of  lipase  B  from  Candida antarctica,  Structure  2  (1994)  293 –308,  doi:http://dx.doi.org/10.1016/S0969- 2126(00)00031-9 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"132  (2015)  1–15,  doi:http://dx.doi.org/10.1002/ app.42125 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"35  (2004)  126 –139,  doi: http://dx.doi.org/10.1016/j.enzmictec.2003.12.013 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"60  (2012)  16–24,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"27  (2012)  324 –331,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Schauer,  One-step  electrospinning  of  cross-linked  Chitosan ﬁbers,  Biomacromolecules  8  (2007)  2665 –2667,  doi:http://dx.doi.org/10.1021/ bm7006983 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"4  (2014) 1583,  doi:http://dx.doi.org/10.1039/c3ra45991h .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"47 (2012)  1220 –1227,  doi:http://dx.doi.org/10.1016/j.procbio.2012.04.019 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"71  (2015)  53–57,  doi:http://dx.doi.org/ 10.1016/j.enzmictec.2015.02.001 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Lipids  93  (1998)  185 –197,  doi:http://dx.doi.org/10.1016/ S0009-3084(98)00042-5 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"37  (2005)  456 –462,  doi:http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"39  (2006)  274 –280, doi:http://dx.doi.org/10.1016/j.enzmictec.2005.10.014 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Fernandes,  Production  of biodiesel  by  ultrasound  assisted  esteri ﬁcation  of  Oreochromis  niloticus  oil, Fuel  89  (2010)  275 –279,  doi:http://dx.doi.org/10.1016/j.fuel.2009.05.030 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"704  (2009),  doi:http://dx.doi.org/ 10.2307/1270613 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"51  (2008)  100 – 109,  doi:http://dx.doi.org/10.1016/j.molcatb.2007.11.016 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"10  (1988)  375 –382,  doi: http://dx.doi.org/10.1016/0141-0229(88)90018-X .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"15  (1993)  546 –550,  doi:http://dx.doi.org/ 10.1016/0141-0229(93)90016-U .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"5  (2015)  11212 –11222,  doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"248  (2005)  133 –140,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"72  (1976)  248 –254,  doi:http://dx.doi.org/10.1016/0003-2697 (76)90527-3 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
501  (1987)  73–79  (http://www.scopus.com/inward/ record.url?eid=2-s2.0-0023077096&partnerID=tZOtx3y1 ).,Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"83 (2002)  125 –129,  doi:http://dx.doi.org/10.1016/s0960-8524(01)00203-6 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"[59]  V.  Rathore,  G.  Madras,  Synthesis  of  biodiesel  from  edible  and  non-edible  oils  in supercritical  alcohols  and  enzymatic  synthesis  in  supercritical  carbon  dioxide, Fuel  86  (2007)  2650 –2659,  doi:http://dx.doi.org/10.1016/j.fuel.2007.03.014 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Energy  35 (2010)  2581 –2584,  doi:http://dx.doi.org/10.1016/j.renene.2010.03.035 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"38  (2011)  1055 –1066,  doi:http://dx.doi.org/10.1007/s10295-010- 0880-9 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"332  (1993)  143 –149,  doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
Acta  1441  (1999)  205 –214  http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"50  (2015)  918 –927, doi:http://dx.doi.org/10.1016/j.procbio.2015.03.018 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"77  (2015)  1–7,  doi: http://dx.doi.org/10.1016/j.enzmictec.2015.05.001 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"6  (2016)  27329 –27334, doi:http://dx.doi.org/10.1039/C6RA03627A .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"48  (2011)  107 –122,  doi: http://dx.doi.org/10.1016/j.enzmictec.2010.10.003 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"93 (1979)  1–25  http://www.scopus.com/inward/record.url?eid=2-s2.0- 0018408815&partnerID=tZOtx3y1 ,  (Accessed  7  November  2014).. [72]  Y.  Gao,  T.  Tan,  K.  Nie,  F.  Wang,  Immobilization  of  lipase  on  macroporous  resin and  its  application  in  synthesis  of  biodiesel  in  low  aqueous  media,  Chin.",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"22  (2006)  114 –118,  doi:http://dx.doi.org/10.1016/S1872-2075(06) 60008-3 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"111  (2016)  75– 86,  doi:http://dx.doi.org/10.1016/j.bej.2016.03.004 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"90  (2016)  35–44,  doi: http://dx.doi.org/10.1016/j.enzmictec.2016.04.007 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"[75]  G.  Madras,  C.  Kolluru,  R.  Kumar,  Synthesis  of  biodiesel  in  supercritical  ﬂuids, Fuel  83  (2004)  2029 –2033,  doi:http://dx.doi.org/10.1016/j.fuel.2004.03.014 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"23  (2007)  1121 –1128,  doi:http://dx.doi.org/10.1016/s1872-2075 (07)60067-3 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"96  (2005) 769 –777,  doi:http://dx.doi.org/10.1016/j.biortech.2004.05.029 .J.C.S.",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"37  (2005)  42–48,  doi:http://dx.doi.org/ 10.1016/j.enzmictec.2004.12.033 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"36  (2000)  331 –339,  doi:http://dx.doi.org/10.1016/ S0032-9592(00)00218-1 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"57  (2002)  1627 –1632,  doi:http://dx.doi.org/10.1016/S0009- 2509(02)00039-8 .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"99 (1999)  623 –634,  doi:http://dx.doi.org/10.1021/cr970040u .",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"25  (2007)  272 – 280,  doi:http://dx.doi.org/10.1016/j.biotechadv.2006.12.002 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Burguete,  G.  Sánchez-Gómez,  G. López-López,  et  al.,  Supercritical  synthesis  of  biodiesel,  Molecules  17  (2012) 8696 –8719,  doi:http://dx.doi.org/10.3390/molecules17078696 .",OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
"Burguete,  G. Sánchez-Gómez,  et  al.,  Immobilised  lipase  on  structured  supports  containing covalently  attached  ionic  liquids  for  the  continuous  synthesis  of  biodiesel  in scCO  2,  ChemSusChem  5  (2012)  790 –798,  doi:http://dx.doi.org/10.1002/ cssc.201100692 .26  J.C.S.",Non-OADS,/arxiv_data1/oa_pdf/89/57/main.PMC5397107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.011Urology Case Reports 13 (2017) 34 e36,Non-OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
http://dx.doi.org/10.1056/NEJMoa1510665 .,OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
http://dx.doi.org/10.1016/S0022- 5347(05)67699-9 .,OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
2005;23(3):202 e 212. http://dx.doi.org/10.1007/s00345-004-0466-0 .,Non-OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
http://dx.doi.org/10.1056/NEJM199609193351207 .,Non-OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
http://dx.doi.org/10.1016/j.ctrv.2007.12.001 .I.,OADS,/arxiv_data1/oa_pdf/ff/bb/main.PMC5397124.pdf
"However, instead of producing ATP, the mitochondrial membrane potential is uncoupled through the brown fat speci ﬁc protein: Mitochondrial brown fat uncoupling protein 1 (UCP1), resulting in http://dx.doi.org/10.1016/j.redox.2017.04.011 Received 31 March 2017; Accepted 8 April 2017⁎Correspondence to: Centre of In ﬂammation and Metabolism, Rigshospitalet –Section 7641, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
Acknowledgements The Novo Nordisk Foundation Center for Basic Metabolic Research (http://www.metabol.ku.dk ) is supported by an unconditional grant from the Novo Nordisk Foundation to University of Copenhagen.,Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"360 (2009) 1518 –1525, http://dx.doi.org/10.1056/NEJMoa0808949 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"360 (2009) 1500 –1508, http://dx.doi.org/10.1056/ NEJMoa0808718 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"23 (2009) 3113 –3120, http://dx.doi.org/10.1096/fj.09-133546 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"[4] M. Saito, Y. Okamatsu-ogura, M. Matsushita, K. Watanabe, T. Yoneshiro, J. Nio- kobayashi, T. Iwanaga, M. Miyagawa, T. Kameya, K. Nakada, Y. Kawai, M. Tsujisaki, High incidence of metabolically active brown adipose e ﬀects of cold exposure and adiposity, Diabetes 58 (2009) 1526 –1531, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"84 (2004) 277 –359, http://dx.doi.org/10.1152/physrev.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"17 (2013), http://dx.doi.org/ 10.1016/j.cmet.2013.04.011 .",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"19 (2013) 631 –634, http://dx.doi.org/10.1038/nm.3017 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"19 (2013)635 –639, http://dx.doi.org/10.1038/nm.3112 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"[11] P. Trayhurn, Origins and early development of the concept that brown adipose tissue thermogenesis is linked to energy balance and obesity, Biochimie 134 (2016)62–70,http://dx.doi.org/10.1016/j.biochi.2016.09.007 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"13 (2016) 26 –35,http://dx.doi.org/10.1038/nrendo.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"24 (2016) 246 –255, http://dx.doi.org/10.1016/j.cmet.2016.07.004 .",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Spiegelman, Beige adipo-cytes are a distinct type of thermogenic fat cell in mouse and human, Cell 150 (2012) 366 –376, http://dx.doi.org/10.1016/j.cell.2012.05.016 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"9 (2009) 203 –209, http://dx.doi.org/10.1016/j.cmet.2008.12.014 .",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Spiegelman, Mitochondrial ROS regulate thermogenic energyexpenditure and sulfenylation of UCP1, Nature 532 (2016) 112 –116, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Müller, A. Pfeifer, Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors, Nature 516 (2014) 395 –399, http://dx.doi.org/10.1038/ nature13816 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"360 (2009)1509 –1517, http://dx.doi.org/10.1056/NEJMoa0810780 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Sidossis, Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans, Diabetes 63 (2014) 4089 –4099, http://dx.doi.org/10.2337/db14-0746 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"122(2012) 545, http://dx.doi.org/10.1172/JCI60433DS1 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"8 (2017) 14146,http://dx.doi.org/10.1038/ncomms14146 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"123 (2013) 3395 –3403, http://dx.doi.org/10.1172/JCI68993 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"21 (2015) 6 –10,http://dx.doi.org/10.1038/nm.3891 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"23 (2016) 602 –609, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Lazar, The nuclearreceptor Rev-erb αcontrols circadian thermogenic plasticity, Nature 503 (2013) 410 –413, http://dx.doi.org/10.1038/nature12642 .",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Van Marken Lichtenbelt, Short-term cold acclimation recruits brown adipose tissue in obese humans, Diabetes (2016), http://dx.doi.org/10.2337/db15-1372 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"23 (2016) 1200 –1206, http://dx.doi.org/10.1016/j.cmet.2016.04.029 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"21 (2015) 33–38,http://dx.doi.org/10.1016/j.cmet.2014.12.009 .",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"123 (2013) 3404 –3408, http://dx.doi.org/10.1172/JCI67803 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"9 (2009) 99 –109, http://dx.doi.org/10.1016/j.cmet.2008.",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"124 (2014) 2099 –2112, http://dx.doi.org/ 10.1172/JCI71643 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"22 (2016) 312 –318, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"1 (2005) 63 –72,http://dx.doi.org/10.1016/j.cmet.",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"7 (2001) 941 –946, http://dx.doi.org/10.1038/90984 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"121 (2011) 96 –105, http://dx.doi.org/10.1172/JCI44271 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"285 (2010) 7153 –7164, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Acta 2013 (1831) 950 –959, http://dx.doi.org/10.1016/j.bbalip.2013.02.005 .",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"32 (2015) e4–e8,http://dx.doi.org/10.1111/dme.12595 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"112 (2003) 1796 –1808, http://dx.doi.org/10.1172/JCI200319246 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"22 (2015) 219 –227, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"19 (2013) 1252 –1263, http://dx.doi.org/10.1038/nm.3361 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Spiegelman, A PGC1a dependent myokine that derives browning of white fat and thermogenesis, Nature 481 (2012) 463 –468, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"20 (2014) 433 –447, http://dx.doi.org/10.1016/j.cmet.2014.",OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Spiegelman, Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia, Nature 1 (2014) 1 –19,http://dx.doi.org/10.1038/nature13528 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"[57] T. Yoneshiro, S. Aita, M. Matsushita, Y. Okamatsu-Ogura, T. Kameya, Y. Kawai, M. Miyagawa, M. Tsujisaki, M. Saito, Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans, Obesity 19 (2011) 1755 –1760, http://dx.doi.org/10.1038/oby.2011.125 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"37 (2013) 993 –998, http://dx.doi.org/10.1038/ijo.2012.161 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"21 (2015) 760 –768, http://dx.doi.org/10.1038/nm.3881 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"21 (2015) 389 –394, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
"Spiegelman, PRDM16 controls a brown fat/skeletal muscle switch, Nature 454 (2008) 961 –967, http://dx.doi.org/10.1038/nature07182 .",Non-OADS,/arxiv_data1/oa_pdf/f1/2e/main.PMC5397125.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"However,  surgeons  must  consider catecholamine-secreting  tumors  as  a  differential  diagnosis,  and  the http://dx.doi.org/10.1016/j.ijscr.2017.03.040 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"33  (July  (7))  (2015)  433–436, http://dx.doi.org/10.1007/s11604-015-0436-z ,  Epub  30  May  2015.",Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"1073 (2006)  21–29,  http://dx.doi.org/10.1196/annals.1353.002 .",Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"188  (2007)  1054–1058,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"5 (March) (2010) 19, http://dx.doi.org/10.1186/1749-8090-5-19 .",Non-OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"97  (March  (3))  (2014)  1077–1080,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/15/d5/main.PMC5397129.pdf
"Thirty two months after his ﬁrst http://dx.doi.org/10.1016/j.mmcr.2017.04.002 Received 3 March 2017; Received in revised form 31 March 2017; Accepted 5 April 2017⁎Corresponding author at: Department of Microbiology, ICBS, Universidade Federal do Rio Grande do Sul.",Non-OADS,/arxiv_data1/oa_pdf/18/1c/main.PMC5397130.pdf
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/18/1c/main.PMC5397130.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.03.009 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"Teixeira,  K.  Inaba,  D.  Oncel,  J.  DuBose,  L.  Chan,  P.  Rhee,  et  al.,  Blunt  cardiac rupture: a  5-year  NTDB  analysis,  J.  Trauma  67  (2009)  788–791,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"Muckart, et  al.,  Blunt  cardiac  injury  in  critically  ill  trauma  patients:  a  single  centre experience, Injury 46 (2015)  66–70,  http://dx.doi.org/10.1016/j.injury.2014.",OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"38  (2012)  563–568,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"A prospective  study, Injury 36  (2005)  745–750,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"55  (2010)  82–84,  http://dx.doi.org/10.1111/j.1556- 4029.2009.01207.x .",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"17  (2010)  339–343,  http://dx.doi.org/10.1016/j.jﬂm.2010.",OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"20  (2012) 64–65,  http://dx.doi.org/10.1177/0218492311421444 .",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"17 (2009)  64,  http://dx.doi.org/10.1186/1757- 7241-17-64 .",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"[15] I˙Akar, I˙I˙nce, C.  Aslan,  M.  C¸  eber,  I˙Kaya,  Left  atrial  rupture  due  to  blunt  thoracic trauma, Ulus  Travma  Acil  Cerrahi  Derg  21  (2015)  303–305,  http://dx.doi.org/ 10.5505/tjtes.2015.24968 .",Non-OADS,/arxiv_data1/oa_pdf/45/fa/main.PMC5397131.pdf
"5–8 Currently more than 48 CC loci have been identiﬁed, and morethan 35 of them have been associated with causative mutationsin speciﬁc genes, as delineated in the Cat-Map database (http://cat-map.wustl.edu/, in the public domain).",Non-OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
Primerpairs for individual exons in the critical interval were designed online with the Primer3 program (http://primer3.sourceforge.,OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"Sequence changes observed were checked forcosegregation in the family and for presence or absence in atleast 96 healthy control individuals as well as the 1000 Genomes (http://www.internationalgenome.org/home, in the public domain) and ExAC (http://exac.broadinstitute.org/, inthe public domain) databases, although low frequencies ofheterozygous changes were not considered to exclude pathogenicity.",OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"Pathogenicity Assessment of Identiﬁed Variants A mutation was considered novel if it was not present in the Human Mutation Database (http://www.hgmd.cf.ac.uk/ac, inthe public domain) or the NCBI dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/index.html, in the public do-Pakistani Cataracts IOVSjApril 2017 jVol.",OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"main) and not in Cat-Map (http://cat-map.wustl.edu, in the public domain).",Non-OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"A sequence variation was considered patho- genic when it cosegregated with the disease in the family; wasnot present in 96 randomly selected controls from the Pakistani population; altered a well-conserved amino acid, preferably in a conserved region (http://www.ebi.ac.uk/Tools/clustalw2/index.html, in the public domain); and it was judgedsigniﬁcant in computational tests for pathogenicity.",Non-OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"Missense variants were assessed for possible causality with the online programs Sorting Intolerant From Tolerant (SIFT; http://sift.jcvi.org/www/SIFT_enst_submit.html, in the public domain) and polymorphism phenotyping (Polyphen-2; http://genetics.",OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"bwh.harvard.edu/pph2/, in the public domain), as well asCondel (http://bg.upf.edu/fannsdb/, in the public domain),which uses input from multiple programs in its assessment.",OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
EPH Receptor A2 (EPHA2 ) Variation of Uncertain Signiﬁcance This variant (rs753345828) has a reported minor allele frequency of 0.00005 in dbSNP (https://www.ncbi.nlm.nih.gov/projects/SNP/) and was not seen in 192 ethnically matched control chromosomes (96 individuals).,Non-OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"35Expressed widely including the eye (UniGene, https://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/08/31/i1552-5783-58-4-2207.PMC5397132.pdf
"Electrical measurement I-Vcharacteristics were conducted using a semiconductor parameter analyzer (HP 4156A) and measured in a liquid nitrogen –cooled cryo- stat (ASK, 700 K) at a pressure of approximately 10 −3torr in a dark environment.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602726/DC1Supplementary Textfig.",OADS,/arxiv_data1/oa_pdf/47/b6/1602726.PMC5397133.pdf
"The data are described in detail in the Supplementary Materials and are available from https://iu.app.box.com/patents/1/779886700/7307669062/1, https://iu.app.box.com/patents/1/779886700/ 15411270285/1, and https://dataverse.harvard.edu/dataverse/patent.",OADS,/arxiv_data1/oa_pdf/06/50/1601315.PMC5397134.pdf
"Specifically, the values of BIC goodness-of-fit statistics for analyses with and DmandDqare as follows:SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1601315/DC1section S1.",Non-OADS,/arxiv_data1/oa_pdf/06/50/1601315.PMC5397134.pdf
"After data correction, a two-way unsupervised hierarchical clustering heat map was generated using the Next-Generation Clustered Heat Map (NG-CHM) tool (http://bioinformatics.mdanderson.org/main/NG-CHM: Overview).",OADS,/arxiv_data1/oa_pdf/63/9c/1600957.PMC5397135.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1600957/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/63/9c/1600957.PMC5397135.pdf
Population was estimated from gridded globalpopulation data from the 2008 LandScan data set (http://web.ornl.,Non-OADS,/arxiv_data1/oa_pdf/7e/2d/1600582.PMC5397136.pdf
"Using satellite observations provided by the National Snow and Ice Data Cente r (NSIDC; http://www.nsidc.org) and the Aquarius Mission (http://aquarius.umaine.edu; NASA andSpace Agency of Argentina), we analyzed the extent of the Arctic ice cap and the spatial distribution of sea surface salinity to infer boundaries for the patterns of surface circulation.",OADS,/arxiv_data1/oa_pdf/7e/2d/1600582.PMC5397136.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1600582/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/7e/2d/1600582.PMC5397136.pdf
Seasonal cycle of ocean surface salinities for 2013 provided by the Aquarius Mission(NASA and Space Agency of Argentina; http://aquarius.umaine.edu).fig.,OADS,/arxiv_data1/oa_pdf/7e/2d/1600582.PMC5397136.pdf
Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org/en/m/science/les-labos-impliques/).,Non-OADS,/arxiv_data1/oa_pdf/7e/2d/1600582.PMC5397136.pdf
Homozygosity Mapping and Linkage Analysis One hundred eighty genes or loci associated with inherited retinal diseases were selected from RetNet (https://sph.uth.,OADS,/arxiv_data1/oa_pdf/a8/b7/i1552-5783-58-4-2218.PMC5397137.pdf
Assessing Pathogenicity of Identiﬁed Variants A mutation was considered novel if it was not present in the Human Mutation Database Professional Version on Biobase (https://portal.biobase-international.com/cgi-bin/portal/login.cgi; in the public domain) or the National Center forBiotechnology Information dbSNP database (http://www.,OADS,/arxiv_data1/oa_pdf/a8/b7/i1552-5783-58-4-2218.PMC5397137.pdf
"1% in the ExAC database (http://exac.broadinstitute.org/; in the public domain); and for missense changes were judged pathogenic in a computational test for mutations, including sorting intolerant from tolerant (SIFT and PROVEAN, http://sift.",OADS,/arxiv_data1/oa_pdf/a8/b7/i1552-5783-58-4-2218.PMC5397137.pdf
"jcvi.org/; in the public domain) analysis, polymorphism phenotyping (PolyPhen2, http://genetics.bwh.harvard.edu/ pph2/; in the public domain), and Condel (http://bg.upf.edu/ fannsdb/; in the public domain).",OADS,/arxiv_data1/oa_pdf/a8/b7/i1552-5783-58-4-2218.PMC5397137.pdf
"Splicing changes were predicted using Automated Splice Site Analyses (http://www.fruitﬂy.org/seq_tools/splice.html; in the public domain).Intragenic Haplotype Analysis for Families Sharing the Same Variation If the same variation was detected in more than one family, haplotypes of single nucleotide polymorphisms (SNPs) intra-genic or within 1 Mb of the mutated gene were genotyped.",OADS,/arxiv_data1/oa_pdf/a8/b7/i1552-5783-58-4-2218.PMC5397137.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602935/DC1Supplementary Materials and Methodstable S1.,Non-OADS,/arxiv_data1/oa_pdf/b8/d9/1602935.PMC5397138.pdf
"P. J. Armitage, http://arxiv.org/abs/1509.06382 (2015).",Non-OADS,/arxiv_data1/oa_pdf/b8/d9/1602935.PMC5397138.pdf
Data and materials availability: Our ALMA data can also be obtained from the ALMA science data archive (https://almascience.nao.ac.jp/alma-data).,OADS,/arxiv_data1/oa_pdf/b8/d9/1602935.PMC5397138.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602809/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/43/1602809.PMC5397139.pdf
Data analysis was carried out us-ing R packages (R Core Team 2016) through the wessa.net framework ( http://www.wessa.net/ version 1.1.23-r7.),OADS,/arxiv_data1/oa_pdf/51/f4/gkw1292.PMC5397147.pdf
Data handling and extraction was done in R (http://www.R-project.org .,OADS,/arxiv_data1/oa_pdf/51/f4/gkw1292.PMC5397147.pdf
Stressinducible cryptic transcripts (abbreviated as SITs) and other non-annotated transcripts were selected manu- allybyscreeningthegenomewideexpressiondatainaheat maprepresentationavailableat http://steinmetzlab.embl.de/ schueller ino80/index.html .,OADS,/arxiv_data1/oa_pdf/51/f4/gkw1292.PMC5397147.pdf
The results represented as searchableheatmaps are available online ( http://steinmetzlab.embl.de/ schueller ino80/index.html ).,OADS,/arxiv_data1/oa_pdf/51/f4/gkw1292.PMC5397147.pdf
"(2016) R:ALanguageandEnvironmentforStatistical Computing .RFoundationforStatisticalComputing,Vienna, Austria, http://www.R-project.org .",Non-OADS,/arxiv_data1/oa_pdf/51/f4/gkw1292.PMC5397147.pdf
The script for the Fluidigm C1 has been submitted to the Fluidigm C1 OpenApp script repository ( https://www.fluidigm.com/ c1openapp ).,OADS,/arxiv_data1/oa_pdf/0b/83/gkw1242.PMC5397152.pdf
"Additional quality control ofthe remaining libraries was performed using the R pack- age ‘Single-cell analysis toolkit for gene expression data in R’ (scater version 1.0.4, https://www.bioconductor.org ).",OADS,/arxiv_data1/oa_pdf/0b/83/gkw1242.PMC5397152.pdf
"Three WRN siRNA sequences targeted to 5 /primeUTR were designed by siDirect ( http://sidirect2.rnai.jp ) and synthe- sizedbyIDT(IntegratedDNATechnologies;USA)(WRN siRNA 710–732; ACAAUAUCUGAAAGAAAACCC andGUUUUCUUUCAGAUAUUGUUU,WRNsiRNA 719–741; AAAUACAAAACAAUAUCUGAA and",OADS,/arxiv_data1/oa_pdf/1e/64/gkx065.PMC5397154.pdf
"Data analysis Reads of low quality were discarded, adapter sequences were trimmed and sequences were sorted according tothe specific barcodes used in each condition of IP us- ingcutadaptsoftware( https://cutadapt.readthedocs.org/en/ stable/).",OADS,/arxiv_data1/oa_pdf/e4/41/gkw1289.PMC5397155.pdf
"Cleans reads were then mapped to HIV-1 NL4-3 sequence (GenBank ID: AF324493.2) or hg19 UCSC H. sapiensgenome.Inafirstanalysis,trimmedreadsofatleast 15 nucleotides length were mapped using Bowtie software(http://bowtie-bio.sourceforge.net/index.shtml with the fol- lowing parameters: -a -n1 –best –strata).",OADS,/arxiv_data1/oa_pdf/e4/41/gkw1289.PMC5397155.pdf
"In order to find the best align- ment parameters, long reads were aligned using Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/ )totheconcate- nation of the human and viral genome with variable com- binations of seed substring (-L), tolerated mismatches per seed(-N)andinterval betweenseedsubstring(-i).Thebestmappingstatisticstothereferencewereobtainedbyusing- L3-N0-iS,1,1.5,parameterstoleratingmismatchesthatin- creasedsensitivitybutturnedthealignmentlongtorun.Inordertoexcludeambiguousreads,wealignedlongreadsto thehumanandviralgenomes.Viralmappersnotpresentin the human alignment were selected.",OADS,/arxiv_data1/oa_pdf/e4/41/gkw1289.PMC5397155.pdf
"Identifying thelifespan of SDARs The Internet Archive (IA) is the world’s largest and old- est public archive of the WWW via its Wayback Ma- chine,availableat https://archive.org/web .Itperiodicallyac- cesses URLs across the Internet and takes a ‘snapshot’ of the site, while recording the HyperText Transfer Protocol (HTTP) code ( https://tools.ietf.org/html/rfc2616 ) returned upon each attempt to access a URL (e.g.",OADS,/arxiv_data1/oa_pdf/91/0e/gkx182.PMC5397159.pdf
"CalculatingtheHBondscores(HBS)ofall11ntlongGT sequences within exon 7 and the downstream intron (( 6); https://www.hhu.de/rna/html/hbond score.php ) confirmed thatthephysiological5/primesshadthehighestHBS,indicativeof thehighestcomplementaritytoU1snRNA,followedbyac- tivatedcrypticsplicesitesintheneighborhoodofthephys-iological 5 /primess (Figure 1).",OADS,/arxiv_data1/oa_pdf/d0/66/gkw1317.PMC5397162.pdf
"In line with this, assess- ment of the hydrogen bonding patterns of potential U1 snRNA binding sites ( http://www.uni-duesseldorf.de/rna/ html/hbond score.php ) within FGB exon 7 revealed that the authentic 5’ss had a higher HBS than the cryptic sites and that in turn the cryptic sites were stronger than the re- mainingpotentialU1snRNAbindingsites.Incidentally,wefoundthesplicesitep1withinthedownstreamintron,which wasusedinthepresenceofthec.1244+1G >Tmutationand whichseemedtobebelowdetectionlimitinpreviousexper-iments but had an HBS comparable to c1 ( 25).",OADS,/arxiv_data1/oa_pdf/d0/66/gkw1317.PMC5397162.pdf
We identified potential binding sites of HuR using the HuR binding motif in the 3/primeUTR ofCtn RNA (RBPmap–– http://rbpmap.technion.ac.il/ and Supplemen- tary Table S2A) ( 45).,OADS,/arxiv_data1/oa_pdf/65/c5/gkw1304.PMC5397167.pdf
"The detailed information about the sitesof predicted SEs, mother and daughter enhancers was pre- sented in Additional material ( http://dx.doi.org/10.13140/ RG.2.2.22940.49286 ).",OADS,/arxiv_data1/oa_pdf/04/e8/gkw1283.PMC5397169.pdf
ACCESSION NUMBERS Sequencing data and genome assemblies are publicly avail- ableintheNCBISequenceReadArchiveandGenbankun- der projectaccession PRJNA344006 and PRJNA341910.AVAILABILITY The perl codes to process the yeast library and the floun- der library are available at https://github.com/ZhichaoXu/ pBACode-perl-code .,OADS,/arxiv_data1/oa_pdf/a7/e8/gkw1261.PMC5397170.pdf
"A self-consistent set of molecular dynamics derived hydrogen bond, stacking and solvation energies (kcal /mol) for double helical dinucleotide steps Dinucleotide Hydrogenbond Stackingenergy Solvation AA -5.44 -26.71 -171.84 AC -7.14 -27.73 -171.11AG -6.27 -26.89 -174.93 AT -5.35 -27.20 -173.70 CA -7.01 -27.15 -179.01CC -8.48 -26.28 -166.76 CG -8.05 -27.93 -176.88 CT -6.27 -26.89 -174.93GA -7.80 -26.78 -167.60GC -8.72 -28.13 -165.58 GG -8.48 -26.28 -166.76 GT -7.14 -27.73 -171.11TA -5.83 -26.90 -174.35TC -7.80 -26.78 -167.60 TG -7.01 -27.15 -179.01 TT -5.44 -26.71 -171.84 (ftp://ftp.ncbi.nih.gov/genomes/ ).",Non-OADS,/arxiv_data1/oa_pdf/89/d3/gkw1236.PMC5397174.pdf
Complete RNA data set and computed parametersareprovidedinpublicdomainat http://www.scfbio-iitd.res.,OADS,/arxiv_data1/oa_pdf/89/d3/gkw1236.PMC5397174.pdf
AVAILABILITY Complete RNA data set and computed parameters are provided in public domain at http://www.scfbio-iitd.res.in/ software/data RNA.jsp .,OADS,/arxiv_data1/oa_pdf/89/d3/gkw1236.PMC5397174.pdf
"AUC ROC and area under the precision-recall curve values are calcu- lated using the packages ROCR(version 1.0-5) ( 21)a n d pracma(version 1.7.0; http://cran.r-project.org/package= pracma), respectively.",OADS,/arxiv_data1/oa_pdf/25/d4/gkw1260.PMC5397177.pdf
"Assessment of the influence of cross- validation schemes on the estimated performances is doneby comparing AUC ROC or precision values, grouped ac- cording to the cross-validation scheme applied, using the Friedmantest( 24).Post-hocanalysisisperformedwiththe Wilcoxon–Nemenyi–McDonald–Thompson test ( 24), us- ingthecoin(version1.0-23)( 25)and multcomp (version1.3- 4;http://cran.r-project.org/package=multcomp ) packages.",OADS,/arxiv_data1/oa_pdf/25/d4/gkw1260.PMC5397177.pdf
( PDBePISA protein–protein interaction server: http://www.ebi.ac.uk/msd-srv/prot int/andPDBsumgener- ate:http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/ Generate.html ).,OADS,/arxiv_data1/oa_pdf/e9/9b/gkx009.PMC5397183.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 20, Number 2, 2017Mary Ann Liebert, Inc.DOI: 10.1089/pop.2016.0033 90",Non-OADS,/arxiv_data1/oa_pdf/ab/2a/pop.2016.0033.PMC5397196.pdf
"(18),andimplementedinDAVIDBioinformaticsResource (https://david.ncifcrf.gov/ ) to measure gene pair functional similarityandidentifyfunctionalclustersofgenes.Basedon thegenome-widegene-to-genefunctionalsimilaritymatrix, SLICE then uses a K-means clustering algorithm to parti- tionBintomdistinct functional groups Fwithd(x,y)= 1−κ(x,y) as the distancemeasure.",OADS,/arxiv_data1/oa_pdf/8c/31/gkw1278.PMC5397210.pdf
We used the R ‘princurve’ package ( https://cran.r-project.org/web/ packages/princurve )forprincipalcurvefittingandcellpro- jection.,OADS,/arxiv_data1/oa_pdf/8c/31/gkw1278.PMC5397210.pdf
Thirty participantsReceived: 25 November 2016 Revised: 26 January 2017 Accepted: 11 April 2017 Heliyon 3 (2017) e00297 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
"For instance, we know that financial resources ( Herath and Henson, 2010 ), cultural differences (Azanza and Zamora-Luna, 2005 ;Bas et al., 2007 ;Panisello and Quantick, 2001 ; Vela and Fernandez, 2003 ), and lack or insufficient application of pre-requisite Article No~e00297 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Definitions from Participants Number (%) Average Self-Score (1 through 6) Correct for: Hazard 40 (56) 3.5 Risk 19 (27) 3.5 Both 14 (20) 3.5 Incorrect for: Hazard 31 (44) 3.3 Risk 52 (73) 3.4 Both 23 (32) 3.3 Article No~e00297 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
"This questionnaire included a series of statement columns to assess understanding “ [10_TD$DIFF]Now ”versus “Before ”with the possible answers for Now and Before as: A little (1); Somewhat (2); A good bit (3); Got it (4) (values given to each answer): Understand the definition of hazard and risk Recognize the differences between these terms Recognize the importance of these terms in food safety There were also two open-ended questions, and two programmatic rating questions: Article No~e00297 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Participants (%)1 Sex Female 29 (41) 7 (24) Male 42 (59) 7 (17) Age 18 –30 26 (38) 7 (27) 31–40 19 (28) 2 (11) 41–50 13 (19) 3 (23) 51–60 8 (12) 1 (13) 61 and over3 (4) 1 (33) Highest education level attainedHS2diplo- ma23 (33) 3 (13) Associate degree5 (7) 0 BS/BA3 degree34 (49) 10 (29) Post grad work2 (3) 0 Master ’s degree5 (7) 1 (20) Beyond MS/MA41 (1) 0 Years of work with foodsLess than 1 year7 (10) 3 (43) 1–5 years 22 (31) 4 (18) 6–10 years 15 (21) 1 (7) 11–20 years18 (25) 4 (22) 21–35 years9 (13) 2 (22) 36 years and over00 Food commodities I work withProduce and fruits30 5 Eggs 16 2 Meat and poultry25 2 Processed foods33 7 Dairy pro- ducts42 6 (Continued ) Article No~e00297 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
"Unfortunately, these terms are not clear for some Article No~e00297 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
"In a survey of personnel from food businesses, 85% were not able to Article No~e00297 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
"U.S. Department of Agriculture, Food Safety and Article No~e00297 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
"Title 21 of the Code of Federal Regulation Part 117 —Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food, https://federalregister.gov/a/2015-21920 .",Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
https://www.federalregister.gov/documents [19_TD $DIFF] [1_TD$ DIFF]/2015/09/17/2015- 21920/current-good-manufactu ring-practice-hazard-analysis-and-risk-based-pre- ventive-controls-for-human .,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
http://www.haccpalliance.org/sub/intro-course.html .,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
http://www.joe.org/joe/2004december/ iw4.php .,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
http://www.joe.org/joe/ 2013august/rb7.php .,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
http://www.joe.org/joe/2015august/ tt7.php .,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Article No~e00297 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00297 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/c2/main.PMC5397212.pdf
Data shows thatReceived: 4 December 2016 Revised: 22 February 2017 Accepted: 6 April 2017 Heliyon 3 (2017) e00294 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"Although, this has been a very simple, easy, and cheap means of disposal while avoiding the regulation of environmental agencies, it is often no longer Article No~e00294 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"These structures have varying size cages or channels, and have strong ion exchange properties due to the negative charge on the Article No~e00294 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"[ °C] Harwood 30.09.11 15:00 Bagasse 204 114 6.8 n/a 844 27 4.10.11 14:30 Bagasse 223 131 4.8 n/a 896 27 5.10.11 15:00 Bagasse 207 119 5.5 n/a 893 25 6.10.11 15:30 Bagasse 200 126 4 n/a 908 22 11.10.11 10:30 Coal & oil 193 89 11.1 n/a 761 2712.10.11 14:50 Coal, oil & bagasse 216 127 5.1 n/a 869 29 14.10.11 16:00 Bagasse 182 117 4.3 n/a 858 27 26.10.11 15:45 Bagasse 225 122 5.1 n/a 873 27 27.10.11 16:00 Bagasse 226 124 5.5 n/a 856 27 2.11.11 15:00 Bagasse 240 120 6.7 n/a 851 334.11.11 10:40 Coal, oil & bagasse 226 128 5 n/a 889 28 8.11.11 15:45 Bagasse 226 128 4.8 n/a 880 32 9.11.11 15:00 Bagasse 225 124 4.9 n/a 868 34 10.11.11 16:00 Bagasse 217 130 3.8 n/a 902 33 17.11.11 14:00 Bagasse 223 123 4.8 n/a 884 31 Condong 10.10.11 13:30 Wood chip (camphor) 245.4 85.2 2.13 1053 509.3 35.3 11.10.11 12:30 Bagasse & wood chip 222.2 104.4 3.7 214 506.1 40.213.10.11 12:00 Bagasse & wood chip 214.6 106.12 2.46 392 512.1 39 15.10.11 15:00 Wood chip 231.3 84.94 4.24 1052 506.1 40.5 16.10.11 17:11 Wood chip 205.6 70.91 6.15 1053 479.6 40.1 20.10.11 11:30 Bagasse 231.1 100.34 4.26 266 489.2 40.8 21.10.11 11:45 Bagasse 209.6 86.9 4.12 194 472 45 27.10.11 15:20 Bagasse 219.9 97.56 3.64 378 490.5 41.3 (Continued ) Article No~e00294 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
[ °C] 28.10.11 11:00 Bagasse & wood chip 218.1 80.71 4.8 161 472.2 47.1 1.11.11 14:40 Bagasse 173.1 92.7 5.88 107 486 41.4 3.11.11 13:00 Bagasse 216 94.85 3.79 114 486.9 41.4 4.11.11 15:00 Bagasse & wood chip 196.9 92.29 5.53 152 494.1 42.6 5.11.11 11:30 Bagasse & wood chip 183.8 63.7 5.91 214 461.4 49.2 6.11.11 11:10 Wood chip (mixed) 177.2 60.22 6.64 376 458 43.97.11.11 12:30 Bagasse & wood chip 227.1 89.99 4.67 185 499.2 39.9 8.11.11 16:00 Bagasse & wood chip 184.6 81.72 4.11 228 480 41 10.11.11 08:35 Bagasse 214.2 92.82 5.6 114 492.5 41.7 11.11.11 15:30 Bagasse & wood chip 224 88.36 5.97 211 489 43 Broadwater 15.09.11 06:00 Bagasse & wood chip 235 115 4 n/a 480 254 20.09.11 06:00 Bagasse & wood chip 235 115 4 n/a 480 254 26.09.11 06:00 Bagasse & wood chip 235 115 4 n/a 480 25426.10.11 06:00 Bagasse & wood chip 235 115 4 n/a 480 254 2.11.11 n/a Bagasse & wood chip n/a n/a n/a n/a n/a n/a 16.11.11 n/a Bagasse & wood chip n/a n/a n/a n/a n/a n/a 30.11.11 n/a Bagasse & wood chip n/a n/a n/a n/a n/a n/a 12.12.11 n/a Bagasse & wood chip n/a n/a n/a n/a n/a n/a Article No~e00294 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"The medium to high voltage and low beam current provides very good resolution, while minimising potential surface charging problems of flaring, Article No~e00294 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This Article No~e00294 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"Plant origin Fuel Sample date Fe 2O3SiO 2Al2O3MnO TiO 2CaO MgO K 2OP 2O5Na2O LOI Harwood Bagasse 30.09.11 3.10 70.68 13.79 0.12 0.84 0.99 0.95 2.57 0.27 1.24 5.45 Bagasse 4.10.11 3.11 70.57 13.68 0.15 0.82 0.81 0.87 2.41 0.25 1.28 6.05 Bagasse 5.10.11 3.48 71.33 13.64 0.11 0.83 0.87 0.91 2.50 0.25 1.34 4.74 Bagasse 6.10.11 2.83 69.27 12.98 0.14 0.75 1.29 0.95 2.69 0.29 1.20 7.61 Coal & oil 11.10.11 1.83 61.60 14.89 0.08 0.93 0.80 0.52 1.71 0.18 0.79 16.67 Coal, oil & bagasse 12.10.11 3.13 69.11 14.13 0.10 0.84 0.83 1.00 2.81 0.30 1.30 6.45 Bagasse 14.10.11 2.87 74.68 12.82 0.13 0.78 0.79 0.88 2.28 0.23 1.05 3.49 Bagasse 26.10.11 2.71 70.17 17.38 0.07 0.94 0.59 0.94 2.39 0.22 1.12 3.47 Bagasse 27.10.11 3.21 73.00 13.72 0.14 0.91 1.01 1.02 2.59 0.21 1.50 2.69 Bagasse 2.11.11 2.86 71.17 12.50 0.10 0.79 1.20 1.03 2.18 0.22 1.33 6.62 Coal, oil & bagasse 4.11.11 2.86 72.42 13.04 0.13 0.83 0.92 1.05 2.44 0.23 1.42 4.66 Bagasse 8.11.11 2.76 74.19 12.42 0.08 0.76 0.76 1.09 2.16 0.25 1.07 4.46 Bagasse 9.11.11 2.94 74.47 11.84 0.08 0.78 0.89 1.03 2.18 0.26 1.21 4.32 Bagasse 10.11.11 2.35 75.81 11.38 0.08 0.74 0.73 1.01 2.12 0.24 1.15 4.39 Bagasse 17.11.11 2.63 73.49 11.44 0.10 0.73 1.07 1.13 2.39 0.26 1.64 5.12 Condong Wood chip (camphor) 10.10.11 1.14 24.39 3.68 0.40 0.36 10.81 4.26 5.31 0.53 0.31 48.81 Bagasse & wood chip 11.10.11 2.40 68.76 9.46 0.11 0.95 1.46 0.82 2.23 0.37 0.89 12.55 Bagasse & wood chip 13.10.11 2.08 51.55 7.43 0.15 0.83 4.30 1.35 2.62 0.40 0.86 28.43 Wood chip 15.10.11 0.80 14.44 2.78 0.33 0.37 9.44 2.88 2.16 0.44 0.28 66.08 Wood chip 16.10.11 1.20 16.90 3.52 0.36 0.45 10.01 3.18 4.52 0.40 0.32 59.14 Bagasse 20.10.11 4.29 66.19 12.01 0.15 1.47 1.66 0.99 2.04 0.43 0.85 9.92 Bagasse 21.10.11 3.89 65.03 13.24 0.19 1.44 1.42 1.11 2.14 0.48 0.63 10.43 Bagasse 27.10.11 4.77 65.64 14.55 0.16 1.55 1.25 1.29 1.95 0.37 0.96 7.51 Bagasse & wood chip 28.10.11 3.13 66.64 9.63 0.13 1.19 2.20 1.18 1.63 0.25 0.86 13.16 Bagasse 1.11.11 3.55 68.01 13.88 0.08 1.32 1.30 1.25 1.91 0.39 0.99 7.32 Bagasse 3.11.11 3.09 65.86 12.78 0.14 1.04 1.25 1.49 2.56 0.40 0.85 10.54 Bagasse & wood chip 4.11.11 2.78 60.36 10.02 0.17 1.02 2.76 1.69 2.41 0.40 0.88 17.51 Bagasse & wood chip 5.11.11 2.20 70.34 7.69 0.17 0.84 2.79 1.53 2.35 0.34 0.72 11.03 Wood chip (mixed) 6.11.11 2.01 56.20 5.44 0.34 0.89 10.58 3.46 2.77 0.43 0.49 17.39 Bagasse & wood chip 7.11.11 2.39 54.62 8.60 0.22 0.81 5.33 2.79 3.29 0.39 0.31 21.25 Bagasse & wood chip 8.11.11 2.77 67.98 13.11 0.10 1.00 1.45 1.15 2.29 0.32 0.89 8.94 Bagasse 10.11.11 2.48 67.09 10.17 0.09 0.92 1.41 1.32 2.05 0.45 0.97 13.05 Bagasse & wood chip 11.11.11 2.22 53.11 7.23 0.14 0.71 3.45 1.33 1.84 0.36 0.83 28.78 Broadwater Bagasse & wood chip 15.09.11 3.89 66.67 12.10 0.12 1.73 1.00 0.60 1.55 0.46 0.27 11.61 (Continued ) Article No~e00294 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
(Continued ) Plant origin Fuel Sample date Fe 2O3SiO 2Al2O3MnO TiO 2CaO MgO K 2OP 2O5Na2O LOI Bagasse & wood chip 20.09.11 3.80 63.14 14.07 0.12 2.03 1.53 0.52 2.10 0.40 0.77 11.52 Bagasse & wood chip 26.09.11 4.70 64.95 14.77 0.17 1.90 0.96 0.45 1.68 0.30 0.40 9.72 Bagasse & wood chip 26.10.11 2.32 70.86 7.97 0.15 0.91 1.68 0.61 1.25 0.25 0.08 13.92 Bagasse & wood chip 2.11.11 4.17 68.96 12.45 0.10 2.15 0.78 1.00 1.55 0.33 0.08 8.43 Bagasse & wood chip 16.11.11 2.13 52.48 9.61 0.25 1.04 3.02 1.36 1.86 0.39 0.04 27.82 Bagasse & wood chip 30.11.11 4.92 64.67 12.41 0.11 2.11 0.93 1.22 1.63 0.33 0.81 10.86 Bagasse & wood chip 12.12.11 4.96 63.66 12.33 0.12 2.12 0.96 1.25 1.67 0.34 0.81 11.78 Article No~e00294 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"Plant origin Fuel Sample date CuO NiO CoO Cr 2O3PbO SO 2 ZnO As 2O5 SnO 2 SrO ZrO BaO V 2O5 Cl Harwood Bagasse 30.09.11 0.015 <0.001 0.002 0.005 0.004 0.151 0.011 <0.001 <0.001 0.014 0.029 0.052 0.008 <0.001 Bagasse 4.10.11 0.015 <0.001 0.001 0.006 0.004 0.011 0.01 <0.001 <0.001 0.012 0.03 0.049 0.009 <0.001 Bagasse 5.10.11 0.015 <0.001 0.002 0.006 0.005 0.011 0.011 <0.001 <0.001 0.013 0.027 0.047 0.007 <0.001 Bagasse 6.10.11 0.016 <0.001 <0.001 0.006 0.004 0.023 0.012 <0.001 <0.001 0.015 0.028 0.05 0.001 <0.001 Coal & oil 11.10.11 0.017 <0.001 0.001 0.003 <0.001 0.017 0.024 <0.001 <0.001 0.018 0.032 0.05 0.016 <0.001 Coal, oil & bagasse 12.10.11 0.015 <0.001 0.001 0.005 0.004 0.011 0.014 <0.001 <0.001 0.014 0.025 0.047 0.008 <0.001 Bagasse 14.10.11 0.016 <0.001 0.002 0.005 0.006 0.011 0.012 <0.001 <0.001 0.011 0.028 0.049 0.007 <0.001 Bagasse 26.10.11 0.033 0.011 0.021 0.018 0.023 0.011 0.021 0.014 0.03 0.022 0.04 0.044 0.014 0.008 Bagasse 27.10.11 0.034 0.01 0.021 0.019 0.024 0.015 0.02 0.014 0.031 0.025 0.048 0.047 0.009 0.007 Bagasse 2.11.11 0.035 0.016 0.02 0.02 0.021 0.013 0.018 0.014 0.027 0.025 0.047 0.038 0.011 0.013 Coal, oil & bagasse 4.11.11 0.034 0.01 0.022 0.02 0.022 0.013 0.018 0.014 0.027 0.024 0.045 0.044 0.011 0.007 Bagasse 8.11.11 0.035 0.01 0.021 0.019 0.022 0.017 0.02 0.014 0.026 0.021 0.039 0.037 0.01 0.009 Bagasse 9.11.11 0.036 0.01 0.021 0.02 0.023 0.011 0.021 0.013 0.023 0.021 0.043 0.042 0.009 0.012 Bagasse 10.11.11 0.033 0.016 0.021 0.019 0.022 0.011 0.02 0.014 0.026 0.021 0.04 0.036 0.01 0.012 Bagasse 17.11.11 0.038 0.01 0.021 0.021 0.021 0.011 0.018 0.014 0.018 0.025 0.043 0.039 0.008 0.013 Condong Wood chip (camphor) 10.10.11 <0.001 0.004 <0.001 0.003 0.004 0.103 0.007 <0.001 <0.001 0.08 0.038 0.156 <0.001 0.154 Bagasse & wood chip 11.10.11 0.015 <0.001 <0.001 0.005 0.002 0.092 0.014 <0.001 <0.001 0.014 0.023 0.041 <0.001 0.06 Bagasse & wood chip 13.10.11 0.012 <0.001 <0.001 0.004 <0.001 0.158 0.009 <0.001 <0.001 0.027 0.021 0.05 <0.001 0.082 Wood chip 15.10.11 0.033 0.001 <0.001 0.003 <0.001 0.052 0.001 <0.001 <0.001 0.065 0.03 0.077 <0.001 0.154 Wood chip 16.10.11 0.037 0.003 <0.001 0.005 <0.001 0.065 0.006 <0.001 <0.001 0.079 0.041 0.1 <0.001 0.298 Bagasse 20.10.11 0.024 <0.001 0.002 0.008 0.004 0.176 0.016 <0.001 <0.001 0.016 0.026 0.047 0.005 0.039 Bagasse 21.10.11 0.026 <0.001 0.002 0.01 0.003 0.136 0.019 <0.001 <0.001 0.013 0.023 0.051 0.005 0.023 Bagasse 27.10.11 0.027 0.014 0.021 0.023 0.021 0.118 0.025 0.015 0.056 0.025 0.044 0.037 0.01 0.057 (Continued ) Article No~e00294 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
(Continued ) Plant origin Fuel Sample date CuO NiO CoO Cr 2O3PbO SO 2 ZnO As 2O5 SnO 2 SrO ZrO BaO V 2O5 Cl Bagasse & wood chip 28.10.11 0.047 0.013 0.02 0.023 0.019 0.072 0.019 0.015 0.046 0.03 0.044 0.034 0.007 0.047 Bagasse 1.11.11 0.029 0.012 0.021 0.02 0.021 0.142 0.026 0.014 0.045 0.025 0.04 0.035 0.01 0.054 Bagasse 3.11.11 0.032 0.011 0.021 0.019 0.019 0.166 0.031 0.015 0.04 0.025 0.037 0.04 0.008 0.213 Bagasse & wood chip 4.11.11 0.038 0.04 0.02 0.029 0.018 0.091 0.025 0.015 0.047 0.036 0.045 0.044 0.006 0.168 Bagasse & wood chip 5.11.11 0.044 0.013 0.02 0.022 0.02 0.173 0.021 0.015 0.038 0.036 0.049 0.042 0.006 0.108 Wood chip (mixed) 6.11.11 0.105 0.013 0.019 0.028 0.024 0.085 0.023 0.014 0.076 0.100 0.103 0.099 0.004 0.074 Bagasse & wood chip 7.11.11 0.107 0.015 0.019 0.021 0.019 0.05 0.018 0.015 0.054 0.058 0.054 0.081 0.004 0.113 Bagasse & wood chip 8.11.11 0.042 0.011 0.02 0.021 0.021 0.124 0.022 0.014 0.036 0.027 0.042 0.046 0.009 0.128 Bagasse 10.11.11 0.033 0.01 0.019 0.02 0.018 0.089 0.022 0.014 0.034 0.023 0.033 0.037 0.009 0.057 Bagasse & wood chip 11.11.11 0.045 0.012 0.018 0.02 0.011 0.071 0.019 0.017 0.039 0.03 0.036 0.034 0.004 0.065 Broadwater Bagasse & wood chip 15.09.11 0.028 <0.001 <0.001 0.009 0.001 0.09 0.018 <0.001 <0.001 0.015 0.032 0.046 <0.001 0.057 Bagasse & wood chip 20.09.11 0.032 <0.001 <0.001 0.01 <0.001 0.100 0.02 <0.001 <0.001 0.021 0.031 0.047 0.003 0.059 Bagasse & wood chip 26.09.11 0.03 <0.001 <0.001 0.009 0.002 0.084 0.012 <0.001 <0.001 0.014 0.035 0.051 <0.001 0.061 Bagasse & wood chip 26.10.11 0.016 <0.001 0.001 0.005 0.003 0.059 0.009 0.002 <0.001 0.014 0.037 0.036 0.003 0.112 Bagasse & wood chip 2.11.11 0.017 0.013 0.021 0.024 0.02 0.083 0.021 0.014 0.074 0.021 0.05 0.025 0.007 0.083 Bagasse & wood chip 16.11.11 0.026 0.029 0.019 0.022 0.011 0.057 0.017 0.017 0.046 0.033 0.039 0.034 0.004 0.337 Bagasse & wood chip 30.11.11 0.017 0.012 0.021 0.022 0.018 0.089 0.022 0.015 0.07 0.025 0.045 0.032 0.008 0.133 Bagasse & wood chip 12.12.11 0.017 0.015 0.021 0.026 0.018 0.091 0.023 0.015 0.072 0.024 0.046 0.029 0.007 0.148 Article No~e00294 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"Fuel Fe 2O3SiO 2Al2O3MnO TiO 2CaO MgO K 2OP 2O5Na2O LOI Bagasse 3.16 70.37 13.01 0.12 0.97 1.07 1.07 2.28 0.30 1.13 6.51 Bagasse & wood chip 3.18 63.05 10.56 0.15 1.33 2.16 1.18 2.00 0.35 0.59 15.46 Wood chip 1.29 27.98 3.86 0.36 0.52 10.21 3.45 3.69 0.45 0.35 47.86 Coal & oil 1.83 61.6 14.89 0.08 0.93 0.8 0.52 1.71 0.18 0.79 16.67 Coal, oil & bagasse 3.00 70.77 13.59 0.12 0.84 0.88 1.03 2.63 0.27 1.36 5.56 Article No~e00294 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"6 C), which are larger than in the bagasse-only samples Article No~e00294 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Low Pressure polymorphs of silica (After http://www.quartzpage.de/atf.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Quartz Polymorph Stable at Meta-stable at high- or β-polymorph β-Quartz 573 –870 °C - β-Tridymite 870 –1470 °C 117 –870 °C β-Cristobalite 117 –870 °C 270 –1470 °C low- or α-polymorph α-Quartz <573 °C - α-Tridymite - <117 °C α-Cristobalite - <270 °C Article No~e00294 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Dolomite-like minerals (kutnohorite) and calcite are readily decomposed at temperatures around 750 °C to their respective calcia (CaO) and periclase (MgO) end members Article No~e00294 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
2 –4) suggesting that localized temperatures in the boilers are Article No~e00294 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Solubility of low pressure polymorphs of silica in water at 25 °C (After http://www.quartzpage.de/atf.html ).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"Substance Silica solubility in Water at 25 °C Macro-crystalline α−Quartz 2.9 mg/L ( Holleman and Wyberg, 1985 )/6–11 mg/L ( Rykart, 1995 ) Chalcedony 22 –34 mg/L ( Rykart, 1995 ) α−Cristobalite 6 mg/L ( Holleman and Wyberg, 1985 ) α−Tridymite 4.5 mg/L ( Holleman and Wyberg, 1985 ) Stishovite 11 mg/L ( Holleman and Wyberg, 1985 ) Quartz Glass (amorphous) 39 mg/L ( Holleman and Wyberg, 1985 )/120 mg/L ( Rykart, 1995 ) Article No~e00294 26 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Observational data from the phytoliths present in many of the ashes suggest that burn temperatures are much higher than those derived from the mill-supplied boiler Article No~e00294 27 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 28 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 29 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 30 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 31 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
doi:http://dx.doi.org/10.1016/j.fuel.2009.02.012 .,OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 32 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
Article No~e00294 33 http://dx.doi.org/10.1016/j.heliyon.2017.e00294 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/main.PMC5397219.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BIOPRESERVATION AND BIOBANKING Volume 15, Number 2, 2017Mary Ann Liebert, Inc.DOI: 10.1089/bio.2016.0092 126",Non-OADS,/arxiv_data1/oa_pdf/05/09/bio.2016.0092.PMC5397220.pdf
"Available at: http://biospecimens.cancer.gov/meeting/brnsymposium/ 2011/docs/Compton-508.pdf Accessed September 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/05/09/bio.2016.0092.PMC5397220.pdf
"Available at: http://journals.lww.com/oncology- times/Fulltext/2010/11100/Poor_Quality_of_Biospecimens_ Called__1_Limiting.9.aspx Accessed September 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/05/09/bio.2016.0092.PMC5397220.pdf
Available at: http://metadata-standards.org/11179/.,OADS,/arxiv_data1/oa_pdf/05/09/bio.2016.0092.PMC5397220.pdf
"Available at: https://github.com/ICO-ontology/ICO Accessed September 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/05/09/bio.2016.0092.PMC5397220.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part C Volume 23, Number 4, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tec.2016.0388 219",Non-OADS,/arxiv_data1/oa_pdf/99/31/ten.tec.2016.0388.PMC5397222.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 20, Number 2, 2017Mary Ann Liebert, Inc.DOI: 10.1089/pop.2016.0030 87",Non-OADS,/arxiv_data1/oa_pdf/0f/28/pop.2016.0030.PMC5397234.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 20, Number 2, 2017Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0185 93",Non-OADS,/arxiv_data1/oa_pdf/89/3e/pop.2015.0185.PMC5397237.pdf
"2015. http://professional2.diabetes.org/admin/UserFiles/0%20-%20Sean/Documents/Fast_Facts_ 12-2015a.pdf Accessed March 24, 2016.",Non-OADS,/arxiv_data1/oa_pdf/89/3e/pop.2015.0185.PMC5397237.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 23, Numbers 7 and 8, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2016.0364 275",Non-OADS,/arxiv_data1/oa_pdf/cc/1d/ten.tea.2016.0364.PMC5397242.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.CELL CYCLE 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"7, 634 –648 http://dx.doi.org/10.1080/15384101.2017.1288326",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Proc Natl Acad Sci U S A 2013; 110:15247-52; PMID:23986494; http://dx.doi.org/10.1073/ pnas.1314715110CELL CYCLE 645,OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Curr Opin Immunol 2013; 25:4-12; PMID:23312890; http://dx.doi.org/10.1016/j.coi.2012.12.005 [3] Messick TE, Greenberg RA.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"J Immunol2013; 190:4037-45; PMID:23509369; http://dx.doi.org/10.4049/jimmunol.1300173 [5] Cheung KJ, Ewald AJ.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Science 2016; 352:167-9; PMID:27124449; http://dx.doi.org/10.1126/science.aaf6546 [6] Clague MJ, Heride C, Urbe S. The demographics of the ubiquitin sys- tem.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Proc Natl Acad Sci U S A 2014;111:13870-5; PMID:25189770; http://dx.doi.org/10.1073/ pnas.1414358111 [8] Wu Z, Shen S, Zhang Z, Zhang W, Xiao W. Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasisthrough nuclear factor-small ka, CyrillicB mediated matrix metallo- proteinase-1 gene regulation.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Breast Cancer Res 2014; 16:R75; PMID:25022892; http://dx.doi.org/10.1186/bcr3692 [9] Deryugina EI, Quigley JP.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer Metastasis Rev 2006; 25:9-34; PMID:16680569; http://dx.doi.org/10.1007/s10555-006-7886-9 [10] Fujita T, Ikeda H, Kawasaki K, Taira N, Ogasawara Y, Nakagawara A, Doihara H. Clinicopathological relevance of UbcH10 in breast cancer.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Cancer Sci 2009; 100:238-48; PMID:19038004; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"J Cell Biol 2010; 188:83-100; PMID:20065091; http://dx.doi.org/10.1083/jcb.200906147 [12] Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Durst M, Schneider A, Pothuri B, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Genes Chromosomes Cancer 2007; 46:373-84; PMID:17243165; http://dx.doi.org/10.1002/gcc.20418 [13] Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, Hoang A, Efsta- thiou E, Sircar K, Navone NM, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Clin Cancer Res 2012; 18:666-77; PMID:22156612; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer GenetCytogenet 2006; 168:30-5; PMID:16772118; http://dx.doi.org/10.1016/j.cancergencyto.2005.12.011 [15] Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Kim WH, Im DS.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Med 2006; 12:809-16; PMID:16819549; http://dx.doi.org/10.1038/nm1440 [16] Rankin EB, Giaccia AJ.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Science 2016; 352:175-80; PMID:27124451; http://dx.doi.org/10.1126/science.aaf4405 [17] Witkiewicz AK, McMillan EA, Balaji U, Baek G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Commun 2015; 6:6744; PMID:25855536; http://dx.doi.org/10.1038/ncomms7744 [18] Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Mar- otz C, Giannopoulou E, Chakravarthi BV, Varambally S, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Nat Med 2016; 22:298-305; PMID:26855148; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Struct Mol Biol 2014; 21:301-7; PMID:24699078; http://dx.doi.org/10.1038/nsmb.2780 [20] Deshaies RJ, Joazeiro CA.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Annu Rev Biochem 2009; 78:399-434; PMID:19489725; http://dx.doi.org/ 10.1146/annurev.biochem.78.101807.093809 [21] Jang KW, Lee KH, Kim SH, Jin T, Choi EY, Jeon HJ, Kim E, Han YS, Chung JH.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Cell Biol 2009; 11:312-9; PMID:19198599; http://dx.doi.org/10.1038/ncb1839 [23] Wang Y, Ren F, Wang Y, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJ, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Carci-nogenesis 2014; 35:983-91; PMID:24302614; http://dx.doi.org/ 10.1093/carcin/bgt393 [24] Wang T, Yang J, Xu J, Li J, Cao Z, Zhou L, You L, Shu H, Lu Z, Li H, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oncotarget 2014; 5:1969-86; PMID:24722501; http://dx.doi.org/10.18632/oncotarget.1890 [25] Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H, Gelmon K, Chia S, Mar C, Wan A, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2015; 518:422-6; PMID:25470049; http://dx.doi.org/10.1038/nature13952 [26] Welcker M, Clurman BE.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/ 10.1038/nrc2290 [27] Ibusuki M, Yamamoto Y, Shinriki S, Ando Y, Iwase H. Reduced expression of ubiquitin ligas e FBXW7 mRNA is associated with poor prognosis in breast can cer patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer Sci 2011; 102:439-45; PMID:21134077; http://dx.doi.org/10.1111/j.1349- 7006.2010.01801.x [28] Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oncotarget2015; 6:6310-25; PMID:25749036; http://dx.doi.org/10.18632/ oncotarget.3355 [30] Quail DF, Joyce JA.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Med 2013; 19:1423-37;PMID:24202395; http://dx.doi.org/10.1038/nm.3394 [31] Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Nature 2014; 507:508-12; PMID:24553136; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cell reports 2015; 10:88-102;PMID:25543140; http://dx.doi.org/10.1016/j.celrep.2014.12.012 [33] Tsai YC, Mendoza A, Mariano JM, Zhou M, Kostova Z, Chen B, Veenstra T, Hewitt SM, Helman LJ, Khanna C, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Med 2007; 13:1504-9; PMID:18037895; http://dx.doi.org/10.1038/nm1686 [34] Zhang L, Zhou F, Garcia de Vinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Cell 2013; 51:559-72; PMID:23973329; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"J Pathol 2015; 237:179-89; PMID:26095796; http://dx.doi.org/10.1002/path.4573 [36] Lin JH, Hsieh SC, Chen JN, Tsai MH, Chang CC.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116:221-31; PMID:23849376; http://dx.doi.org/10.1016/j.oooo.2013.05.006 [37] Cheng Q, Cao X, Yuan F, Li G, Tong T. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Biochem Biophys ResCommun 2014; 448:248-54; PMID:24792179; http://dx.doi.org/10.1016/j.bbrc.2014.04.117 [38] Zhang L, Wu Z, Ma Z, Liu H, Wu Y, Zhang Q. WWP1 as a potential tumor oncogene regulates PTEN-Akt signaling pathway in humangastric carcinoma.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Tumour Biol 2015; 36:787-98; PMID:25293520;http://dx.doi.org/10.1007/s13277-014-2696-0 [39] Chen C, Zhou Z, Ross JS, Zhou W, Dong JT.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Int J Cancer2007; 121:80-7; PMID:17330240; http://dx.doi.org/10.1002/ijc.22653 [40] Chen C, Zhou Z, Sheehan CE, Slodkowska E, Sheehan CB, Bogunie- wicz A, Ross JS.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Int J Cancer 2012; 130:1504-10;PMID:21480222; http://dx.doi.org/10.1002/ijc.26122 [42] Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W, Zhou Z, Petros J, Frierson HF, Jr., Vessella RL, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oncogene 2007; 26:2386- 94; PMID:17016436; http://dx.doi.org/10.1038/sj.onc.1210021 [43] Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scienti ﬁc review.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Eur J Hum Genet 2011; 19:617-23; PMID:21386872; http://dx.doi.org/10.1038/ejhg.2010.175 [44] Feng C, Sun Y, Ding G, Wu Z, Jiang H, Wang L, Ding Q, Wen H. PI3Kbeta inhibitor TGX221 selectively inhibits renal cell carcinomacells with both VHL and SETD2 mutations and links multiple path-ways.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Scienti ﬁc reports 2015; 5:9465; PMID:25853938; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer Res 2011; 71:5500-11; PMID:21715564; http://dx.doi.org/10.1158/0008-5472.CAN-11-0757 [46] Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J, Mur- amatsu H, O ’Keefe C, Hsi E, Paquette RL, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"J Clin Oncol 2009;27:6109-16; PMID:19901108; http://dx.doi.org/10.1200/ JCO.2009.23.7503 [47] Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O ’Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Blood 2010; 115:1969-75; PMID:20008299; http://dx.doi.org/10.1182/blood-2009-06-226340 [48] Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C, Kreil S, Jones A, Score J, Metzgeroth G, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Blood 2009; 113:6182-92; PMID:19387008;http://dx.doi.org/10.1182/blood-2008-12-194548 [49] Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S, Mullighan CG, Chen L, Bergstraesser E, Bueso-Ramos CE, et al.Mutations in CBL occur frequently in juvenile myelomonocytic leu-kemia.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Blood 2009; 114:1859-63; PMID:19571318; http://dx.doi.org/ 10.1182/blood-2009-01-198416 [50] Sargin B, Choudhary C, Crosetto N, Schmidt MH, Grundler R, Rensinghoff M, Thiessen C, Tickenbrock L, Schwable J, Brandts C,et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Blood 2007; 110:1004-12; PMID:17446348; http://dx.doi.org/10.1182/blood-2007-01-066076 [51] Kassenbrock CK, Anderson SM.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Ann Hematol 2015; 94:1817-28; PMID:26341754; http://dx.doi.org/10.1007/s00277-015-2474-0 [54] Cancer Genome Atlas Research N. Comprehensive molecular char- acterization of urothelial bladder carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2014; 507:315- 22; PMID:24476821; http://dx.doi.org/10.1038/nature12965 [55] Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman V, Jaiswal BS, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2012; 488:660-4;PMID:22895193; http://dx.doi.org/10.1038/nature11282 [56] Jones S, Stransky N, McCord CL, Cerami E, Lagowski J, Kelly D, Angiuoli SV, Sausen M, Kann L, Shukla M, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Commun 2014; 5:5006;PMID:25233892; http://dx.doi.org/10.1038/ncomms6006 [57] Muller E, Brault B, Holmes A, Legros A, Jeannot E, Campitelli M, Rousselin A, Goardon N, Frebourg T, Krieger S, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer Med 2015; 4:1484-93; PMID:26155992; http://dx.doi.org/10.1002/cam4.492 [58] Aydin IT, Melamed RD, Adams SJ, Castillo-Martin M, Demir A, Bryk D, Brunner G, Cordon-Cardo C, Osman I, Rabadan R, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"J Natl Cancer Inst 2014; 106:dju107; PMID:24838835; http://dx.doi.org/10.1093/jnci/dju107 [59] Sato M, Rodriguez-Barrueco R, Yu J, Do C, Silva JM, Gautier J. MYC is a critical target of FBXW7.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oncotarget 2015; 6:3292-305; PMID:25669969; http://dx.doi.org/10.18632/oncotarget.3203 [60] Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R, Susaki E, Nakagawa T, Matsumoto A, Nakayama KI.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"PLoS One 2014; 9:e89388; PMID:24586741; http://dx.doi.org/10.1371/journal.pone.0089388 [63] Villaruz LC, Socinski MA.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Lung cancer (Amsterdam, Netherlands) 2014; 83:300-1; PMID:24360397; http://dx.doi.org/10.1016/j.lungcan.2013.11.018 [64] Morrison BJ, Morris JC, Steel JC.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Target Oncol 2013; 8:159-72; PMID:23314952; http://dx.doi.org/10.1007/s11523-012-0247-4 [65] Kh ammanivong A, Gopalakrishnan R, Dickerson EB.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Mol Cancer 2014; 13:260; PMID:25471937; http://dx.doi.org/10.1186/1476-4598-13-260CELL CYCLE 647,Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Onco-target 2014; 5:5591-601; PMID:25015320; http://dx.doi.org/ 10.18632/oncotarget.2149 [67] Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A, Stagg LJ, Lad- bury JE, Cai Z, Xu D, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cell 2013; 154:556-68; PMID:23911321; http://dx.doi.org/10.1016/j.cell.2013.06.048 [68] Aki D, Zhang W, Liu YC.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cell Death Dis 2014; 5:e1203; http://dx.doi.org/10.1038/cddis.2014.113 [70] Bongiorno-Borbone L, Giacobbe A, Compagnone M, Eramo A, De Maria R, Peschiaroli A, Melino G. Anti-tumoral effect of desmethyl- clomipramine in lung cancer stem cells.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oncotarget 2015; 6:16926-38; PMID:26219257; http://dx.doi.org/10.18632/oncotarget.4700 [71] Takeishi S, Nakayama KI.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Br J Cancer 2014;111:1054-9; PMID:24853181; http://dx.doi.org/10.1038/bjc.2014.259 [72] Wang Y, Liu Y, Lu J, Zhang P, Wang Y, Xu Y, Wang Z, Mao JH, Wei G. Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal can-cer cells.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Biochem Biophys Res Commun 2013; 434:352-6;PMID:23558291; http://dx.doi.org/10.1016/j.bbrc.2013.03.077 [73] Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A, Nakayama KI.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer Cell 2013; 23:347-61; PMID:23518349; http://dx.doi.org/10.1016/j.ccr.2013.01.026 [74] D ’Arcy P, Wang X, Linder S. Deubiquitinase inhibition as a cancer therapeutic strategy.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Pharmacol Ther 2015; 147:32-54;PMID:25444757; http://dx.doi.org/10.1016/j.pharmthera.2014.11.002 [75] Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Mol Cancer Ther 2009; 8:2286-95; PMID:19671755; http://dx.doi.org/10.1158/1535-7163.MCT-09-0097 [76] Zhao GY, Lin ZW, Lu CL, Gu J, Yuan YF, Xu FK, Liu RH, Ge D, Ding JY.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Tumour Biol 2015; 36:1721-9; PMID:25519684; http://dx.doi.org/10.1007/s13277-014-2773-4 [77] Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feld- stein J, Pandol ﬁPP.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2008; 455:813-7; PMID:18716620; http://dx.doi.org/10.1038/nature07290 [78] Rivlin N, Katz S, Doody M, Sheffer M, Horesh S, Molchadsky A, Koifman G, Shetzer Y, Gold ﬁnger N, Rotter V, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2010; 463:103-7; PMID:20023629; http://dx.doi.org/10.1038/nature08646 [81] Kushwaha D, O ’Leary C, Cron KR, Deraska P, Zhu K, D ’Andrea AD, Kozono D. USP9X inhibition promotes radiation-induced apoptosisin non-small cell lung cancer cells expressing mid-to-high MCL1.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cancer Biol Ther 2015; 16:392-401; PMID:25692226; http://dx.doi.org/10.1080/15384047.2014.1002358 [82] Gu YY, Yang M, Zhao M, Luo Q, Yang L, Peng H, Wang J, Huang SK, Zheng ZX, Yuan XH, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"The de-ubiquitinase UCHL1 pro- motes gastric cancer metastasis via the Akt and Erk1/2 pathways.Tumour Biol 2015; 36:8379-87; PMID:26018507; http://dx.doi.org/ 10.1007/s13277-015-3566-0 [83] Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, Kim HJ, Lee KJ.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Commun 2015; 6:6153; PMID:25615526; http://dx.doi.org/10.1038/ncomms7153 [85] Xiang T, Li L, Yin X, Yuan C, Tan C, Su X, Xiong L, Putti TC, Oberst M, Kelly K, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"PLoS One 2012; 7:e29783;PMID:22279545; http://dx.doi.org/10.1371/journal.pone.0029783 [86] Ummanni R, Jost E, Braig M, Lohmann F, Mundt F, Barett C, Schlomm T, Sauter G, Senff T, Bokemeyer C, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Mol Cancer 2015; 14:8; PMID:25623341;http://dx.doi.org/10.1186/s12943-014-0280-2 [88] Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, Yu H, Lin J, Ye W, Liu J, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Mol Cancer 2014; 13:258;PMID:25431208; http://dx.doi.org/10.1186/1476-4598-13-258 [89] Karunarathna U, Kongsema M, Zona S, Gong C, Cabrera E, Gomes AR, Man EP, Khongkow P, Tsang JW, Khoo US, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Oncogene 2016; 35:1433-44; PMID:26148240; http://dx.doi.org/10.1038/onc.2015.208 [90] Huang X, Dixit VM.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Cell Res 2016; 26:484-98; PMID:27002218; http://dx.doi.org/10.1038/cr.2016.31 [91] Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y, Lim E. Clinical Overview of MDM2/X-Targeted Therapies.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Front Oncol 2016; 6:7;PMID:26858935; http://dx.doi.org/10.3389/fonc.2016.00007 [92] Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer.,OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
Nature 2012; 487:330-7;PMID:22810696; http://dx.doi.org/10.1038/nature11252 [93] Cancer Genome Atlas Research N. Comprehensive molecular char- acterization of gastric adenocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2014; 513:202-9; PMID:25079317; http://dx.doi.org/10.1038/nature13480 [94] Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nature 2013; 497:67-73; PMID:23636398; http://dx.doi.org/10.1038/nature12113 [95] Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"Nat Genet 2016; 48:607-16; PMID:27158780; http://dx.doi.org/10.1038/ng.3564 [96] Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, et al.",OADS,/arxiv_data1/oa_pdf/8b/02/kccy-16-07-1288326.PMC5397262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.CELL CYCLE 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"7, 613 –633 http://dx.doi.org/10.1080/15384101.2017.1288322",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"ORCID Michalis Fragkos http://orcid.org/0000-0003-2721-4327 References [1] Sirbu BM, Cortez D. DNA damage response: three levels of DNA repair regulation.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Cold Spring Harb Perspect Biol 2013; 5(8): a012724; PMID:23813586; http://dx.doi.org/10.1101/cshperspect.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Nat Cell Biol 2014; 16(1):2-9; PMID:24366029; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2003; 300(5625):1542-8;PMID:12791985; http://dx.doi.org/10.1126/science.1083430 [4] Branzei D, Foiani M. The checkpoint response to replication stress.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Front Genet 2013; 4, 26; PMID:23493417; http://dx.doi.org/10.3389/fgene.2013.00026 [6] Bergoglio V, Boyer AS, Walsh E, Naim V, Legube G, Lee MY, Rey L, Rosselli F, Cazaux C, Eckert KA, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2013; 201(3):395-408; PMID:23609533;http://dx.doi.org/10.1083/jcb.201207066 [7] Le Beau MM, Rassool FV, Neilly ME, Espinosa R 3rd, Glover TW, Smith DI, McKeithan TW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"HumMol Genet 1998; 7(4):755-61; PMID:9499431; http://dx.doi.org/ 10.1093/hmg/7.4.755 [8] Widrow RJ, Hansen RS, Kawame H, Gartler SM, Laird CD.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Proc Natl Acad Sci U S A 1998; 95(19):11246-50; PMID:9736721; http://dx.doi.org/ 10.1073/pnas.95.19.11246 [9] Hirano T. Chromosome Dynamics during Mitosis.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Cold Spring Harb Perspect Biol 2015; 7(6):1 –14; PMID:25722466; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"CurrBiol 2014; 24(4):R148-9; PMID:24556433; http://dx.doi.org/ 10.1016/j.cub.2014.01.019 [12] Naim V, Rosselli F. The FANC pathway and BLM collaborate dur- ing mitosis to prevent micro-nucleation and chromosome abnor-malities.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"NatCell Biol 2009; 11(6):753-60; PMID:19465922; http://dx.doi.org/ 10.1038/ncb1882 [14] Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM, Gronroos E, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2013; 494(7438):492-6; PMID:23446422;http://dx.doi.org/10.1038/nature11935 [15] Naim V, Rosselli F. The FANC pathway and mitosis: a replication legacy.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO J 2007; 26(14):3397-409; PMID:17599064; http://dx.doi.org/10.1038/sj.emboj.7601777 [17] Lukas C, Savic V, Bekker-Jensen S, Doil C, Neumann B, Pedersen RS, Grøfte M, Chan KL, Hickson ID, Bartek J, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Cell Biol 2011; 13(3):243-53; PMID:21317883; http://dx.doi.org/10.1038/ncb2201 [18] Harrigan JA, Belotserkovskaya R, Coates J, Dimitrova DS, Polo SE, Bradshaw CR, Fraser P, Jackson SP.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2011; 193(1):97-108; PMID:21444690; http://dx.doi.org/10.1083/jcb.201011083 [19] Baumann C, K €orner R, Hofmann K, Nigg EA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2007; 128(1):101-14;PMID:17218258; http://dx.doi.org/10.1016/j.cell.2006.11.041 [20] Naim V, Wilhelm T, Debatisse M, Rosselli F. ERCC1 and MUS81- EME1 promote sister chromatid separation by processing late repli-cation intermediates at common fragile sites during mitosis.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"NatCell Biol 2013; 15(8):1008-15; PMID:23811686; http://dx.doi.org/ 10.1038/ncb2793 [21] Ying S, Minocherhomji S, Chan KL, Palmai-Pallag T, Chu WK, Wass T, Mankouri HW, Liu Y, Hickson ID.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Cell Biol 2013; 15(8):1001-7; PMID:23811685; http://dx.doi.org/10.1038/ncb2773 [22] Minocherhomji S, Ying S, Bjerregaard VA, Bursomanno S, Aleliu- naite A, Wu W, Mankouri HW, Shen H, Liu Y, Hickson ID.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature2015; 528(7581):286-90; PMID:26633632; http://dx.doi.org/10.1038/nature16139 [23] Pedersen RT, Kruse T, Nilsson J, Oestergaard VH, Lisby M. TopBP1 is required at mitosis to reduce transmission of DNA dam-age to G1 daughter cells.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2015; 210(4):565-82;PMID:26283799; http://dx.doi.org/10.1083/jcb.201502107 [24] Wild P, Matos J.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Curr Opin Cell Biol 2016; 40, 74-80; PMID:26970388; http://dx.doi.org/10.1016/j.ceb.2016.02.018 [25] Fragkos M, Ganier O, Coulombe P, M /C19echali M. DNA replication origin activation in space and time.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Mol Cell Biol 2015; 16 (6):360-74; PMID:25999062; http://dx.doi.org/10.1038/nrm4002 [26] Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ, Hartford SA, Tye BK, Schimenti JC.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice.Nat Genet 2007; 39(1):93-8; PMID:17143284; http://dx.doi.org/10.1038/ng1936 [27] Kawabata T, Luebben SW, Yamaguchi S, Ilves I, Matise I, Buske T, Botchan MR, Shima N. Stalled fork rescue via dormant replicationorigins in unchallenged S phase promotes proper chromosome seg-regation and tumor suppression.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2011; 41(5):543-53; PMID:21362550; http://dx.doi.org/10.1016/j.molcel.2011.02.006 [28] Letessier A, Millot GA, Koundrioukoff S, Lachag /C18es AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M. Cell-type-speci ﬁc replication initiation programs set fragility of the FRA3B fragile site.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2011; 470(7332):120-3; PMID:21258320; http://dx.doi.org/10.1038/nature09745 [29] Ozeri-Galai E, Lebofsky R, Rahat A, Bester AC, Bensimon A, Kerem B.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cell 2011; 43(1):122-31; PMID:21726815; http://dx.doi.org/10.1016/j.molcel.2011.05.019 [30] Aparicio OM.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genes Dev 2013; 27(2):117-28; PMID:23348837; http://dx.doi.org/10.1101/gad.209999.112 [31] Toledo LI, Altmeyer M, Rask MB, Lukas C, Larsen DH, Povlsen LK, Bekker-Jensen S, Mailand N, Bartek J, Lukas J. ATR prohibits repli- cation catastrophe by preventing global exhaustion of RPA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell2013; 155(5):1088-103; PMID:24267891; http://dx.doi.org/10.1016/j.cell.2013.10.043 [32] Magdalou I, Lopez BS, Pasero P, Lambert SA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"The causes of replica- tion stress and their consequences on genome stability and cell fate.Semin Cell Dev Biol 2014; 30, 154-64; PMID:24818779; http://dx.doi.org/10.1016/j.semcdb.2014.04.035 [33] Blow JJ, Ge XQ, Jackson DA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Trends Biochem Sci 2011; 36(8):405-14;PMID:21641805; http://dx.doi.org/10.1016/j.tibs.2011.05.002 [34] Ge XQ, Jackson DA, Blow JJ.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genes Dev 2007; 21(24):3331-41; PMID:18079179; http://dx.doi.org/10.1101/gad.457807 [35] Woodward AM, G €ohler T, Luciani MG, Oehlmann M, Ge X, Gart- ner A, Jackson DA, Blow JJ.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Excess Mcm2-7 license dormant originsof replication that can be used under conditions of replicative stress.J Cell Biol 2006; 173(5):673-83; PMID:16754955; http://dx.doi.org/ 10.1083/jcb.200602108 [36] Ibarra A, Schwob E, M /C19endez J.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2003; 114(3):385-94; PMID:12914702; http://dx.doi.org/10.1016/S0092-8674(03)00569-5 [38] Rybak P, Walig /C19orska A, Bujnowicz º, Hoang A, Dobrucki JW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Cell Cycle 2015; 14(16):2634-47; PMID:26212617; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"DNA Repair (Amst) 2015; 32, 149-57; PMID:25957489; http://dx.doi.org/10.1016/j.dnarep.2015.04.026 [40] Branzei D, Foiani M. Interplay of replication checkpoints and repair proteins at stalled replication forks.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
DNA Repair (Amst) 2007; 6 (7):994-1003; PMID:17382606; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Nat Struct Mol Biol 2016; 23(2):103-9; PMID:26840898; http://dx.doi.org/10.1038/nsmb.3163 [43] Lehmann AR.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Replication of UV-damaged DNA: new insights into links between DNA polymerases, mutagenesis and human disease.Gene 2000; 253(1):1-12; PMID:10925197; http://dx.doi.org/ 10.1016/S0378-1119(00)00250-X [44] Ward IM, Minn K, Chen J. UV-induced ataxia-telangiectasia- mutated and Rad3-related (ATR) activation requires replicationstress.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Hum Genet 1984; 67(2):136-42; PMID:6430783; http://dx.doi.org/10.1007/BF00272988 [46] Byrnes JJ.,Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biochem 1984; 62(1):13- 24; PMID:6330522; http://dx.doi.org/10.1007/BF00230073 [47] Cheng CH, Kuchta RD.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Biochem J 2004; 382(Pt 2):535-43; PMID:15175013; http://dx.doi.org/10.1042/BJ20031833 [49] Poli J, Tsaponina O, Crabb /C19e L, Keszthelyi A, Pantesco V, Chabes A, Lengronne A, Pasero P. dNTP pools determine fork progression and origin usage under replication stress.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO J 2012; 31(4):883-94; PMID:22234185; http://dx.doi.org/10.1038/emboj.2011.470 [50] Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. Hydroxy- urea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart andrepair.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2010; 37(4):492-502; PMID:20188668; http://dx.doi.org/10.1016/j.molcel.2010.01.021 [51] Aparicio JG, Viggiani CJ, Gibson DG, Aparicio OM.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol 2004; 24(11):4769-80; PMID:15143171; http://dx.doi.org/10.1128/ MCB.24.11.4769-4780.2004 [52] Bickmore WA, Carothers AD.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Cancer 2006; 6(10):789-802; PMID:16990856;http://dx.doi.org/10.1038/nrc1977 [54] Lambert S, Carr AM.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Chromosoma2013; 122(1-2):33-45; PMID:23446515; http://dx.doi.org/10.1007/s00412-013-0398-9 [55] Tarsounas M, Tijsterman M. Genomes and G-quadruplexes: for better or for worse.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Mol Biol 2013; 425(23):4782-9;PMID:24076189; http://dx.doi.org/10.1016/j.jmb.2013.09.026[56] Mendoza O, Bourdoncle A, Boul /C19e JB, Brosh RM Jr, Mergny JL.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2016; 44(5):1989-2006; PMID:26883636; http://dx.doi.org/10.1093/nar/gkw079 [57] Branzei D, Foiani M. Maintaining genome stability at the replica- tion fork.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Mol Cell Biol 2010; 11(3):208-19; PMID:20177396; http://dx.doi.org/10.1038/nrm2852 [58] Martinez P, Blasco MA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Trends Biochem Sci 2015; 40(9):504-15; PMID:26188776; http://dx.doi.org/10.1016/j.tibs.2015.06.003 [59] Zimmer J, Tacconi EM, Folio C, Badie S, Porru M, Klare K, Tumiati M, Markkanen E, Halder S, Ryan A, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2016; 61(3):449-60; PMID:26748828; http://dx.doi.org/10.1016/j.molcel.2015.12.004 [60] Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T. Mammalian telomeres resemble fragile sites and require TRF1 for ef ﬁcient replication.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2009; 138(1):90- 103; PMID:19596237; http://dx.doi.org/10.1016/j.cell.2009.06.021 [61] Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, Ding H, Boul- ton SJ.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2012; 149(4):795-806;PMID:22579284; http://dx.doi.org/10.1016/j.cell.2012.03.030 [62] Aguilera A, Garcia-Muse T. Causes of genome instability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Annu Rev Genet 2013; 47, 1-32; PMID:23909437; http://dx.doi.org/10.1146/annurev-genet-111212-133232 [63] Lebofsky R, Bensimon A. DNA replication origin plasticity and per- turbed fork progression in human inverted repeats.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol 2005; 25(15):6789-97; PMID:16024811; http://dx.doi.org/10.1128/MCB.25.15.6789-6797.2005 [64] Akamatsu Y, Kobayashi T. The Human RNA Polymerase I Tran- scription Terminator Complex Acts as a Replication Fork Barrier That Coordinates the Progress of Replication with rRNA Transcrip- tion Activity.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol 2015; 35(10):1871-81; PMID:25776556; http://dx.doi.org/10.1128/MCB.01521-14 [65] Brewer BJ, Fangman WL.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 1988; 55(4):637-43;PMID:3052854; http://dx.doi.org/10.1016/0092-8674(88)90222-X [66] Kobayashi T, Horiuchi T. A yeast gene product, Fob1 protein, required for both replication fork blocking and recombinationalhotspot activities.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genes Cells 1996; 1(5):465-74; PMID:9078378;http://dx.doi.org/10.1046/j.1365-2443.1996.d01-256.x [67] Linskens MH, Huberman JA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol1988; 8(11):4927-35; PMID:3062373; http://dx.doi.org/10.1128/ MCB.8.11.4927 [68] Lopez-estrano C, Schvartzman JB, Krimer DB, Hern /C19andez P. Co- localization of polar replication fork barriers and rRNA transcrip-tion terminators in mouse rDNA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Mol Biol 1998; 277(2):249-56; PMID:9514756; http://dx.doi.org/10.1006/jmbi.1997.1607 [69] Gerber JK, G €ogel E, Berger C, Wallisch M, M €uller F, Grummt I, Grummt F. Termination of mammalian rDNA replication: polararrest of replication fork movement by transcription termination factor TTF-I.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Cell 1997; 90(3):559-67; PMID:9267035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Differentia- tion 2008; 76(1):15-23; PMID:17825083; http://dx.doi.org/10.1111/ j.1432-0436.2007.00220.x [71] Porter AC, Farr CJ.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Chromosome Res 2004; 12(6):569-83; PMID:15289664; http://dx.doi.org/10.1023/B:CHRO.0000036608.91085.d1 [72] Rouzeau S, Cordeli /C18eres FP, Buhagiar-Labarch /C18ede G, Hurbain I, Onclercq-Delic R, Gemble S, Magnaghi-Jaulin L, Jaulin C, Amor- Gu/C19eret M. Bloom ’s syndrome and PICH helicases cooperate with topoisomerase IIalpha in centromere disjunction before anaphase.PLoS One 2012; 7(4):e33905; PMID:22563370; http://dx.doi.org/10.1371/journal.pone.0033905 [73] Azvolinsky A, Dunaway S, Torres JZ, Bessler JB, Zakian VA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"20(22):3104-16; PMID:17114583; http://dx.doi.org/10.1101/ gad.1478906 [74] Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, et al.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2005; 434(7035):907-13; PMID:15829965; http://dx.doi.org/10.1038/nature03485 [75] Halazonetis TD, Gorgoulis VG, Bartek J.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2008; 319(5868):1352-5; PMID:18323444; http://dx.doi.org/10.1126/science.1140735 [76] Maya-Mendoza A, Ostrakova J, Kosar M, Hall A, Duskova P, Mis- trik M, Merchut-Maya JM, Hodny Z, Bartkova J, Christensen C, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Oncogene 2008; 27 (23):3256-64 [78] Bartkova J, Horejs /C19ıZ, Koed K, Kr €amer A, Tort F, Zieger K, Guld- berg P, Sehested M, Nesland JM, Lukas C. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.Nature 2005; 434(7035):864-70; PMID:15829956; http://dx.doi.org/10.1038/nature03482 [79] Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al.Oncogene-induced senescence is part of the tumorigenesis barrierimposed by DNA damage checkpoints.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2006; 444 (7119):633-7; PMID:17136093; http://dx.doi.org/10.1038/ nature05268 [80] Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V, Fumagalli M, Di Micco R, Mirani N, Gurung RL.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO J 2012; 31(13):2839-51;PMID:22569128; http://dx.doi.org/10.1038/emboj.2012.132 [81] Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre 0M, Nuciforo PG, Bensimon A, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2006; 444(7119):638-42; PMID:17136094; http://dx.doi.org/10.1038/nature05327 [82] Hills SA, Dif ﬂey JF.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Curr Biol 2014; 24(10):R435-44; PMID:24845676; http://dx.doi.org/10.1016/j.cub.2014.04.012 [83] Ekholm-Reed S, M /C19endez J, Tedesco D, Zetterberg A, Stillman B, Reed SI.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2004; 165(6):789-800; PMID:15197178; http://dx.doi.org/10.1083/jcb.200404092 [84] Jones RM, Mortusewicz O, Afzal I, Lorvellec M, Garc /C19ıa P, Helleday T, Petermann E. Increased replication initiation and con ﬂicts with transcription underlie Cyclin E-induced replication stress.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Onco- gene 2013; 32(32):3744-53; PMID:22945645; http://dx.doi.org/ 10.1038/onc.2012.387 [85] Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B. Nucleotide de ﬁ- ciency promotes genomic instability in early stages of cancer devel- opment.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2011; 145(3):435-46; PMID:21529715; http://dx.doi.org/10.1016/j.cell.2011.03.044 [86] Xie M, Yen Y, Owonikoko TK, Ramalingam SS, Khuri FR, Curran WJ, Doetsch PW, Deng X. Bcl2 induces DNA replication stress byinhibiting ribonucleotide reductase.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cancer Res 2014; 74(1):212-23;PMID:24197132; http://dx.doi.org/10.1158/0008-5472.CAN-13- 1536-T [87] Burhans WC, Weinberger M. DNA replication stress, genome instability and aging.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2007; 35(22):7545-56;PMID:18055498; http://dx.doi.org/10.1093/nar/gkm1059 [88] Ogrunc M, Di Micco R, Liontos M, Bombardelli L, Mione M, Fumagalli M, Gorgoulis VG, d ’Adda di Fagagna F. Oncogene- induced reactive oxygen species fuel hyperproliferation and DNAdamage response activation.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Death Differ 2014; 21(6):998- 1012; PMID:24583638; http://dx.doi.org/10.1038/cdd.2014.16 [89] Wilhelm T, Ragu S, Magdalou I, Machon C, Dardillac E, T /C19echer H, Guitton J, Debatisse M, Lopez BS.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"PLoS Genet 2016; 12(5):e1006007;PMID:27135742; http://dx.doi.org/10.1371/journal.pgen.1006007 [90] Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amineoxidase homolog LSD1.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2004; 119(7):941-53; PMID:15620353;http://dx.doi.org/10.1016/j.cell.2004.12.012 [91] Brooks PJ, Theruvathu JA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Alcohol 2005; 35(3):187-93; PMID:16054980; http://dx.doi.org/10.1016/j.alcohol.2005.03.009 [92] Garaycoechea JI, Patel KJ.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Biol Chem 2005; 280 (47):39337-45; PMID:16188892; http://dx.doi.org/10.1074/jbc.M503320200 [94] Groth A, Rocha W, Verreault A, Almouzni G. Chromatin chal- lenges during DNA replication and repair.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2007; 128(4):721-33; PMID:17320509; http://dx.doi.org/10.1016/j.cell.2007.01.030 [95] Clemente-Ruiz M, Prado F. Chromatin assembly controls replica- tion fork stability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO Rep 2009; 10(7):790-6; PMID:19465889; http://dx.doi.org/10.1038/embor.2009.67 [96] Mejlvang J, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Chromosoma 2016; 125(3):523-33; http://dx.doi.org/ 10.1007/s00412-015-0545-6 [98] Tabancay AP, Jr., Forsburg SL.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2006; 281(5382):1502-6;PMID:9727975; http://dx.doi.org/10.1126/science.281.5382.1502 [100] Gottipati P, Cassel TN, Savolainen L, Helleday T. Transcription- associated recombination is dependent on replication in Mamma- lian cells.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol 2008; 28(1):154-64; PMID:17967877; http://dx.doi.org/10.1128/MCB.00816-07 [101] Poli J, Gerhold CB, Tosi A, Hustedt N, Seeber A, Sack R, Herzog F, Pasero P, Shimada K, Hopfner KP, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genes Dev 2016; 30(3):337-54; PMID:26798134; http://dx.doi.org/10.1101/ gad.273813.115 [102] Lafon A, Taranum S, Pietrocola F, Dingli F, Loew D, Brahma S, Bartholomew B, Papamichos-Chronakis M. INO80 Chromatin Remodeler Facilitates Release of RNA Polymerase II from Chro- matin for Ubiquitin-Mediated P roteasomal Degradation.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2015; 60(5):784-96; PMID:26656161; http://dx.doi.org/10.1016/j.molcel.2015.10.028 [103] Poveda AM, Le Clech M, Pasero P. Transcription and replication: breaking the rules of the road causes genomic instability.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Transcrip-tion 2010; 1(2):99-102; PMID:21326900; http://dx.doi.org/10.4161/ trns.1.2.12665 [104] Santos-Pereira JM, Aguilera A. R loops: new modulators of genome dynamics and function.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Genet 2015; 16(10):583-97;PMID:26370899; http://dx.doi.org/10.1038/nrg3961 [105] Sollier J, Stork CT, Garc /C19ıa-Rubio ML, Paulsen RD, Aguilera A, Cim- prich KA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cell 2014; 56(6):777-85; PMID:25435140; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2012; 151(4):835-46;PMID:23141540; http://dx.doi.org/10.1016/j.cell.2012.09.041 [107] Li X, Manley JL.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genes Dev 2006; 20(14):1838-47; PMID:16847344; http://dx.doi.org/10.1101/gad.1438306 [108] Gomez-Gonzalez B, Garc /C19ıa-Rubio M, Bermejo R, Gaillard H, Shira- hige K, Mar /C19ın A, Foiani M, Aguilera A. Genome-wide function of THO/TREX in active genes prevents R-loop-dependent replicationobstacles.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO J 2011; 30(15):3106-19; PMID:21701562; http://dx.doi.org/10.1038/emboj.2011.206 [109] Stirling PC, Chan YA, Minaker SW, Aristizabal MJ, Barrett I, Sipahimalani P, Kobor MS, Hieter P. R-loop-mediated genomeinstability in mRNA cleavage and polyadenylation mutants.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"GenesDev 2012; 26(2):163-75; PMID:22279048; http://dx.doi.org/ 10.1101/gad.179721.111 [110] Wahba L, Gore SK, Koshland D. The homologous recombination machinery modulates the formation of RNA-DNA hybrids andassociated chromosome instability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Elife 2, e00505; PMID:23795288; http://dx.doi.org/10.7554/eLife.00505 [111] Ginno PA, Lim YW, Lott PL, Korf I, Ch /C19edin F. (2013) GC skew at the 5 0and 30ends of human genes links R-loop formation to epige- netic regulation and transcription termination.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genome Res 2013; 23(10):1590-600; PMID:23868195; http://dx.doi.org/10.1101/gr.158436.113 [112] Aguilera A, Garcia-Muse T. R loops: from transcription byproducts to threats to genome stability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2012; 46(2):115-24; PMID:22541554; http://dx.doi.org/10.1016/j.molcel.2012.04.009 [113] Tuduri S, Crabb /C19e L, Conti C, Tourri /C18ere H, Holtgreve-Grez H, Jauch A, Pantesco V, De Vos J, Thomas A, Theillet C, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Cell Biol 2009; 11(11):1315-24; PMID:19838172; http://dx.doi.org/10.1038/ncb1984 [114] Bermejo R, Capra T, Gonzalez-Huici V, Fachinetti D, Cocito A, Natoli G, Katou Y, Mori H, Kurokawa K, Shirahige K, et al.Genome-organizing factors Top2 and Hmo1 prevent chromosomefragility at sites of S phase transcription.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2009; 138(5):870-84; PMID:19737516; http://dx.doi.org/10.1016/j.cell.2009.06.022 [115] Bermejo R, Capra T, Jossen R, Colosio A, Frattini C, Carotenuto W, Cocito A, Doksani Y, Klein H, G /C19omez-Gonz /C19alez B, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2011; 146(2):233-46; PMID:21784245; http://dx.doi.org/10.1016/j.cell.2011.06.033 [116] Durkin SG, Glover TW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Annu Rev Genet 41, 169-92; PMID:17608616; http://dx.doi.org/10.1146/annurev.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Hum Mol Genet 2009; 18(23):4501-12; PMID:19717471; http://dx.doi.org/10.1093/hmg/ddp410 [120] Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Cancer Lett 2006; 232(1):48-57; PMID:16221525; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Trends Genet 2012; 28(1):22-32; PMID:22094264; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Mol Life Sci2014; 71(23):4489-94; PMID:25248392; http://dx.doi.org/10.1007/ s00018-014-1720-2 [124] Ozeri-Galai E, Tur-Sinai M, Bester AC, Kerem B.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Mol Life Sci 2014; 71(23):4495-506; PMID:25297918; http://dx.doi.org/10.1007/s00018-014-1719-8 [125] Sarni D, Kerem B.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Curr Opin Cell Biol 40, 131-6; PMID:27062332; http://dx.doi.org/10.1016/j.ceb.2016.03.017 [126] Miotto B, Ji Z, Struhl K. (2016) Selectivity of ORC binding sites and the relation to replication timing, fragile sites, and deletions in can-cers.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2011; 44(6):966-77; PMID:22195969; http://dx.doi.org/10.1016/j.molcel.2011.10.013 [128] Wilson TE, Arlt MF, Park SH, Rajendran S, Paulsen M, Ljungman M, Glover TW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Genome Res 2015; 25(2):189-200; PMID:25373142; http://dx.doi.org/10.1101/gr.177121.114 [129] Gros J, Kumar C, Lynch G, Yadav T, Whitehouse I, Remus D. Post- licensing Speci ﬁcation of Eukaryotic Replication Origins by Facili- tated Mcm2-7 Sliding along DNA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2015; 60(5):797-807;PMID:26656162; http://dx.doi.org/10.1016/j.molcel.2015.10.022 [130] Snyder M, Sapolsky RJ, Davis RW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol 1988; 8(5):2184-94; PMID:3290652;http://dx.doi.org/10.1128/MCB.8.5.2184 [131] Looke M, Reimand J, Sedman T, Sedman J, J €arvinen L, V €arv S, Peil K, Kristjuhan K, Vilo J, Kristjuhan A. Relicensing of transcription-ally inactivated replication origins in budding yeast.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Biol Chem2010; 285(51):40004-11; PMID:20962350; http://dx.doi.org/ 10.1074/jbc.M110.148924 [132] Miron K, Golan-Lev T, Dvir R, Ben-David E, Kerem B. Oncogenes create a unique landscape of fragile sites.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Commun 2015; 6,7094; PMID:25959793; http://dx.doi.org/10.1038/ncomms8094 [133] Miron K, Kerem B.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Oncol 2016; 3(1):e1072657; PMID:27308576; http://dx.doi.org/10.1080/23723556.2015.1072657 [134] Barlow JH, Faryabi RB, Call /C19en E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Cell 2013; 152(3):620-32; PMID:23352430; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
PLoS Genet 2013; 9(7):e1003643; PMID:23874235; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2014; 204(2):165-75; PMID:24421333; http://dx.doi.org/10.1083/jcb.201306023 [137] Mankouri HW, Huttner D, Hickson ID.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO J 2013; 32(20):2661- 71; PMID:24065128; http://dx.doi.org/10.1038/emboj.2013.211 [138] Hossain M, Stillman B. Meier-Gorlin syndrome mutations disrupt an Orc1 CDK inhibitory domain and cause centrosome reduplica- tion.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Nucleic Acids Res 2011; 39(14):5935-44; PMID:21459848; http://dx.doi.org/10.1093/nar/gkr187628 M. FRAGKOS AND V. NAIM,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Cell Biol 2004; 6 (9):884-91; PMID:15311285; http://dx.doi.org/10.1038/ncb1165 [143] Chan KL, Hickson ID.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Semin Cell Dev Biol 2011; 22(8):906- 12; PMID:21782962; http://dx.doi.org/10.1016/j.semcdb.2011.07.001 [144] Biebricher A, Hirano S, Enzlin JH, Wiechens N, Streicher WW, Huttner D, Wang LH, Nigg EA, Owen-Hughes T, Liu Y, et al.PICH: a DNA translocase specially adapted for processing anaphasebridge DNA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2014; 204(1):45- 59; PMID:24379413; http://dx.doi.org/10.1083/jcb.201305157 [146] Liu Y, Nielsen CF, Yao Q, Hickson ID.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Curr Opin Genet Dev 2014; 26, 1-5; PMID:24795279; http://dx.doi.org/10.1016/j.gde.2014.03.003 [147] Nasmyth K, Haering CH.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Annu Rev Genet 2009; 43, 525-58; PMID:19886810; http://dx.doi.org/10.1146/annurev-genet-102108-134233 [148] Wang LH, Schwarzbraun T, Speicher MR, Nigg EA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Chromosoma 2008; 117(2):123-35; PMID:17989990; http://dx.doi.org/10.1007/s00412-007-0131-7 [149] Wang LH, Mayer B, Stemmann O, Nigg EA.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Sci 2010; 123(Pt 5):806-13; PMID:20144989; http://dx.doi.org/10.1242/jcs.058255 [150] Bare ﬁeld C, Karlseder J.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2012; 40(15):7358-67; PMID:22576367; http://dx.doi.org/10.1093/nar/gks407 [151] d ’Alcontres MS, Palacios JA, Mejias D, Blasco MA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Cycle 2014; 13(9):1463-81; PMID:24626180; http://dx.doi.org/10.4161/cc.28419 [152] Nera B, Huang HS, Lai T, Xu L. Elevated levels of TRF2 induce telo- meric ultra ﬁne anaphase bridges and rapid telomere deletions.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Commun 2015; 6, 10132; PMID:26640040; http://dx.doi.org/10.1038/ncomms10132 [153] Zaaijer S, Shaikh N, Nageshan RK, Cooper JP.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Rep 2016; 16(1):148-60; PMID:27320927; http://dx.doi.org/10.1016/j.celrep.2016.05.077 [154] Sofueva S, Osman F, Lorenz A, Steinacher R, Castagnetti S, Ledesma J, Whitby MC.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2011; 39(15):6568-84; PMID:21576223; http://dx.doi.org/10.1093/nar/gkr340 [155] Martinez P, Thanasoula M, Mu ~noz P, Liao C, Tejera A, McNees C, Flores JM, Fern /C19andez-Capetillo O, Tarsounas M, Blasco MA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"EMBO J 2011; 30(16):3309-21; PMID:21743438; http://dx.doi.org/10.1038/emboj.2011.226[157] Kaulich M, Cubizolles F, Nigg EA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Chromosoma2012; 121(4):395-408; PMID:22527115; http://dx.doi.org/10.1007/s00412-012-0370-0 [158] Nielsen CF, Huttner D, Bizard AH, Hirano S, Li TN, Palmai-Pallag T, Bjerregaard VA, Liu Y, Nigg EA, Wang LH.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Cycle 2016; 15(20):2704-11; PMID:27565185; http://dx.doi.org/ 10.1080/15384101.2016.1222336 [160] Broderick R, Nieminuszczy J, Blackford AN, Winczura A, Niedz- wiedz W. TOPBP1 recruits TOP2A to ultra- ﬁne anaphase bridges to aid in their resolution.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Commun 2015; 6, 6572; PMID:25762097; http://dx.doi.org/10.1038/ncomms7572 [161] Vinciguerra P, Godinho SA, Parmar K, Pellman D, D ’Andrea AD.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Clin Invest 2010; 120(11):3834-42; PMID:20921626; http://dx.doi.org/10.1172/JCI43391 [162] Mattarocci S, Hafner L, Lezaja A, Shyian M, Shore D. Rif1: A Con- served Regulator of DNA Replication and Repair Hijacked by Telo-meres in Yeasts.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Front Genet 2016; 7, 45; PMID:27066066; http://dx.doi.org/10.3389/fgene.2016.00045 [163] Hengeveld RC, de Boer HR, Schoonen PM, de Vries EG, Lens S M ,v a nV u g tM A .R i f 1I sR e q u i r e df o rR e s o l u t i o no fU l t r a ﬁne DNA Bridges in Anaphase to Ensure Genomic Stability.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Dev Cell 2015; 34(4):466-74; PMID:26256213; http://dx.doi.org/ 10.1016/j.devcel.2015.06.014 [164] Rodrigue A, Coulombe Y, Jacquet K, Gagn /C19e JP, Roques C, Gobeil S, Poirier G, Masson JY.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Sci 2013; 126(Pt 1):348-59; PMID:23108668; http://dx.doi.org/10.1242/jcs.114595 [165] Galgoczy DJ, Toczyski DP.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol 2001; 21(5):1710-8; PMID:11238908; http://dx.doi.org/ 10.1128/MCB.21.5.1710-1718.2001 [166] Syljuasen RG, Jensen S, Bartek J, Lukas J.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cancer Res 2006; 66(21):10253-7; PMID:17079442; http://dx.doi.org/10.1158/0008-5472.CAN-06-2144 [167] Yoo HY, Kumagai A, Shevchenko A, Shevchenko A, Dunphy WG.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2004; 117(5):575-88; PMID:15163406; http://dx.doi.org/10.1016/S0092-8674 (04)00417-9 [168] Eykelenboom JK, Harte EC, Canavan L, Pastor-Peidro A, Calvo- Asensio I, Llorens-Agost M, Lowndes NF.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Rep 2013; 5(4):1095-107; PMID:24268773; http://dx.doi.org/10.1016/j.celrep.2013.10.027 [169] Torres-Rosell J, De Piccoli G, Cordon-Preciado V, Farmer S, Jarmuz A, Machin F, Pasero P, Lisby M, Haber JE, Arag /C19on L. Anaphase onset before complete DNA replication with intact checkpoint responses.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2007; 315(5817):1411-5; PMID:17347440; http://dx.doi.org/10.1126/science.1134025 [170] Bogliolo M, Surralles J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Curr Opin GenetDev 2015; 33, 32-40; PMID:26254775; http://dx.doi.org/10.1016/j.gde.2015.07.002 [171] C eccaldi R, Sarangi P, D ’Andrea AD.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Mol Cell Biol2016; 17(6):337-49; PMID:27145721; http://dx.doi.org/10.1038/nrm.2016.48 [172] Bluteau D, Masliah-Planchon J, Clairmont C, Rousseau A, Ceccaldi R, Dubois d ’Enghien C, Bluteau O, Cuccuini W, Gachet S, Peffault de Latour R, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Clin Invest 2016; 126(9):3580-4; PMID:27500492; http://dx.doi.org/10.1172/JCI88010 [173] Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51- BRCA1/2.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2013; 51(5):678-90; PMID:23993743; http://dx.doi.org/10.1016/j.molcel.2013.07.023 [175] Sirbu BM, McDonald WH, Dungrawala H, Badu-Nkansah A, Kava- naugh GM, Chen Y, Tabb DL, Cortez D. Identi ﬁcation of proteins at active, stalled, and collapsed replication forks using isolation ofproteins on nascent DNA (iPOND) coupled with mass spectrome- try.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2015; 58(2):323-38; PMID:25843623; http://dx.doi.org/10.1016/j.molcel.2015.02.031 [177] Shigechi T, Tomida J, Sato K, Kobayashi M, Eykelenboom JK, Pes- sina F, Zhang Y, Uchida E, Ishiai M, Lowndes NF, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cancer Res 2012; 72(5):1149-56; PMID:22258451; http://dx.doi.org/10.1158/0008-5472.CAN-11-2904 [178] Tomida J, Itaya A, Shigechi T, Unno J, Uchida E, Ikura M, Masuda Y, M a t s u d aS ,A d a c h iJ ,K o b a y a s h iM ,e ta l .An o v e li n t e r p l a yb e t w e e nthe Fanconi anemia core comple x and ATR-ATRIP kinase during DNA cross-link repair.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2013; 41(14):6930-41; PMID:23723247; http://dx.doi.org/10.1093/nar/gkt467 [179] Stirling PC, Hieter P. Canonical DNA Repair Pathways In ﬂuence R- Loop-Driven Genome Instability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2015; 57(4):636-47; PMID:25699710; http://dx.doi.org/10.1016/j.molcel.2015.01.011 [181] Bhatia V, Barroso SI, Garc /C19ıa-Rubio ML, Tumini E, Herrera- Moyano E, Aguilera A. BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2014;511(7509):362-5; PMID:24896180; http://dx.doi.org/10.1038/ nature13374 [182] Garcia-Rubio ML, P /C19erez-Calero C, Barroso SI, Tumini E, Herrera- Moyano E, Rosado IV, Aguilera A.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
PLoS Genet 2015; 11(11): e1005674; PMID:26584049; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2015; 60(3):351-61;PMID:26593718; http://dx.doi.org/10.1016/j.molcel.2015.09.012 [184] Howlett NG, Taniguchi T, Durkin SG, D ’Andrea AD, Glover TW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cell 2016; 64(2):388-404; PMID:27768874; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2013; 41(13):6444-59;PMID:23658231; http://dx.doi.org/10.1093/nar/gkt348 [188] Deans AJ, West SC.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cell 2009; 36(6):943-53; PMID:20064461; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Annu Rev Biochem2008; 77, 259-87; PMID:18518821; http://dx.doi.org/10.1146/ annurev.biochem.77.070306.102408 [190] Hanada K, Budzowska M, Davies SL, van Drunen E, Onizawa H, Beverloo HB, Maas A, Essers J, Hickson ID, Kanaar R. The struc-ture-speci ﬁc endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Struct Mol Biol 2007; 14(11):1096-104; PMID:17934473; http://dx.doi.org/10.1038/nsmb1313 [191] Guervilly JH, Takedachi A, Naim V, Scaglione S, Chawhan C, Lovera Y, Despras E, Kuraoka I, Kannouche P, Rosselli F, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2015; 57(1):123-37; PMID:25533188; http://dx.doi.org/10.1016/j.molcel.2014.11.014 [192] Ouyang J, Garner E, Hallet A, Nguyen HD, Rickman KA, Gill G, Smogorzewska A, Zou L. Noncovalent interactions with SUMO andubiquitin orchestrate distinct functions of the SLX4 complex in genome maintenance.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cell 2015; 57(1):108-22; PMID:25533185; http://dx.doi.org/10.1016/j.molcel.2014.11.015 [193] Kim Y. Nuclease delivery: versatile functions of SLX4/FANCP in genome maintenance.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cells 2014; 37(8):569-74; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 2013; 41(4):2328-39; http://dx.doi.org/10.1093/nar/gks1442 [195] Luebben SW, Kawabata T, Johnson CS, O ’Sullivan MG, Shima N. A concomitant loss of dormant origins and FANCC exacerbatesgenome instability by impairing DNA replication fork progression.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"PLoS Genet 2015; 11(7):e1005384; PMID:26181065; http://dx.doi.org/10.1371/journal.pgen.1005384 [197] Malkova A, Ira G. Break-induced replication: functions and molec- ular mechanism.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Curr Opin Genet Dev 2013; 23(3):271-9;PMID:23790415; http://dx.doi.org/10.1016/j.gde.2013.05.007 [198] Anand RP, Lovett ST, Haber JE.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cold Spring Harb Perspect Biol 2013; 5(12):a010397;PMID:23881940; http://dx.doi.org/10.1101/cshperspect.a010397 [199] Lydeard JR, Jain S, Yamaguchi M, Haber JE.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2007; 448(7155):820-3; PMID:17671506; http://dx.doi.org/10.1038/nature06047 [200] Costantino L, Sotiriou SK, Rantala JK, Magin S, Mladenov E, Helle- day T, Haber JE, Iliakis G, Kallioniemi OP, Halazonetis TD.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2014; 343(6166):88-91; PMID:24310611; http://dx.doi.org/10.1126/science.1243211 [201] Lahkim Bennani-Belhaj K, Rouzeau S, Buhagiar-Labarch /C18ede G, Chabosseau P, Onclercq-Delic R, Bayart E, Cordeli /C18eres F, Couturier J, Amor-Gu /C19eret M. The Bloom syndrome protein limits the lethality associated with RAD51 de ﬁciency.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Can- cer Res 2010; 8(3):385-94; PMID:20215422; http://dx.doi.org/10.1158/1541-7786.MCR-09-0534 [202] Heijink AM, Krajewska M, van Vugt MA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mutat Res 2013; 750(1-2):45-55; PMID:23880065; http://dx.doi.org/10.1016/j.mrfmmm.2013.07.003630 M. FRAGKOS AND V. NAIM,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol2010; 190(2):197-207; PMID:20660628; http://dx.doi.org/10.1083/jcb.200911156 [204] Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, Escribano-Diaz C, Durocher D. Mitosis inhib-its DNA double-strand break repair to guard against telomere fusions.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2010; 37(5):690-701; PMID:20227372; http://dx.doi.org/10.1016/j.molcel.2010.02.008 [206] Matos J, West SC.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"DNA Repair (Amst) 2014; 19, 176-81; PMID:24767945; http://dx.doi.org/10.1016/j.dnarep.2014.03.013 [207] Neelsen KJ, Zanini IM, Herrador R, Lopes M. Oncogenes induce genotoxic stress by mitotic processing of unusual replication inter-mediates.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"PLoS Genet 2012; 8(9):e1002979; PMID:23071463; http://dx.doi.org/10.1371/journal.pgen.1002979 [209] Ho CK, Maz /C19on G, Lam AF, Symington LS.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2010; 40(6):988-1000; PMID:21172663; http://dx.doi.org/10.1016/j.molcel.2010.11.016 [210] Mayle R, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Oncol 2016; 3(2):e1008297; PMID:27308578; http://dx.doi.org/10.1080/23723556.2015.1008297 [212] Knipscheer P, R €aschle M, Smogorzewska A, Enoiu M, Ho TV, Sch€arer OD, Elledge SJ, Walter JC.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Science 2009; 326(5960):1698-701; PMID:19965384; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Microbiol Mol Biol Rev 2009; 73(1):134-54; PMID:19258535; http://dx.doi.org/10.1128/MMBR.00034-08 [214] Friedberg EC.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Mol Cell Biol 2005; 6(12):943-53; PMID:16341080; http://dx.doi.org/10.1038/nrm1781 [215] Branzei D, Szakal B. DNA damage tolerance by recombination: Molecular pathways and DNA structures.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"DNA Repair (Amst) 2016; 44, 68-75; PMID:27236213; http://dx.doi.org/10.1016/j.dnarep.2016.05.008 [216] Goodman MF, Woodgate R. Translesion DNA polymerases.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cold Spring Harb Perspect Biol 2013; 5(10):a010363; PMID:23838442; http://dx.doi.org/10.1101/cshperspect.a010363 [217] Kannouche PL, Wing J, Lehmann AR.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2004; 14(4):491-500; PMID:15149598; http://dx.doi.org/10.1016/S1097-2765(04)00259-X [218] Chen X, Bosques L, Sung P, Kupfer GM.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Oncogene 2016; 35(1):22-34; PMID:25893307; http://dx.doi.org/10.1038/onc.2015.68 [219] Gallina I, Christiansen SK, Pedersen RT, Lisby M, Oestergaard VH.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"CellCycle 2016; 15(2):176-83; PMID:26701150; http://dx.doi.org/10.1080/15384101.2015.1128595 [220] Boyer AS, Grgurevic S, Cazaux C, Hoffmann JS.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Mol Biol 2013; 425(23):4767-81; PMID:24095858; http://dx.doi.org/10.1016/j.jmb.2013.09.022 [221] Baranovskiy AG, Lada AG, Siebler HM, Zhang Y, Pavlov YI, Tahirov TH.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Biol Chem 2012; 287(21):17281-7; PMID:22465957; http://dx.doi.org/10.1074/jbc.M112.351122 [222] Johnson RE, Prakash L, Prakash S. Pol31 and Pol32 subunits of yeast DNA polymerase delta are also essential subunits of DNApolymerase zeta.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Mol Cell 2015; 60(6):860-72; PMID:26669261; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Biomed Sci 2007; 14(4):491-7; PMID:17525869;http://dx.doi.org/10.1007/s11373-007-9175-1 [227] Harris SL, Levine AJ.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Oncogene 2005; 24(17):2899-908; PMID:15838523;http://dx.doi.org/10.1038/sj.onc.1208615 [228] Yaswen P, Campisi J. Oncogene-induced senescence pathways weave an intricate tapestry.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2007; 128(2):233-4; PMID:17254959; http://dx.doi.org/10.1016/j.cell.2007.01.005 [229] Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Nat Rev Mol Cell Biol 2011; 12(6):385-92; PMID:21527953; http://dx.doi.org/10.1038/nrm3115 [230] Fukasawa K. Oncogenes and tumour suppressors take on centro- somes.,Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"PLoS One 2011; 6(8):e22946; PMID:21853057; http://dx.doi.org/10.1371/journal.pone.0022946 [232] Moreno A, Carrington JT, Albergante L, Al Mamun M, Haa- gensen EJ, Komseli ES, Gorgoulis VG, Newman TJ, Blow JJ.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2012; 199(6):871-81; PMID:23229895;http://dx.doi.org/10.1083/jcb.201210040 [234] Zimmermann M, de Lange T. 53BP1: pro choice in DNA repair.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Trends Cell Biol 2014; 24(2):108-17; PMID:24094932; http://dx.doi.org/10.1016/j.tcb.2013.09.003 [235] Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2011; 333(6051):1895-8;PMID:21960636; http://dx.doi.org/10.1126/science.1210214 [236] Passerini V, Ozeri-Galai E, de Pagter MS, Donnelly N, Schmalbrock S, Kloosterman WP, Kerem B, Storchov /C19a Z.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Commun 2016; 7,10754; PMID:26876972; http://dx.doi.org/10.1038/ncomms10754 [237] Ohashi A, Ohori M, Iwai K, Nakayama Y, Nambu T, Morishita D, Kawamoto T, Miyamoto M, Hirayama T, Okaniwa M, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Commun 2015; 6, 7668; PMID:26144554; http://dx.doi.org/ 10.1038/ncomms8668CELL CYCLE 631",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Oncol 2015; 2(2):e976491; PMID:27308438; http://dx.doi.org/10.4161/23723556.2014.976491 [239] Nicholson JM, Cimini D. Link between aneuploidy and chromo- some instability.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mutat Res 2000; 455(1-2):81-95; PMID:11113469; http://dx.doi.org/10.1016/S0027- 5107(00)00065-8 [241] Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D. DNA breaks and chromosome pulverization from errors in mitosis.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2012; 482(7383):53-8; PMID:22258507; http://dx.doi.org/10.1038/nature10802 [242] Norden C, Mendoza M, Dobbelaere J, Kotwaliwale CV, Biggins S, Barral Y.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell2006; 125(1):85-98; PMID:16615892; http://dx.doi.org/10.1016/j.cell.2006.01.045 [243] Mendoza M, Norden C, Durrer K, Rauter H, Uhlmann F, Barral Y.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Cell Biol 2009; 11(4):477-83; PMID:19270692; http://dx.doi.org/10.1038/ncb1855 [244] Steigemann P, Wurzenberger C, Schmitz MH, Held M, Guizetti J, Maar S, Gerlich DW.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2009; 136(3):473-84; PMID:19203582; http://dx.doi.org/10.1016/j.cell.2008.12.020 [245] Amaral N, Vendrell A, Funaya C, Idrissi FZ, Maier M, Kumar A, Neurohr G, Colomina N, Torres-Rosell J, Geli MI, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Cell Biol 2016; 18 (5):516-26; PMID:27111841; http://dx.doi.org/10.1038/ncb3343 [246] Amaral N, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"PLoS One 2016; 11(1):e0147420; PMID:26784746; http://dx.doi.org/10.1371/journal.pone.0147420 [248] Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T, Kanda T. When, where and how the bridge breaks: anaphase bridge breakage plays a crucial role in gene ampli ﬁcation and HSR generation.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Exp Cell Res 2005; 302(2):233-43; PMID:15561104; http://dx.doi.org/10.1016/j.yexcr.2004.09.001 [249] Mackay DR, Ullman KS.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"ATR and a Chk1-Aurora B pathway coor- dinate postmitotic genome surveillance with cytokinetic abscission.Mol Biol Cell 2015; 26(12):2217-26; PMID:25904336; http://dx.doi.org/10.1091/mbc.E14-11-1563 [250] Jasencakova Z, Groth A. Replication stress, a source of epigenetic aberrations in cancer?",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Bioessays 2010; 32(10):847-55;PMID:20726011; http://dx.doi.org/10.1002/bies.201000055 [251] Jasencakova Z, Groth A.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Semin Cell Dev Biol 2010; 21(2):231-7; PMID:19815085; http://dx.doi.org/10.1016/j.semcdb.2009.09.018 [252] Dabin J, Fortuny A, Polo SE.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2016; 62(5):712-27; PMID:27259203; http://dx.doi.org/10.1016/j.molcel.2016.04.006 [253] Alabert C, Groth A. Chromatin replication and epigenome mainte- nance.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Mol Cell Biol 2012; 13(3):153-67; PMID:22358331; http://dx.doi.org/10.1038/nrm3288 [254] Khurana S, Oberdoerffer P. Replication Stress: A Lifetime of Epige- netic Change.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2010; 40(5):703-13; PMID:21145480; http://dx.doi.org/10.1016/j.molcel.2010.11.009 [256] Jasencakova Z, Scharf AN, Ask K, Corpet A, Imhof A, Almouzni G, Groth A. Replication stress interferes with histone recycling andpredeposition marking of new histones.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell 2010; 37(5):736- 43; PMID:20227376; http://dx.doi.org/10.1016/j.molcel.2010.01.033 [257] Saveliev A, Everett C, Sharpe T, Webster Z, Festenstein R. DNA triplet repeats mediate heterochromatin-protein-1-sensitive varie- gated gene silencing.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature 2003; 422(6934):909-13; PMID:12712207; http://dx.doi.org/10.1038/nature01596 [258] Nyce J, Liu L, Jones PA.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nucleic Acids Res 1986; 14(10):4353-67; PMID:3086840; http://dx.doi.org/10.1093/nar/14.10.4353 [259] Tran V, Lim C, Xie J, Chen X, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Science 2012; 338(6107):679-82; PMID:23118191; http://dx.doi.org/10.1126/science.1226028 [260] Gaillard H, Garc /C19ıa-Muse T, Aguilera A, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nat Rev Cancer 2015; 15(5):276-89; PMID:25907220; http://dx.doi.org/10.1038/nrc3916 [261] Burrow AA, Williams LE, Pierce LC, Wang YH, et al.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"BMC Genomics 2009; 10, 59; PMID:19183484; http://dx.doi.org/10.1186/1471-2164-10-59 [262] Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Nature2010; 463(7283):893-8; PMID:20164919; http://dx.doi.org/ 10.1038/nature08768 [263] Le Tallec B, Millot GA, Blin ME, Brison O, Dutrillaux B, Debatisse M. Common fragile site pro ﬁling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites host- ing large genes.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Annu Rev Pathol 2015; 10, 425-48; PMID:25621662; http://dx.doi.org/10.1146/annurev-pathol-012414-040424 [265] Ma K, Qiu L, Mrasek K, Zhang J, Liehr T, Quintana LG, Li Z. Com- mon fragile sites: genomic hotspots of DNA damage and carcino- genesis.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell Mol Life Sci 2014; 71 (23):4601-15; PMID:25300511; http://dx.doi.org/10.1007/s00018- 014-1753-6 [267] Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.Cell 1996; 84(4):587-97; PMID:8598045; http://dx.doi.org/10.1016/ S0092-8674(00)81034-X [268] Waters CE, Saldivar JC, Hosseini SA, Huebner K. The FHIT gene product: tumor suppressor and genome “caretaker.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"”Cell Mol Life Sci 2014; 71(23):4577-87; PMID:25283145; http://dx.doi.org/ 10.1007/s00018-014-1722-0 [269] Bednarek AK, Keck-Waggoner CL, Daniel RL, La ﬂin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"2014; 46(6):588-94; PMID:24793136; http://dx.doi.org/10.1038/ ng.2981 [273] Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene ampli ﬁ- cation and sets boundaries to early amplicons.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 1997; 89(2):215- 25; PMID:9108477; http://dx.doi.org/10.1016/S0092-8674(00)80201-9 [274] Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, Mayau V, El Marhomy S, Guardiola J, Bernheim A, Coullin P, et al.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Hum Mol Genet 2002; 11 (23):2887-94; PMID:12393800; http://dx.doi.org/10.1093/hmg/ 11.23.2887 [275] Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cancer Cell 2002; 1(1):89-97; PMID:12086891; http://dx.doi.org/10.1016/S1535-6108(02)00017-X [276] Mazouzi A, Velimezi G, Loizou JI.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
Exp Cell Res 2014; 329(1):85-93; PMID:25281304; http://dx.doi.org/10.1016/j.yexcr.2014.09.030 [277] Constantinou A.,OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Fragile sites and chromo- some instability: the distribution of breaks induced by cis-diamine- dichloro-platinum (II) in Fanconi anemia lymphocyte cultures.Hum Genet 1991; 86(3):256-60; PMID:1997377; http://dx.doi.org/10.1007/BF00202404 [279] Fundia A, Gorla N, Larripa I. Spontaneous chromosome aberra- tions in Fanconi ’s anemia patients are located at fragile sites and acute myeloid leukemia breakpoints.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Hereditas 1994; 120(1):47-50; PMID:8206783; http://dx.doi.org/10.1111/j.1601-5223.1994.00047.x[280] Schoder C, Liehr T, Velleuer E, Wilhelm K, Blaurock N, Weise A, Mrasek K. New aspects on chromosomal instability: chromosomalbreak-points in Fanconi anemia patients co-localize on the molecu-lar level with fragile sites.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cytogenet 2016; 9(1):70; PMID:27625703;http://dx.doi.org/10.1186/s13039-016-0280-6 [282] Pawlikowska P, Fouchet P, Vainchenker W, Rosselli F, Naim V. Defective endomitosis during megakaryopoiesis leads to thrombo- cytopenia in Fanca-/- mice.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Blood 2014; 124(24):3613-23;PMID:25261197; http://dx.doi.org/10.1182/blood-2014-01-551457 [283] Mohaghegh P, Hickson ID.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Hum Mol Genet 2001; 10(7):741-6; PMID:11257107; http://dx.doi.org/10.1093/hmg/10.7.741 [284] Pirzio LM, Pichierri P, Bignami M, Franchitto A. Werner syndrome helicase activity is essential in maintaining fragile site stability.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"J Cell Biol 2008; 180(2):305-14; PMID:18209099; http://dx.doi.org/10.1083/jcb.200705126 [285] Wei PC, Chang AN, Kao J, Du Z, Meyers RM, Alt FW, Schwer B.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Cell 2016; 164(4):644-55; PMID:26871630;http://dx.doi.org/10.1016/j.cell.2015.12.039 [286] Yuce O, West SC.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"Mol Cell Biol2013; 33(2):406-17; PMID:23149945; http://dx.doi.org/10.1128/ MCB.01195-12 [287] Andriani GA, Vijg J, Montagna C. Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain.",OADS,/arxiv_data1/oa_pdf/ed/e5/kccy-16-07-1288322.PMC5397263.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES Volume 27, Number 4, 2017Mary Ann Liebert, Inc.DOI: 10.1089/lap.2016.0576 375",Non-OADS,/arxiv_data1/oa_pdf/18/c1/lap.2016.0576.PMC5397272.pdf
"https://doi.org/10.1177/1176935117702878 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Cancer Informatics Volume 16: 1–6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176935117702878 Introduction Glioma is a type of primary brain neoplasm derived from neu- roglial cells.",Non-OADS,/arxiv_data1/oa_pdf/9c/58/10.1177_1176935117702878.PMC5397276.pdf
Materials and Methods miRNA expression data sets MicroRNA expression data from LGG patient samples were  obtained from The Cancer Genome Atlas (TCGA) database (http://gdc-portal.nci.nih.gov).,OADS,/arxiv_data1/oa_pdf/9c/58/10.1177_1176935117702878.PMC5397276.pdf
"https://doi.org/10.1177/1177271917702895 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Biomarker Insights Volume 12: 1–12 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177271917702895 Introduction Acute lymphoblastic leukemia (ALL) is the most common  childhood cancer and the leading cause of cancer-related death in children in the United States.",Non-OADS,/arxiv_data1/oa_pdf/52/84/10.1177_1177271917702895.PMC5397277.pdf
"Redwood, CA: Ingenuity Systems, Inc.  http://www.ingenuity.com/ .",Non-OADS,/arxiv_data1/oa_pdf/52/84/10.1177_1177271917702895.PMC5397277.pdf
Release 7.1.June 2016.  http://www.targetscan.org/vert_71/.,Non-OADS,/arxiv_data1/oa_pdf/52/84/10.1177_1177271917702895.PMC5397277.pdf
"https://doi.org/10.1177/1178630217703390 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Environmental Health Insights Volume 11: 1–14 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178630217703390 Introduction Pesticides can reduce crop losses in farming, but improper use  of pesticides can result in the development of pest resistance and have negative impacts on human health and the ecosys-tem.",Non-OADS,/arxiv_data1/oa_pdf/88/a2/10.1177_1178630217703390.PMC5397278.pdf
"Washington, DC: International Food  Policy Research Institute; 2010. http://www.ifpri.org/publication/impact-farmer-field-schools-agricultural-productivity-and-poverty-east-africa.",Non-OADS,/arxiv_data1/oa_pdf/88/a2/10.1177_1178630217703390.PMC5397278.pdf
"https://doi.org/10.1177/1176935117702389 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Cancer Informatics Volume 16: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176935117702389 Introduction In recent years, there has been considerable interest in estimat- ing causal relationships between random variables in a graphi-cal framework.",Non-OADS,/arxiv_data1/oa_pdf/d2/ea/10.1177_1176935117702389.PMC5397279.pdf
can be downloaded from http://science.sciencemag.org/content/suppl/2005/   04/21/308.5721.523.DC1.,Non-OADS,/arxiv_data1/oa_pdf/d2/ea/10.1177_1176935117702389.PMC5397279.pdf
TCGA ovarian cancer data can be downloaded via TCGA data portal https://tcga-data.nci.nih.gov.,OADS,/arxiv_data1/oa_pdf/d2/ea/10.1177_1176935117702389.PMC5397279.pdf
"https://doi.org/10.1177/1177271917704193 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Biomarker Insights Volume 12: 1–6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177271917704193 Introduction The urokinase-type plasminogen activator receptor (uPAR) is  present on immune cells and certain tumor cells.1 It is a mem- brane-bound receptor that mediates cellular adhesion, differ-entiation, migration, and proliferation.",Non-OADS,/arxiv_data1/oa_pdf/e8/67/10.1177_1177271917704193.PMC5397280.pdf
"https://doi.org/10.1177/1178630217703391 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Environmental Health Insights Volume 11: 1–10 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178630217703391 Introduction Synthetic pesticides are widely used to control pests in agricul- ture.",Non-OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
http://www.fao.org/agriculture/crops/ thematic-sitemap/theme/pests/ipm/en/.,Non-OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
http://www.fao.org/agriculture/crops/thematic-sitemap/theme/ pests/ipm/more-ipm/en/.,Non-OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
http://countrystat.org/home.aspx?c=UGA&tr=1.,Non-OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
http://www.ubos.org.,Non-OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
http://faostat.fao.org/site/423/DesktopDefault.aspx?PageID=423-ancor.,Non-OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
http://www.fao.org/faostat/en/#data/RT.,OADS,/arxiv_data1/oa_pdf/a4/8e/10.1177_1178630217703391.PMC5397281.pdf
"https://doi.org/10.1177/1179172117701742 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Ophthalmology and Eye Diseases Volume 9: 1–3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179172117701742 Prof Lalit Prakash Agarwal was a visionary who planned the  first-ever blindness control program of the world.",Non-OADS,/arxiv_data1/oa_pdf/51/f9/10.1177_1179172117701742.PMC5397293.pdf
"Agarwal, and her website http://www.drkavitasharma.org/ for valuable information and support.",Non-OADS,/arxiv_data1/oa_pdf/51/f9/10.1177_1179172117701742.PMC5397293.pdf
http://www.drkavitasharma.org/family.html.,Non-OADS,/arxiv_data1/oa_pdf/51/f9/10.1177_1179172117701742.PMC5397293.pdf
https://www.youtube.com/watch?v=2FP4f8TrePQ.,Non-OADS,/arxiv_data1/oa_pdf/51/f9/10.1177_1179172117701742.PMC5397293.pdf
http://www.aiims.edu/en/history-and-evolution.html.,Non-OADS,/arxiv_data1/oa_pdf/51/f9/10.1177_1179172117701742.PMC5397293.pdf
